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Abstract
Glycolytic Flux Control of Glyceraldehyde 3-Phosphate
Dehydrogenase in Yeast
J.C.W. Odendaal
Department of Biochemistry,
University of Stellenbosch,
Private Bag X1, Matieland 7602, South Africa.
Thesis: MSc (Biochemistry)
December 2019
To save precious experimental time and resources and to gain a deeper 
understanding of living systems, modelling approaches and systems biological 
tools like Metabolic Control Analysis (MCA) offer the opportunity to analyse 
these systems at the level of integrated reaction networks. These tools can aid 
in the discovery of promising industrial and pharmaceutical metabolic targets.
In addition, modelling promises to reduce duplication of work by allowing 
for the integration of existing models into larger networks that have extended 
predictive capacity. This is known as the modular approach to model 
construction.
A cornerstone of the modular approach to metabolic modelling is that 
model expansion increases the predictive abilities of a given model instead of 
just changing it to describe a new, narrow set of behaviours. Glycolysis - a 
ubiquitous pathway responsible for glucose catabolism - was probably the first 
metabolic pathway to be modelled and a history of iterative model expansion 
is now starting to take shape based on this model.
The model by Teusink et al. [1] and its descendent by Du Preez et 
al. [2] are two existing glycolytic models of Saccharomyces cerevisiae that 
represent such an expansion. Du Preez and colleagues adapted the steady-state 
Teusink model in silico to describe glycolytic oscillations. This presents a good 
opportunity to test whether the adjustment expanded the model’s predictive 
capacity or just changed it to a new, narrow set of behaviours.
Iodoacetic acid (IAA), a specific, irreversible inhibitor of glyceraldehyde
3-phosphate dehydrogenase (GAPDH), was used to perturb yeast glycolysis
for the calculation of the glycolytic flux control coefficient of GAPDH. The
ii
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ability of the model to correctly predict the flux control of GAPDH would be
a validation of the model.
We found that both the Teusink and the Du Preez models predicted the
glycolytic control of GAPDH to be close to zero, which was in good agreement
with our experimental finding. Furthermore, the models could predict the
effect of larger perturbations of GAPDH reasonably well. This finding is also
exciting as it validates the usefulness of IAA as a chemical perturbant that can
be used to experimentally measure GAPDH’s glycolytic flux control, which
can be reapplied to other metabolic systems where it might have clinical or
industrial significance.
iii
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Uittreksel
Glikolise-fluksiekontrole van
Gliseraldehied-3-fosfaat-dehidrogenase in Gis
(“ Glycolytic Flux Control of Glyceraldehyde 3-Phosphate Dehydrogenase in Yeast”)
J.C.W. Odendaal
Departement Biochemie,
Universiteit van Stellenbosch,
Privaatsak X1, Matieland 7602, Suid-Afrika.
Tesis: MSc (Biochemie)
Desember 2019
Om kosbare eksperimentele tyd en hulpbronne te bespaar en om 
’n dieper begrip van lewende sisteme te bekom, bied modellering en 
sisteembiologiese middele die geleentheid om lewende sisteme op die vlak 
van geïntegreede-reaksienetwerke te analiseer. Dit kan help om belowende 
nywerheids- en farmaseutiese teikens in die metabolisme uit te lig.
Verder beloof modellering om herhaling van werk te verminder deur vir 
die integrasie van bestaande modelle in groter netwerke toe te laat - hierdie 
uitgebreide netwerke het dan ook uitgebreide voorspellingsvermoë. Dit staan 
bekend as die modulêre benadering tot modelkonstruksie.
’n Hoeksteen van die modulêre benadering to metabolismemodellering is 
dat modeluitbreiding die voorspellingsvermoë van ’n gegewe model verbeter 
en nie bloot aanpas tot ’n nuwe, noue stel metaboliese gedrag nie. Glikolise -
’n algemene padweg verantwoordelik vir glukoseafbraak - was waarskynlik die 
eerste gemodelleerde padweg en ’n geskiedenis van herhaalde modeluitbreiding 
is aan’t groei gebaseer op hierdie padweg..
Die model deur Teusink et al. [1] en sy afstammeling deur Du Preez 
et al. [2] is twee bestaande glikolisemodelle van Saccharomyces cerevisiae 
wat só ’n uitbreiding verteenwoordig. Du Preez en kollegas het die 
bestendige-toestand-model deur Teusink aangepas in silico om glikolitiese 
ossillasies te kan beskryf. Dit bied ’n goeie geleentheid vir ’n toets: is die 
model se voorspellingsvermoë uitgebrei, of bloot verstel na ’n nuwe, noue 
gedragsrepertoire?
iv
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Jodoasynsuur (IAA), ’n spesifieke, onomkeerbare inhibitor van
gliseraldehied-3-fosfaat dehidrogenase (GAPDH), is gebruik om gisglikolise te
perturbeer vir die berekening van die glikolisefluksie-kontrokontolekoëffisiënt
van GAPDH. Die vermoë om die fluksiekontrole van GAPDH akkuraat te
voorspel, sal ’n validering van die model wees.
Ons het bevind dat beide die Teusink- and die Du Preez-modelle voorspel
het dat die glikolisekontrole van GAPDH byna nul is, wat goed met ons
eksperimentele data ooreenstem. Verder, kon die modelle die effek van
groter perturbasies van GAPDH-aktiwiteit redelik goed voorspel. Dit is ’n
belowende bevinding, want dit valideer ook die nut van IAA as ’n chemiese
perturbasiemiddel wat eksperimenteel aangewend kan word om GAPDH se
glikolitiesefluksie-beheer te bepaal. Dít kan nou gebruik word in ander
metaboliese stelsels wat van kliniese of industriële belang is.
v
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Chapter 1
Introduction
Computational models offer biologists the ability to integrate component-level
knowledge into networks, elucidating systemic properties that might otherwise
have been hidden from view [4]. Metabolic models, especially, show promise as
helpful research tools, given that metabolic enzymes are readily isolated and
characterised, and that high flux rates are seen in vivo - these properties allow
us to easily measure their activity in the laboratory [5].
Glycolysis occupies a particularly relevant position within metabolism,
given its ubiquity and its position as the initial pathway in carbohydrate
catabolism in most organisms [6]. Accurate kinetic models of glycolysis
have historically been very important to the endeavour of molecular systems
biology as a model pathway for the development of the theoretical tools for
bottom-up systems biology: for instance, it was probably the first pathway
to be kinetically modelled [7] and the whole framework of Metabolic Control
Analysis (MCA) has, in large part, red blood-cell glycolysis to thank for its
existence [8].
Beyond its status as a model pathway, a better understanding of glycolysis
also has many important practical implications, for instance as the industrially
important pathway in alcoholic fermentation [9], and as drug target in the
blood-borne stages of Plasmodium falciparum (the causal agent of malaria;
10) and Tryposonoma brucei (responsible for African sleeping sickness; 11).
A major use of kinetic modelling and analysis tools, like MCA, is to direct
research and to avoid wasteful experimenting by, for instance, indicating where
to intervene in the metabolic network of a pathogen [12]. Fundamental to the
success of these predictions, is having models that are valid descriptors of
metabolism in the relevant cell, pathogenic or otherwise.
The process of validating computational models - within the Silicon Cell
paradigm [13] - lies beyond just investigating a model’s ability to simulate the
behaviour on which it was trained [14]. It is important that models are tested
for their ability to predict behaviour that they have not seen before, so that
"model construction and validation are completely separate" [5].
To avoid unnecessary duplication of modelling work, it is important to
1
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construct models that are re-usable, accurate representations of what is truly
happening in a cell. One of the advantages of re-using models is that the
process of adjusting them to new behaviours allows one to refine and improve
them with each new study, leading to complementary instead of duplicative
work [13]. The alternative is the construction of very specific models that
predict only a narrow range of behaviour for a particular organism at particular
conditions, which - even though this approach might be useful in certain
circumstances - would exponentially increase the amount of modelling work
that must be done [15].
One attempt to not duplicate glycolytic modelling work but rather to
iteratively refine an existing model, was the work of Du Preez et al. [2]
on glycolytic oscillations. They computationally adjusted an existing model
of glycolysis in S. cerevisiae which was originally constructed to predict
steady-state behaviour [1]. The adjusted model was then validated for its
ability to predict glycolytic oscillatory behaviour, implicitly verifying the
original model as flexible enough to describe at least one qualitatively new
behaviour without the need for complete re-parameterisation.
One of the ways of determining how accurate the models are, is to test their
ability to make correct predictions about metabolic behaviour to which they
have not been exposed before [16]. Core predictions (predictions that implicate
not just a single parameter but the entire set of parameters in a model) are
a powerful way of doing this [17]. Usually, models are adjusted to predict
the new behaviour, as was the case for Du Preez et al. [2]. If the process of
model expansion is carried out according to the Silicon Cell approach, each
new iteration of the model should improve on the ability of the original to
describe in vivo behaviour [18].
It is important, however, that the expansion of a model’s predictive
capacity does not strip the original model of its ability to predict the behaviours
for which it was designed - doing that would amount to the same duplicative,
ad hoc modelling approach that bottom-up systems biology strives to avoid
[15]. It is important that models, through the process of refinement, retain
some important network characteristics that relate the individual enzyme to
each other.
MCA offers a good framework for testing this. MCA allows systems
biologists to link observed systems-level metabolic phenomena directly to
component-level reactions [19]. The flux control coefficient, for instance,
quantifies the importance of a single step in maintaining the flux through a
pathway. The summation theorem - which states that all of the metabolic flux
control coefficients have a additive value of 1 - necessarily implicates the entire
pathway in a prediction about the flux control of a single step [20], rendering
it an effective core prediction for testing model validity [17].
In this study, we wanted to test whether the model by Du Preez et al.
[2] retained (or improved on) the ability of the original Teusink et al. [1]
model to predict the control of GAPDH over glycolytic flux. We used a
2
Stellenbosch University https://scholar.sun.ac.za
CHAPTER 1. INTRODUCTION
specific, irreversible inhibitor of glyceraldehyde 3-phosphate dehydrogenase
(GAPDH) to determine the glycolytic flux control coefficient of GAPDH in
Baker’s yeast. Iodoacetic acid (IAA) - known as one of the classical examples of
specific and irreversible enzyme inhibition [21–24] - allows us to incrementally
inhibit GAPDH activity. The relative change in flux over the relative change
in GAPDH activity is the flux control of GAPDH [25].
Beyond this, the irreversibility of IAA offers another opportunity. If an
inhibitor is administered to whole-cells and cell-free extract separately, the
observed inhibition might be confounded by additional unknowns, e.g. the
differences in intracellular availability of the inhibitor to the enzyme [26].
Since we lack clear kinetics describing this disparity, model simulations cannot
be adjusted to compensated for this difference. An irreversible inhibitor,
however, allows one to expose whole-cells to IAA and to use those same
cells for flux measurements and for making cell-free extract for enzyme
activity measurement. This hypothetically eliminates disparities in inhibitor
availability between flux and enzyme activity data.
The aims (each with their objectives sub-listed below them) of this study
were:
1. Optimise IAA administration conditions and method
a) confirm the irreversibility of IAA
b) determine the difference in measured activity in prelytically
inhibited cell-free extract versus extract that received IAA in vitro
c) test whether differences in intracellular en cell-extract redox
conditions can account for any disparities in measured activity
2. Experimentally determine the glycolytic flux control of GAPDH
a) independently measure the effect of a IAA titration on GAPDH
activity and glycolytic flux in yeast
b) determine the glycolytic flux control coefficient of GAPDH at [IAA]
= 0 µM
3. Analyse Du Preez and Teusink models for GAPDH flux control
predictions
a) adapt both models to simulate the conditions and the inhibition
mechanism used in the experiments
b) calculate glycolytic flux control of GAPDH as the relative inhibition
of glycolytic flux as a fraction of relative inhibition of GAPDH
c) compare the flux control predictions of both models to each other
and to the experimental data
3
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The aims listed above were constructed to test hypotheses about IAA as a
useful chemical perturbant for flux control coefficient calculation, and on the
success of Du Preez et al. [2] in their model expansion. The hypotheses tested,
in summary, will be:
• incubating cells in IAA before cell lysis allows the experimenter
to disregard the unknown variables contributing to IAA availability
involved when comparing flux perturbations and GAPDH activity
perturbations;
• the Du Preez and Teusink models both accurately predict the glycolytic
flux control that is seen experimentally;
• [2] succeeded in refining the Teusink model [1] for description of glycolytic
oscillations without seriously compromising its predictive ability with
regards to steady-state flux control.
4
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Chapter 2
Literature Review
2.1 What Does Systems Biology Do?
Systems biology aspires to understand how the interaction of molecules inside
cells can give rise to phenomena like metabolic rhythms, drug resistance, and
coordinated behaviour [27]. Understanding living organisms at this level would
open doors to several medical and biotechnological possibilities: the cell that
is understood at the molecular level can, potentially, also be manipulated at
the molecular level [28]. To understand systems at this level, however, large
amounts of reaction-level data need to be integrated: data which, for the best
part of the history of molecular biology, were arduous to come by [4].
The past quarter century, however, has seen a rapid expansion in the
data-generating capacity of molecular biology. The first fully sequenced
genome - that of the bacterium Haemophilus influenzae [29] - marked a
leap forward in our analytical abilities, culminating quickly in the complete
sequencing of the human genome in 2001 [30]. Long-standing investigations
into other levels of cellular organisation and function soon underwent
accelerations of their own, e.g. with the developments in proteomics [31],
metabolomics [32], and fluxomics [28].
The emergence of high-throughput experimental techniques have made
molecular biology a data-rich field. This has necessitated a move towards
modelling, theory, and simulation to make sense of the rapidly growing pool
of knowledge [4]. These modelling approaches can save valuable laboratory
time and resources (e.g. 33) and hold much promise as tools for accelerating
the discovery of mechanisms in cell functioning that can be engineered for
the benefit of humankind. Flux and concentration control distributions (see
Section 2.3), for instance, pinpoint targets that can be of medical value (as
potential drug targets in parasites and tumour cells) and of industrial value (as
control mechanisms to yield economically valuable metabolites more quickly
and in greater volumes; 25).
As it currently stands, modelling approaches can be loosely divided into
5
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the "top-down" and the "bottom-up" sort [4]. Both approaches provide a
means of integrating knowledge about biochemical components and their
structures, interactions, and functions, with a spatio-temporal description of
their behaviour. Top-down modelling (also known as "inverse modelling";
26) starts at the phenomenological level and attempts to infer responsible
mechanisms lower down in the causal chain. In contrast to this, bottom-up
modelling (or "forward modelling") tries to deductively infer functional
properties from detailed mechanistic descriptions of biochemical components
and their interactions [15].
Despite its labour-intensiveness and intolerance to unknowns, bottom-up
modelling is a powerful approach in that detailed knowledge about the
mechanistic properties of a system are the point of departure. Systemic
properties are then predicted from what is discovered about the building
blocks and their interactions, clearly linking the physiological phenomenology
to defined molecular mechanisms [34]. Top-down modelling, if left entirely
to its own devices, runs the risk of inventing parameter sets that perfectly
describe emergent phenomena under very specific conditions but translate not
at all to other milieus, resulting in a form of biological "stamp collecting" [15].
Another drawback of top-down models is that they are often very small (due
to the challenge of independently perturbing intracellular conditions) and that
the limited range of perturbations leads to very similar model construction
and validation data-sets - begging the question: "What is being validated?".
(16; also see Subsection 2.2.2 for more on model validation). The focus of
systems biology, after all, is not on merely being descriptive of biological
systems at given conditions but on allowing extrapolation to general principles
and qualitatively different behaviours [4]. Computational models based on
detailed mechanistic data are very useful in this regard, insofar as they serve
not only as an end point for model construction studies but often also as sources
of testable hypotheses for subsequent investigations [15]. Beyond that, an
integrative and iterative modelling approach has been shown to be a valuable
quality control tool for experimental data: an advantage that is unavailable to
purely experimental studies [35]. Such models then also have the advantage of
being available for integration into models of larger networks [13], as described
in Subsection 2.2.1.
2.2 The Silicon Cell
"Bioinformatic and computational approaches offer a means of obtaining
full value from experimentally acquired data, extending their interpretation,
suggesting novel hypotheses for future experiments, and guiding the
experimentalist towards potentially rewarding investigations but away from
likely fruitless ones" - Pritchard and Kell [33].
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2.2.1 Parameterising the Silicon Cell
The Silicon Cell initiative [5] aspires to create ever more inclusive replicas
of cellular systems based on detailed reaction kinetics. It builds on the
idea of bottom-up modelling [26] in that it is aimed at describing the
"whole" (metabolic phenotypes) by independently specifying the properties
of the "parts" (enzyme kinetics). The holy grail of this project is the
eventual construction of an accurate computational simulation of an organism’s
complete inner workings from accumulated experimentally determined
parameters [36]. Even if completion is not attainable, however, incremental
progress towards more and more comprehensive dynamic descriptions of
biological function provides a useful way of summarizing the "state of the art"
[27]. Models that are incomplete or not fully correct, mechanistically speaking,
can still have valuable predictive power: this predictive ability constitutes the
intermediate milestones on the way to the Silicon Cell [37].
Because of the number of individual reactions that constitute a cell’s
behaviour at a given metabolic state, individual research groups can,
realistically, only study small subsets of reactions at a time [13]. As
complex behaviours can often arise from collections of simple parts interacting
non-linearly, the impact of the parameters of a system can lead to non-obvious
system behaviour [38]. The independent measurement of in vitro enzyme
kinetics under standardised conditions is suggested to avoid interpretive bias
until the system is assembled [1].
Morohashi et al. [39] define two types of parameter: (A) those that
vary within an organism over the duration of its lifetime (e.g. regulated
gene-activity level, temperature, substrate and product concentrations) and
(B) those that remain constant within an organism but vary across individuals
or species (e.g. reaction rate constants). Parameters from class (B) are the
constants that are sought during parameterisation studies.
What do these parameters mean, however? It is very important, when
building a model, to choose the right level of detail at which to describe
the system. Top-down modelling approaches might infer phenomenological
descriptions (e.g. parameters that describe the collective behaviour of sets of
reactions as a single value) [15], while the bottom-up approach to metabolic
modelling requires more mechanistic parameters (i.e. parameters describing
actual physico-chemical properties of an enzyme).
Simplified, phenomenological descriptors of system behaviour often lead
to a restricted range of applicability, describing a property of an enzyme
that is only relevant under, for instance, starvation conditions, and is
actually a product of more fundamental, mechanistic characteristics [26];
detailed, mechanistic parameters, on the other hand, are often experimentally
inaccessible or excessively laborious to measure [10].
Phenomenological approximations of enzymatic properties provide a useful
way of circumventing overly stringent reductionistic requirements while still
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translating well between varying research questions [26]. "Convenience
kinetics", for instance, offers a biochemically justified way of approximating
mechanistic properties of enzymatic reactions when binding order is
inconsequential [40], while Rohwer et al. [41] posit a generic bi-substrate rate
equation with fewer, more easily determinable parameters but which still have
operational meaning.
Parameterisation approaches are also being facilitated by the development
of software tools for simulation and modelling. As the field of systems
biology matures, tools like these are becoming increasingly available: COPASI
(COmplex PAthway SImulator; 42), for instance, a biochemical simulator,
offers a user friendly parameter estimation functionality, which can accelerate
the process of determining, from experimental data, the Michaelis-Menten
parameters that form a part of many kinetic models (e.g. [1]).
Phenomenological approximations are useful and biochemically meaningful
descriptions of enzyme responses to changes in substrate and product
concentrations [41]. These parameters might not, however, be direct
descriptions of an enzyme’s mechanistic properties and might be subject to
change based on variations in their environment, such as pH and temperature
[6], ambient nutrient availability [43], or less intuitive intracellular factors like
macromolecular crowding [44]. Standardised conditions for determining these
parameters are, therefore, indispensable: differences in ambient conditions may
well lead to discrepancies in the behaviour of different enzymes in a single
model, or to disparity between different models of the same system [45].
Beyond standardisation, however, it is also necessary that the measured in
vitro parameters are valid descriptions of the in vivo properties of a cell. The
inside of a cell is a very complex environment, however: beyond the hundreds
of metabolites, the cytosol of an organism is occupied by a variety of proteins,
long-chain carbohydrates, nucleic acids, and much more [46]. García-Contreras
et al. [46] stated that mimicking the intracellular environment exactly would
be "very difficult, if not impossible", confirming the need for an approximation
of the intracellular environment. Pragmatically, therefore, physiological
buffers are always inexact replications of the intracellular environment but
parameterisation studies in these buffers have yielded encouraging predictions
of in vivo phenomena so far [3, 46]. The use of physiological buffer conditions
then has the added advantage that models constructed in an in vivo-like,
standardised buffer can be reapplied to different contexts and in describing
behaviours that is has not seen before, e.g. [2].
A further goal of the Silicon Cell project and advantage of paramaterisation
in physiologically accurate buffers, is to allow for later integration of models:
both vertical merging (the integration of models at different levels of
organisation, e.g. the combined expression of genetics and kinetics by Bruck et
al. [47]) and horizontal merging (integration of adjacent pathways to increase
the coverage of a model, e.g. the integration of a glycolytic and two branching
pathways in yeast by Snoep et al. [13]) will form part of this modular model
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expansion [37].
Integration exposes the models to more opportunity for the effect of
erroneous parameters to be magnified by an expanded interconnectivity [15]. If
properties of enzymes are described accurately by parameters, however, there is
no reason why models should not be re-usable or integratable [16]. This further
justifies the requirement for the standardisation of experimental conditions
so that the integrated models have parameters sets that were measured in
similar buffer conditions, so the relationship between adjacent parts of an
integrated metabolic model are not an artefact of differences in assay buffer
[13]. Bruck et al. [47], for instance, incorporated transcriptional regulation
into a computational model of yeast glycolysis [1]. The expanded model
did manage to more closely predict experimental results but still failed to
accurately simulate them in many ways. Since the experimental conditions
used for the determination of the kinetic parameters of the original model
differed from those used for determination of adjusted parameters for the new
study, fitting had to be used to find parameters that could otherwise have
been empirically determined [47]; this potentially hid the scrutinising effect of
model integration.
2.2.1.1 Model Management as a Path to the Silicon Cell
Beyond the construction of models using standardised experimental conditions
and the need for the standardised conditions to reflect, as closely as possible,
the in vivo conditions of the cells, standardised model description and central
accessibility are also necessary steps towards the construction of the Silicon
Cell [5]. Efforts at model management hope to reduce duplicative work
by curating models, ensuring that they have been properly validated, and
presenting them in a centrally available database. CellML [48] and SBML
[49] are examples of standardised model description formats that allow for
better collaboration by presenting models in an accessible way. In addition,
a group of systems biologists proposed, in 2005, a set of annotation criteria
(MIRIAM: "minimum information requested in the annotation of biochemical
models"; 50) which ensure that network components and properties are defined
consistently and in a machine-readable format. Presentation of models in
recognised formats according to accepted annotation criteria allows for greater
ease of use: for example, the modelling and simulation tool COPASI [42] allows
users to analyse models that are available in the SBML format much more
conveniently.
Biomodels [50] and JWS Online [51] are examples of curated model
repositories that aim to make them centrally available. JWS Online, for
instance, provides an on-line interface on which users can interact with existing,
curated models. Beyond the avoidance of duplication, such central repositories
also provide the opportunity to identify models describing adjacent subsets of
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reactions. These models can then be linked, in line with the aspiration of the
Silicon Cell project’s modular approach [13].
2.2.2 Validating the Silicon Cell
As smaller models are integrated into ever more complete networks, parameters
will often have to be refitted to reconcile strain or other experimental
differences, (e.g. Bruck et al. 47 nneded to refit many parameters to be
able to combine the gene expression and flux data from the work of Wiebe et
al. [52] with the parameters from the Teusink model [1]). This might amplify
the uncertainty in the parameters that were hidden in the smaller models
(see Subsection 2.2.1). Mechanistic models that are interrogated in isolation
may very well survive scrutiny as some level of fitting or assumption is usually
required; however as models are expanded and integrated (eventually intending
to include all of the the almost 2000 reactions in the yeast metabolome 53),
incorrect parameter sets will - while hiding in plain site - fail to describe
new levels of complexity [15]. Expanded models might also necessitate a
reintepretation of the original model construction data in the light of new
observations [37]: this is a natural part of model integration and refinement
and will require more credible and more sophisticated model recalibration and
validation tools.
Traditionally, validation studies have focused on the identification of
biologically plausible parameter sets for which experimental observations and
model simulations match [14]. For instance, the ability of a model to predict
the steady-state fluxes when provided only with initial rate kinetics is seen
as good initial evidence of model validity [10]. As quantitative models grow
in scope and in complexity, however, the possible parameter space of more
models will become large enough to contain multiple plausible parameter
combinations with conceptually irreconcilable implications [14]. Parameter
estimation strategies, furthermore, open up the risk of disguising gaps in
our knowledge by fitting incorrect parameters that cover up anomalies - a
phenomenon known as "over-fitting" [15].
Most validation assays look for consistency between model predictions and
observed systemic behaviour [54]. Model predictions can take various shapes,
from single-value predictions of variables to so-called "core predictions" [17].
Single-variable predictions can confirm the parameter values associated with
single nodes or edges in the modelled network. Comparing these predictions
to experimental data can be strong validations of single parameter values,
but would impose an impractical experimental burden on researchers. Core
predictions, on the other hand, implicate the full range of parameters and
constitute a much more general validation or invalidation of a proposed
computational model [17]. Since models are inherently an attempt to "zoom
out" from a component-level view to a systems-level view, the ultimate test
of a model lies in evaluating its ability to provide a higher-level perspective
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on a problem [38], rather than in independent confirmation of each individual
predicted variable.
Core predictions can be tested by presenting a model with data that is
qualitatively different from the "training data" used during construction: for
instance, metabolic behaviour that it has not seen before [16]. This addresses
the blind spot of over-fitting as it presents the model with phenomena to which
it could not have been artificially adjusted. In this way, the construction and
validation of the model are kept separate in a very strict sense [5]. The ultimate
result of such an attempted validation can form a useful part of the model
development cycle, as - in the absence of total invalidation or confirmation of
the proposed model - useful refinements can be suggested [18].
In principle, it is impossible to fully verify a model, as this would
require independent confirmation of each one of its possible predictions
and invalidation of each possible alternative set of biochemically plausible
parameters [54]. Cvijovic et al. [37] stress the importance of making optimal
use of the available data since "empirical data will [n]ever cover the entire
possible state space". To To address this issue, tests of model validity are
constructed as invalidation assays, aimed at identifying experimental data
that an inaccurate model could not have predicted by chance [18]. Combined
with the use of core predictions that implicate more than a single parameter,
this type of validation assay is much more feasible for systems biologists to
implement. Each failed attempt at invalidation adds to the credibility of a
model [18].
Du Preez et al.’s repurposing [2] of an established model to describe an
unfamiliar behaviour (glycolytic oscillations in S. cerevisiae), is an example of
a core prediction about the original model’s flexibility: it posed the question
whether relatively minimal changes in the original parameter values could be
applied to describe qualitatively novel behaviour. The original model [1] could
be minimally adjusted to describe an entirely new behaviour - strong evidence
for the validity of the calculated parameters (see Sub-subsection 2.2.4.2).
2.2.3 Glycolysis in silico
Evolving experimental repertoires and analytic techniques are allowing ever
greater forays to be made into bottom-up modelling of a variety of cellular
processes, from signal transduction networks operating in human cancer
cells [55] to autophagosome flux in murine liver cells [56]. These advances
will, without a doubt, open up more avenues for integration across different
modelled cell functions. Metabolic networks, however, remain by far the easiest
networks to study, owing to ease with which their enzymes are isolatable and
characterisable, and exhibit high flux in vivo [13].
Amongst these metabolic networks, glycolysis ranks as the classic example
of a biochemical pathway. Its near-universality and long history of being
studied [6] have made glycolysis an ideal candidate for some of the earliest
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attempts at computationally modelling metabolic flux. The first iteration of
this probably saw the light of day in the early 1960s with the work of Chance
et al. [7]. Some other early pioneers, Heinrich et al. [8], did seminal work in
the construction of a kinetic model of red blood-cell glycolysis, on which they
would base their work on Metabolic Control Analysis (see Section 2.3).
Despite almost 70 years of research, much remains to be discovered about
glycolysis [57]. In keeping with its significance as a model pathway for
biochemists, glycolysis has led to a number of detailed, kinetic models in
the spirit of the Silicon Cell (see 5) which have tried to make sense of the
complexity of glycolytic flux in multiple contexts. This central pathway in
the breakdown of glucose is embedded in a complex network of regulatory
pathways, and feedback and -forward loops [58], the modelling of which has
been a staple of molecular systems biology over the past two decades.
The work of Bakker et al. [11], for instance, on the pathogen responsible
for African sleeping sickness in humans and nagana in animals, Trypsonoma
brucei, yielded a kinetic model of glycolysis which held up well when tested
for its ability to predict steady-state behaviour (11, 59). This model of the
slender, blood-borne form of the parasite has undergone multiple subsequent
updates (59–61) and serves as an example of model re-use and iterative
expansion - an embodiment of the Silicon Cell approach [5]. This model
and its descendants will, for simplicity, not be discussed in detail but will
collectively be referred to as the Bakker model. Important to mention, however,
is that the bloodstream-inhabiting phase of this parasite has no Krebs cycle,
oxidative phosphorylation, or carbohydrate-storage abilities and is killed by a
50% inhibition of its glycolytic flux [34]. This makes the Bakker model not
only valuable as an object of academic interest, but as a promising route to
drug-target identification.
The glycolytic pathway of Plasmodium falciparum, the causal agent of
malaria, was also kinetically modelled [10]. The central carbon metabolism of
the asexual, blood-borne phase of this organism consists only of glycolysis and
a low-flux pentose-phosphate pathway [62]. Intraerythrocytic P. falciparum
relies on glycolysis for ATP production [63] and does not have any carbon
stores [62]. Simulations of steady state fluxes made using this model -
henceforward referred to as the Penkler model - also proved surprisingly robust
under experimental interrogation (10, 64). Multiple potential drug targets
were uncovered, with the glucose transporter being the most potent target
suggested, as experimentally validated in a subsequent study [64].
2.2.4 The Silicon Yeast Cell
For largely economic reasons, Baker’s yeast (Saccharomyces cerevisiae)
glycolysis has been the subject of scientific study for over a century [33]. This
organism has been the model for a number of systems biological studies that
hope to standardise the tool kit for use in other organisms, for instance being
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the first subject for a consensus metabolic network reconstruction [53]. Yeast
was specifically chosen due to its long history of being studied and the fact that
its metabolic network is relatively well characterised. In its glycolysis, all of the
enzymes are localised in a single compartment and have been functionally and
structurally characterised [1], providing present-day researchers with a sturdy
foundation of knowledge to inform further investigations. For the systems
biologist interested in glycolysis, this advantage extends further to the history
of models and model refinements available for S. cerevisiae: multiple models of
yeast glycolysis have now been constructed (e.g. the models of Hynne et al. 65
and Teusink et al. 1) and can serve as the point of departure for comparative
studies.
2.2.4.1 The Teusink model
Teusink et al. [1] addressed a central question of biochemistry: do in vitro
kinetics suffice to describe and explain in vivo behaviour? To answer
this question, a kinetic model based on in vitro experimental data was
constructed without artificially fitting parameters to in vivo data. After model
construction, an analysis was done to determine the minimum parameter
adjustment that would be necessary to predict a steady-state fluxes and
metabolite concentrations. All but three of the in vivo steady-state metabolite
concentrations were predicted to within a factor of two and about half of
the enzymes. Vmax values needed adjustment (all adjustments smaller than a
factor of two) to accurately predict the in vivo fluxes. For the majority of the
concentrations and fluxes that weren’t accurately predicted, suggestions could
be made about how to subsequently resolve the discrepancy [1].
Subsequent iterations of the model have yielded insight into its usefulness
as a starting point for studies of yeast glycolysis. For example, Bruck et al.
[47] attempted, with some success, to test whether the inclusion of enzyme
expression data (which is subsumed under Vmax) could predict glycolytic
flux at changing oxygenation conditions; additionally, Pritchard and Kell [33]
simulated various alternative combinations of Vmax values and calculated, by
simulation, how changes in the rate-limits (Vmax values) of the enzymes (which
is a proxy for transcriptional up- or down-regulation) would redistribute flux
control.
The original model, on which the subsequent studies were based, will be
referred to as the Teusink model and will be regarded as an initial attempt at
describing systemic behaviour in yeast glycolysis in terms of in vitro kinetics.
2.2.4.2 The Du Preez model
Du Preez et al. [2] constructed a new model, based on the work of
Teusink et al. [1], wherein the original model was adapted to predict
qualitatively different behaviour: glycolytic oscillations. Glycolytic oscillations
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are repetitive fluctuations in glycolytic metabolite concentrations and reaction
rates, classically observed in Baker’s yeast [66].
The overarching goal of the work was to explore the potential of re-using
an existing kinetic models to predict behaviour which it was not originally
trained to predict (Subsection 2.2.2). To this end, a stepwise adjustment of
the Teusink model was undertaken [2]:
1. first, the Teusink model was adapted to express of the trehalose and
glycogen synthesis branches in terms of mass-action kinetics instead of
fixed fluxes. Additionally, they rewrote adenylate kinase using rapid
mass-action kinetics in lieu of the existing equilibrium assumption of
the Teusink model. Adenosine phosphates were expressed not as a
single variable but explicitly as ATP and AMP, with ADP calculated
by means of a moiety conservation ratio; ATPase was also rewritten
with saturation kinetics instead of linear kinetics. This was a key change
in the computational simulation of glycolytic oscillations [2]. Glycerol
3-phosphate (G3P) formation was explicitly modelled as an intermediate
step between dihydroxy acetone-phosphate (DHAP, expressed in the
model as part of a triose phosphate pool, together with GAP) and
glycerol. Finally, Du Preez and colleagues also included an acetaldehyde
transport step. None of these structural adjustments altered the
steady-state fluxes by more than a factor of 1.4% (dupreez1);
2. next, a search algorithm looked for the minimal adjustments that are
needed to be made to the Vmax values for oscillations to be simulated
(dupreez2 );
3. then the model’s Vmax values and some Km values were adjusted to yield
oscillations that were similar in phase and amplitude to experimentally
observed oscillations of a yeast X2180 strain; all parameters (except for
the glycerol synthesis branch) were adjusted by factors of between 0.6
and 1.4 (dupreez3 );
4. finally, the inclusion of biomass terms and terms allowing for
synchronisation of oscillations (e.g. acetaldehyde export and removal)
yielded dupreez4, which was used in the present study.
Earlier iterations of the model by Du Preez et al. [2] could qualitatively
predict glycolytic oscillations without having ever seen glycolytic oscillations
before (dupreez2 ) and could describe them quite accurately after exposure to
a small set of training data (dupreez3 ). On top of this, the training data for
parameter recalibrations were from a different strain of yeast (X2180) than
what was used for the construction of the Teusink model (Koningsgist from
DSM Bakery Ingredients, Heerlen, The Netherlands). It is informative to note
that the changes necessary to get from the Teusink model to dupreez4 (which
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will be referred to as the Du Preez model, for simplicity) included a considerable
downward adjustment of most of the Vmax values of the Teusink model,
among others lowering the Vmax of glyceraldehyde 3-phosphate dehydrogenase
(GAPDH) by a factor of four. These changes are relatively small, however,
if the lower temperature of the oscillation experiments for the construction of
the dupreez3 model are considered: a difference of about 10°C would lead to
a lower measured in vitro activity [2].
An additional set of validation experiments were performed by simulating
oscillatory behaviour in a variety of different contexts and comparing the model
predictions to experimental observations [16, 67]. Further derivatives of the
dupreez4 model (named dupreez5 to 7 and gustavsson1 to 4 ) - in which
the experimental conditions of the assays were mimicked (by, for instance,
removing the transport steps for cell-free extract) were able to successfully
predict systemic behaviour for a number of oscillation-related phenotypes.
These results all confer a relatively high degree of confidence on the Du Preez
model.
Having been adjusted and reconfigured to describe the behaviour of a
new strain of yeast (X2180, as opposed to Koningsgist) at new experimental
conditions, it should be interesting to investigate to what degree the two
models predict similar systemic properties. The summation theorems suggest
that the recalibration of the Vmax values to scale the magnitude of the
oscillations to fit experimental data would not change systemic phenotypes
[16]. Since, however, parameters were changed asymmetrically, and the
structure of the network was adjusted at some sites, systemic behaviour cannot
be concluded to remain unaltered without experimental confirmation.
Glycolysis in S. cerevisiae, though subject to inter-strain variation in
enzyme expression [68], has a consistent layout and stoichiometry for the two
strains concerned in this study (X2180 and Koningsgist; [1, 2]). The parameter
scan by Pritchard and Kell [33] suggested that a variation of parameter values
should not, under physiologically relevant conditions, significantly change the
control profile of the model by Teusink et al. [1]. From these premises, one
would expect the distribution of metabolic control (Section 2.3) to remain more
or less consistent under the changes effected to get from the Teusink model to
the Du Preez model.
One of the pillars of the bottom-up approach to systems biology is that
modules of metabolism can be studied in isolation and integrated later-on [13].
The assumption related to this approach is that the modules can be reduced to
characteristics that are context-independent and do not radically change each
time the model is expanded or adapted. The adaptation of the Teusink model
[1] to yield the Du Preez model [2] entailed a refinement of reaction maps
for yeast glycolysis and a recalibration of some parameters to more closely
resemble the oscillatory behaviour of yeast cells as observed experimentally.
Both models were developed for very specific purposes, as is common in
metabolic modelling [37]. If they do describe the same pathway under different
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conditions, however, some characteristics should remain conserved during
model adaptation (see Subsection 2.2.2). Validation of both models using
the same data set could shed light on whether the model adjustment truly
conserved important pathway properties.
2.2.4.3 Model availability
Note that all of the discussed models are available for viewing and simulation
on the JWS Online model database ([51]; available at https://jjj.bio.vu.nl/).
2.3 Metabolic Control Analysis
Concurrent with advances in experimental biology, the second half of the 20th
century also saw a theoretical shift in the way living organisms were viewed:
a shift from "component thinking" to "systems thinking" [4]. Important in
this "systems thinking" paradigm was the development of Metabolic Control
Analysis (MCA) in the 1970s. Foundational work was done by Kascer and
Burns [69] in Scotland and Heinrich and Rapoport [70] in East Germany.
The resulting theoretical framework would prove very useful for the relation
of steady-state network properties to the component reactions [19]. These
approaches would allow for models to contribute to our understanding beyond
just precise prediction based on a set of prior conditions [26].
Much work has been done to refine the theoretical basis of MCA, and at
present it can describe most metabolic networks in terms of the distributed
metabolic control of its component reactions. For brevity, a detailed discussion
of MCA will not be undertaken, but the mathematically inclined reader is
referred to Reder [71], Hofmeyr [19], and Visser and Heijnen [72] for overviews
of the underlying theory.
MCA can be thought of as a sensitivity analysis, structured according to the
stoichiometry of the component reactions [19]. It allows systems biologists to
quantify the contribution of one enzymatic step (or a defined module of steps;
73) to the control of steady-state metabolic flux or metabolite concentration
in a pathway. This is defined as the control coefficient, which, conceptually,
can be expressed as follows:
Cfj ≡
∂f
∂λj
(2.3.1)
where Cfj is the control of any process j over any system function f ;
λj represents a modulation of process j; and the partial derivative indicates
that the control coefficient is a function of multiple potential variables (like
temperature, enzyme concentrations, etc.) but that perturbation in its
parameter space is reserved, in this instance, to a modulation of process j
[26].
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Written more explicitly with regard to the interaction of the reaction rate
of one enzymatic step, vi, with the steady-state flux through the pathway, J ,
this can be reformulated as follows [20]:
CJvi =
dJ/J
dvi/vi
(2.3.2)
where Cfvi is the control of the rate of reaction i, namely vi, to the flux
through the system, J ; dJ/J is the change in the flux normalised to the
wild-type flux; and dvi/vi is the change in the rate of the reaction in question,
normalised to its wild-type value.
To understand the relevance of such a control coefficient, it is first of
all important to understand that metabolic steps add up non-linearly. For
instance, while the mass of the cell is the sum of the masses of its components,
the rate of flux through a metabolic pathway is related to its component steps
in a more complex way: the different steps influence each other in various
combinations and to various magnitudes, resulting in non-obvious pathway
characteristics [26].
The summation theorem posits that the sum of all of the individual flux
control coefficients in pathway up to unity [20]:
CJv1 + C
J
v2 + C
J
v3 + ...+ C
J
vi
= 1 (2.3.3)
It can be understood from Eq. 2.3.3 that if the full magnitude of a change
in steady state flux were 100%, the various individual reactions that constitute
that pathway flux would be responsible for various smaller chunks of the full
change, providing that the full 100% of change is ultimately accounted for.
For example, v1 could be responsible for 30% of the change, v2 for 20%, and
v3 for 50%:
CJv1 + C
J
v2 + C
J
v3 = 0.3 + 0.2 + 0.5 = 1
Metabolic control coefficients are systems level properties that are
determined mechanistically by an enzyme’s sensitivity to changes in the
concentrations of any of its ligands or of itself [25]. This sensitivity (known
in MCA as elasticity and described by the elasticity coefficient), in turn, is
determined by the physicochemical properties of the enzyme. Elasticity is
a local property that is defined as the change in reaction rate in response
to a change in metabolite concentration, or in the enzyme level, or the
concentration of an external effector [72]:
vixj =
x0j
v0i
∂vi
∂xj
(2.3.4)
In Eq. 2.3.4, x
0
j
v0i
is the steady-state (pre-perturbation) concentration of
metabolite, enzyme, or effector j, divided by the unperturbed activity of
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enzyme i. ∂vi
∂xj
is the partial derivative of the reaction rate of through enzyme
i (vi) with respect to the new concentration of metabolite, enzyme, or effector
j. If we were to rewrite this equation to represent the change in the reaction
rate as catalysed by specific enzyme j, for example, in response to the addition
of an inhibitor, one would say:
viIj =
I0j
v0i
∂vi
∂Ij
where I0j is the concentration of the specific inhibitor, j, before perturbation
and Ij its concentration after perturbation.
The elasticity coefficient only describes the local effects of perturbations,
while the control coefficient can relate these effects to behaviour at a
systems-level. The product of these two terms offers a powerful description of
the overall effect of a perturbation as the combination of local and systemic
properties [25]:
RJixk = C
Ji
vj
· vjxk (2.3.5)
Expanding this equation gives us:
RJixk =
x0k
J0i
Ji
dxk
(2.3.6)
This is known as the response coefficient, and it quantifies the response of
steady-state flux to a perturbation in a parameter (e.g. x0k in Eq. 2.3.6). It
can be seen that the response of a systemic property (such as a steady-state
flux) is dependent on both systemic (control coefficient) and local (elasticity
coefficient) properties.
The control-matrix equation (omitted here for simplicity) is a direct
mathematical relation of control and elasticity, since it expresses flux as
a function of elasticity. This direct relation of control to elasticity is
arguably the most powerful feature of metabolic control analysis, as it provides
the theoretical grounding for direct experimental measurement of systemic
properties as a function of component properties [19].
2.3.1 MCA and the Silicon Cell
Validation of mechanistic, kinetic models of glycolysis can benefit enormously
from MCA as a paradigm for making predictions about the link between
component properties and systems phenotypes (see Section 2.3). This has
value both as a validation technique in the development of metabolic models
(see Subsection 2.2.2) and as a direct route to rational drug design (see
Subsection 2.3.2). Control coefficients can be experimentally measured by
perturbing single enzymes and then measuring the perturbed property and
the resultant systemic change independently (e.g. 74).
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Control coefficients are subject to change in response to altered
environments. Hence, control coefficients are at their most useful as systemic
predictions if standard experimental conditions are adhered to (see Subsection
2.2.1 for more on standardisation). The distribution of glycolytic control
can vary, for instance, depending on active enzyme concentration (33, 47)
or substrate availability [43]. The latter can be experimentally fixed but the
former, being a function of, among other things, growth phase [43], is bound to
lead to some error. Growth phase, though it cannot be directly manipulated,
can be indirectly standardised by consistently adhering to one culturing and
harvesting protocol, for instance by growing up yeast cultures to the point of
glucose depletion, or diauxic shift [43].
MCA, then, provides a framework within which systems-level predictions
can be made in an attempt to invalidate an existing model (see Subsection
2.2.2). The summation theorem [20] implicates the entire system in the
prediction of individual control coefficients. Control coefficients can therefore
be seen as network-based properties [4], since a discrepancy in the prediction
of flux control implicate all other control coefficients as well, and a discrepancy
system’s control distribution would imply a change throughout the rest of the
distribution, hence casting doubt on the whole set of model parameters [17].
2.3.2 MCA and Disease
Beyond the fact that MCA has utility as a model validation tool, determining
the control coefficient distribution in a parasite’s metabolism offers a double
advantage as it "gives us the initial assessment of where to intervene in a
network" [12]. This is becoming increasingly important as the (re-)emergence
of resistance is threatening the efficacy of existing treatments. This tendency
calls for the development of new treatments and can be accelerated by rational
approaches to drug target identification [75].
The first thing a drug target needs to be, is essential. Differential gene
expression assays - a mainstay of disease-aetiology determination - suffer from
myopia to the multiple layers of regulatory networks that confer robustness on
a parasite’s pathways [12]. MCA gives us the ability to evaluate which nodes
are more crucial to systemic integrity than others, at the functional level of
organisation (e.g. metabolism; 25).
MCA is useful, for instance, as a means of identifying the site(s) and
relative importance of an effector for controlling certain physiological functions.
This application of MCA to whole-body regulatory networks has been used to
determine the importance of various effectors for controlling their surrounding
pathway. These effectors can then be modulated for therapeutic effect.
The group of M.D. Brand, for example (76–78), investigated the control
of glucagon, phylogeny, and anaesthetics, respectively, over mitochondrial
function by using an MCA approach.
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A second application of MCA to medicine pertains to drug selectivity. The
ability to understand which steps in metabolic pathways are least tolerant to
change can be instrumental in identifying targets for therapies [25]. One of the
big issues with current treatments is that they often come paired with severe
side-effects [75]. Differential metabolic control analysis can aid researchers in
addressing this: a comparison of metabolic control profiles of the parasite and
the host can potentially expose loci of selective drug action (12, 75). Notably,
the use of MCA as a drug-target identification tool can also unveil so-called
"network-based selectivity", where selective action on parasitic enzymes is a
function not of the physicochemical properties of the enzyme directly but of
the distribution of flux control throughout the network [79].
We support the idea of MCA as a tool for drug-target identification, and it
is useful to interrogate the description of "selectivity" by Haanstra et al. [80]:
Selectivity ≡ (dJ/J)pathogen(dJ/J)host (2.3.7)
and
(dJ/J)pathogen
(dJ/J)host
= (C
J
I )pathogen
(CJI )host
· (ε
I
[I]T /Kt)pathogen
(εI[I]T /Kt)host
· (KI)host(KI)pathogen ·
(PI)pathogen
(PI)host
(2.3.8)
In Eq. 2.3.7, "selectivity" pertains to the heightened effect of an inhibitor,
I, on the glycolytic flux of the parasite as opposed to the host. dJ/J expresses
the change in flux, normalised over the wild-type flux (effectively "% change in
flux"). The expression (dJ/J)pathogen(dJ/J)host is therefore a comparison of the percentage
change in flux experienced by the pathogen versus that of the host.
To zoom in on this expression, selectivity can then be expanded into its
contingent terms, as in Eq. 2.3.8. In this equation, CJI refers to the flux
control of the inhibitor and εI[I]T /Kt refers to the sensitivity of the enzyme to
either an increase in inhibitor concentration or an increase in the enzyme’s
affinity for the inhibitor - these terms are both network-based determinants of
selectivity. KI is inversely proportional to the binding affinity of the inhibitor
to the enzyme and captures the structure-based selectivity of the inhibitor.
Finally, PI is known as the "partition coefficient" and is a measure of the
pharmacokinetics of the inhibitor, i.e. the propensity of the inhibitor to reach
its target in the cell after being administered extracellularly.
Of the four determinants of selectivity, therefore, two are network-based,
one is structure-based, and the last one is pharmacokinetic [80]. The fact that
two of the four terms that contribute to the selectivity of a drug target are
network-based, offers a strong argument for the further investigation of these
relational generators of selectivity as a route to drug-target discovery [79].
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Important differences in the control distributions within the essential
network, glycolysis, between pathogens and human hosts have already been
reported, e.g. the observed high differential control of the glucose transporter
(GTr) and GAPDH in the malaria parasite and T. brucei compared to human
red blood cells [59, 81].
In descendants of the Penkler and Bakker models, MCA-based
experimental validations of some key properties have been undertaken. In the
case of the Penkler model, GTr was competitively blocked with the inhibitor,
cytochalasin B, and the differential effects on glucose import and lactate export
calculated as control coefficients [64]; in the Bakker model, phloretin, also
a competitive inhibitor of the GTr, was added in erythrocyte-trypanosome
co-cultures and the differential effect on glycolytic flux between the parasite
and the red blood cells determined [80].
In both of the above-mentioned cases, glycolysis is the principal source of
energy in the blood-borne stages of the parasite (10, 11) and, in both cases,
GTr showed considerable network-based selectivity (59, 81). Intuitively, one
can understand the high control of GTr as being due to its unique position
as the gateway-enzyme to the pathway: by restricting the amount of glucose
that can even enter the pathway, it strongly controls glycolytic flux whenever
external glucose concentrations are not fully saturating [82]. This is not the
case in cells that can make use of alternative energy sources, like red blood
cells. It is, however, useful to open up multiple channels of enquiry after
potential drug targets, not just because this increases the chances of finding
a suitable treatment more quickly, but also because the threat of resistance
to treatments can be more strongly mitigated by combined-drug therapy [12].
GAPDH offers such a possibility, as it has a unique position as the first enzyme
after the branch point in glycolysis (see Section 2.4).
Differential control analysis also goes beyond host-pathogen comparisons,
even showing promise in the identification of drug targets in cancer cells,
where the disease cells are genetically identical to the healthy cells and few
structural differences can be expected. Non-oxidative ribose synthesis via the
pentose-phosphate pathway, for example, is almost unique to tumours and an
analysis of metabolic control identified glucose 6-phosphate dehydrogenase as
a site of high control over tumour growth [83], opening up very useful paths
of network-based enquiry [84].
2.3.3 Control Coefficient Determination: Transporters
and Intracellular Enzymes
As mentioned, selective perturbation of reaction-level parameters is necessary
to connect systems-level phenomena to molecular causes [74]. Perturbation
studies are often undertaken as gene knock-out studies; this method suffers
from the limitation, however, that it can determine, experimentally, the
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consequences of complete abrogation of activity but not intermediate phases
of partial inhibition, as would be required in clinical settings [75]. Chemical
perturbation is therefore more suited to the aims of rational drug design.
Typically, the kinetics of glycolytic enzymes are measured in vitro in
cell-free extracts. A cell-free extract is not, however, an exact reconstruction
of the complexity of a living cell: regulatory effects of very specific intracellular
conditions, like compartmentalisation and co-localisation, might lead to a
considerable level of heterogeneity within a single cell (28, 85). The process
of creating cell-free extract usually homogenises the lysate, destroying any
internal complexity that is present in vivo.
Addressing the differences between the in vivo and in vitro environments
has, to a certain extent, been circumvented by keeping in vitro
parameterisation limited to mechanistic or approximate phenomenological
properties of an enzyme [26]. This was the case in the Teusink, Penkler, and
Bakker models (1, 11, 81): all three models were validated for the ability of
the in vitro kinetics to predict in vivo steady-state metabolite concentrations
(2, 64, 80), bolstering the "phenomenologically approximate" approach to in
vitro parameterisation [26].
The obstacle of in vitro kinetics, however, becomes somewhat harder to
ignore when model validation is in question. The ability of in vitro kinetics
to make accurate core predictions about in vivo systemic behaviour serves
as a general validation that the parameters measured in vitro translate well
to a model of a living system (see Subsection 2.2.2; 17). Those in vivo
measurements to which the model is compared, are measured in intact cells
[28].
The mismatch between the in vitro environment of the enzyme activity
titrations and the whole-cell environment of the flux perturbations can,
hypothetically, be circumvented by keeping the in vitro conditions in which
enzyme activity is assayed, constant [22]. If the effects of an inhibitor on
whole-cell flux and in vitro enzyme kinetics are to be compared, though, one
cannot know for sure that the inhibitor is affecting the same target in the
same way [46]. A work-around for this problem would be to perturb enzymes of
which the activity can be measured without cell lysis, e.g. transporter enzymes.
Much more convincing MCA-based model validations could be carried out,
however, if the flux control of both membrane-bound and intracellular enzymes
could be determined. Refer to Section 3.2 for further elaboration on this
problem.
Control coefficients are not constants, however, but vary with changes in
their environment [22], e.g. at different glucose concentrations [57, 59]. This
has already been discussed as a variable affecting control distribution (see
Subsection 2.3.2; "MCA and Disease").
Flux control is a non-linear function of the enzyme levels [25]. Our
discussion of an increase in IAA being comparable to a decrease in "free
GAPDH" (see Subsection 5.1.2) then implies that as GAPDH activity is
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decreased, every subsequent further decrease might have a different effect.
Flux control coefficients are conventionally referred to as the ratio between
the relative change in flux and the relative change in enzyme activity at zero
inhibitor [25]. Since control changes in response to enzyme activity titration,
the change in flux control over the range of IAA used, can also be compared
for experimental results and model predictions [75].
2.4 GAPDH: A Fork in the Road
GAPDH has been computationally identified as a possible target for rational
drug design in both Plasmodium falciparum and Trypsonoma brucei, due to
the high control exerted by GAPDH in the parasites’ glycolytic pathway versus
its control over erythrocyte glycolysis (see Subsection 2.3.2; [10, 59]).
Shestov et al. [86] also found recurring high control of GAPDH over
glycolysis in human colon cancer cells undergoing aerobic glycolysis. "Aerobic
glycolysis" (also known as the "Warburg effect" in oncology and plant
physiology) refers to the tendency of proliferating cancer cells to upregulate
glucose consumption and produce lactate at an increased rate rather than using
the more efficient oxidative pathway [87]. Unlike blood-borne P. falciparum
and T. brucei, substrate-level phosphorylation is not usually the main source
of energy for mammalian cells under aerobic conditions. The high control of
GAPDH over glycolysis in cells undergoing the Warburg effect coincides with
the increased production of lactate via glycolysis, which is also accompanied
by an increased expression of the enzymes of lower glycolysis, particularly
GAPDH [86]. This is called the "Crabtree effect" in S. cerevisiae cells [9].
GAPDH is positioned just after the branching point of the pathway,
where a 6-carbon sugar phosphate has been converted to two 3-carbon sugar
phosphates [6]. The high glycolytic control of this enzyme in certain organisms
can be ascribed to its reversible reduction of NAD+ to NADH and its close
interaction with phosphoglycerate kinase (PGK) - which reversibly converts
ADP to ATP [86]. Both ATP consumption and NAD+ regeneration have been
shown to be important in regulating glycolytic flux [88], and it is reasonable
to expect some of these regulatory effects to be exerted via GAPDH. On these
grounds, Shestov et al. [86] suggest GAPDH as a potential target for cancer
treatment.
Even in organisms purported to have low GAPDH-driven glycolytic
flux control, like S. cerevisiae [2], GAPDH is repeatedly mentioned for its
importance in controlling certain cellular events. Van Heerden et al. [82],
for example, emphasise GAPDH as a point of control allowing yeast cells to
thermodynamically drive glycolysis in the forward direction by the liberation of
high levels of Pi via the trehalose synthesis pathway. The extensive validation
study on the Du Preez model also identified GAPDH as an important site
in the aetiology of phenotypes associated with cofactor imbalances, e.g. the
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transduction of the effects of acetaldehyde capture by cyanide to PFK via its
ATP sensitivity is ascribed to the GAPDH-PGK module [16].
It appears from these data that GAPDH is an important enzyme where
glycolysis is very active - a phenotype often associated with disease conditions
- qualifying it as an enzyme worthy of investigation.
2.4.1 Iodoacetic Acid: Specific GAPDH Inhibitor
The activity of GAPDH is mediated by an active-site cysteine residue that acts
as a nucleophile during the conversion of glyceraldehyde 3-phosphate (GAP)
to 1,3-bosphosphoglycerate (BPG) [89]. Cysteine is important in the catalytic
mechanisms of many enzymes. Apart from being one of the least abundant
amino acids in the proteome, cysteine also has the most extreme distibution
of abundance and locality among the amino acid residues [90]: typically either
very highly conserved (higher than the expected rate of random mutation) or
very degenerated (much less conserved than random mutation would yield).
This, combined with the tendency of cysteine to be conserved in functional
positions but to degenerate quickly when positioned randomly, is a consequence
of cysteine’s high reactivity. This reactivity - resulting from two unpaired
electrons in the its outer valence shell and the lowered electronegativity of
sulphur compared to oxygen - are two key characteristics of cysteinyl sulphur
[91]. The wide range of biological functions that can be facilitated by cysteine
(catalysis, cofactor binding, regulation), arises from this unique reactivity.
Haloalkenes have been used as irreversible enzyme inhibitors since the 1930s
[92]. They principally act on on enzymes by alkylating cysteine residues,
forming a covalent bond with the thiol in the cysteine residue’s side-chain [93].
Iodoacetate (IAA) and iodoacetamide (IAM) are two examples of such alkenes.
Embden and Meyerhof suggested as early as 1933 that the site of glycolytic
inhibition by IAA lies at the oxidation of triose phosphates [21]. Glycolysis
has been targeted for inhibition via alkylation by IAA in prokatyotes, such as
Streptococcus lactis [94], in unicellular eukaryotes, such as Trypsonoma cruzi
[23], as well as in tissues from multicellular eukaryotes [95]. The inactivation
of GAPDH by IAA is often used as a textbook example of irreversible enzyme
inhibition [93].
The number of enzymes that are known to be affected by IAA counts
in the hundreds [96]. It is not surprising that a simple compound such
as IAA, which acts as a covalent modifier of the functionally important
cysteine residue, is an inhibitor of multiple enzyme-catalysed processes. At
relatively low concentrations, however, (<1 mM) and over short exposure times
(< 1 hour), IAA appears to bind almost exclusively to protein thiols [97],
specifically to the catalytic cysteine residue of GAPDH (though alkylation
of other nucleophilic side-chains are known to occur, but are thought to be
innocuous for most analytical applications; 92). For instance, both Jones
et al. [98] and Whitehead and Rabin [99] used IAA as an alkylating agent
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of cysteine groups in hexokinase and alcohol dehydrogenase, but made use
of millimolar concentrations of the compound. According to the method of
Poolman et al. [22], specificity can be assumed at very low concentrations
of IAA, as this compound only significantly reduces the activity of other
glycolytic enzymes at millimolar concentrations, whereas GAPDH can lose as
much as 90% of its activity by being exposed to only 100 µM of IAA. GAPDH
seems to have the highest affinity for IAA and an inhibited glycolysis has been
repeatedly ascribed to irreversible, specific active-site blocking of GAPDH by
this haloalkene [21–24, 93–95, 100].
Webb [21] indicated that 1 mM could significantly inhibit GAPDH, but
also certain alcohol dehydrogenases (ADH), succinate dehydrogenases, and
proteolytic enzymes. A later study investigated this claim and showed that
IAA targets GAPDH selectively in S. cerevisiae at IAA concentrations below
0.5 mM [101].
It has been suggested that IAA is inappropriate as a thiol-alkylating
agent, due to its negative charge. This charge could lead to substantially
reduced reaction rate when the target site is located in a hydrophobic
environment; furthermore, IAA’s negative charge might also render it
membrane-impermeable [102]. Despite these concerns, however, IAA has been
used successfully as an inhibitor of GAPDH activity in vivo in multiple studies
[22, 24, 86, 93–95, 100, 101, 103, 104].
2.4.1.1 Iodoacetic acid and GAPDH protection
Taking a step back, it must first be mentioned that the possible structural
differences in the enzymes are particularly relevant in case of IAA as inhibitor.
Brodie and Reed [105] showed, using human lung carcinoma cells (A549),
that cells that were oxidatively stressed by the exposure to non-toxic or
mildly toxic concentrations of hydrogen peroxide (H2O2 ), were protected from
IAA-binding in a dose-dependent way. The formation of disulphide bridges
between otherwise catalytically active thiol groups likely contributes to this
protection against IAA [102]. This dose-dependent protection has been shown
to be alleviated by the addition of dithiothreitol (DTT; 106), suggesting that
oxidative damage in cell-free extract might lead to quantitative differences
in the inhibition profile [105]. The intracellular redox environment is very
flexible and is used as a regulatory mechanism to respond to ambient conditions
[107–109].
Work by Segal and Boyer [110], furthermore, has suggested that GAPDH
is protected from IAA alkylation in the presence of its substrates.
Cell lysis will immediately interrupt these ambient factors and lead to
possible differences in the environments in which glycolytic flux and specific
activity are measured, respectively.
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2.4.1.2 Iodoacetic acid and pharmacokinetics
S. cerevisiae cells are enveloped in both a cell wall and a cell membrane [6].
Hansen and Winther [102] suggested, due to the negative charge of iodoacetate
(the conjugate base of IAA, which is more common at the physiological pH
characteristic of yeast; 21), it is membrane-impermeable. Many researchers
who have worked with IAA in a variety of different cell types, have worked
from - and succeeded under - the assumption that extracellular administration
of the inhibitor leads to glycolytic inhibition (including, to name but a few:
22, 86, 93, 101, 103). None of the studies of which we are aware, however,
have quantified the pharmacokinetic properties that define the bioavailability
of IAA at the inhibitory site in GAPDH.
In the next chapter, we outline our approach to addressing this issue
(Chapter 3).
2.4.2 S. cerevisiae and GAPDH Control
From existing literature, it seems that GAPDH has very little control over
glycolysis in yeast. The computational work of Pritchard and Kell [33]
and the experimental work of Bruck et al. [47] looked at the behaviour of
glycolysis at varying possible and even purely hypothetical combinations of
enzyme expression levels. In all cases, lower glycolysis was almost devoid of
flux control. Glycolysis in yeast appears to be almost entirely controlled by
the hexose transporter with some (probably unrealistic) simulated conditions
yielding PFK as the principal site of glycolytic control [33].
The predictions of glycolytic flux control by the existing models can be
tested against experimental data as a way to determine the models’ validity.
Flux control in the models can be simulated as a changing parameter as
the activity of the perturbed enzyme decreases, yielding not a single control
coefficient, but a more complete control profile (see Fig. 5.8). This is an even
stronger model validation, as it tests the ability of the model to track changes
in this systemic property over a range of inhibition [25]. Control profiles are
also useful in pharmaceutical studies, as a sudden precipitous change in the
flux control of an enzyme might have clinical use where this change renders a
pathogen more vulnerable to inhibition at a certain enzyme than its human
host [12].
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Materials and Methods
In this study, we experimentally determine the control of GAPDH over
glycolytic flux as a validation of the model by Teusink et al. [1] and its
descendent, the model by Du Preez et al. [2].
We use the same laboratory strain as Du Preez et al. [2, 16] and the
predictions of metabolic flux control that we test are core predictions and
qualitatively different from anything either model was trained on: in this sense,
the model construction and model validation data are kept strictly separate
[5].
3.1 Cell Cultivation and Preparation
S. cerevisiae X2180 cells were grown in a yeast growth medium consisting of
10 g.L-1 glucose, 6.7 g.L-1 yeast nitrogen base (Sigma-Aldrich, St Louis, MO,
USA), and 100 mM potassium phthalate (Sigma-Aldrich, St Louis, MO, USA)
at a pH of 5.0, shaking on a rotary shaker at 140 rpm (30°C ) as in Gustavsson
et al. [67]. The optical density of two standard cultures was monitored with
spectrophotometric readings at regular intervals at a wavelength of 600 nm.
These cultures were not, themselves, harvested, but served to determine the
growth conditions at which harvesting would take place. The readings were
taken using a SPECTROstarnano spectrophotometer (BMG Labtech, Cape
Town, South Africa). Optical density data were plotted as a function of time
to visualise growth. Concurrent optical density and glucose concentration
readings (obtained using Medi-Test Combi 4/6 Urine Test Strips; Product
Code 4020, Humor Diagnostica, Hermanstad, Pretoria) confirmed that the
point of glucose exhaustion reproducibly coincided with a plateau in the OD600
readings. We isolated our cells at this point, known as diauxic shift [111].
The cells were pelleted by centrifugation at a relative centrifugal force of
4500×g for 5 minutes at 4°C in an Eppendorf 5804 R Centrifuge (Eppendorf,
Hamburg, Germany). They were then washed twice with a volume of 1:10
wash buffer (g cells : mL wash buffer). The wash buffer consisted of 100
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mM potassium phthalate and 2 mM ethylenediaminetetraacetic acid (EDTA)
according to the method of Van Eunen et al. [3]. Three independent biological
samples were grown and harvested in this way. The cells were weighed after
the first centrifugation step and a consistent yield in approximate dry weight
(between 0.4 and 0.6 g per 50 mL of culture) was obtained.
After harvesting, the cells were exposed to known concentrations of a
GAPDH inhibitor, iodoacetic acid (IAA). The precise details of the inhibition
method are discussed at length in Subsection 3.4.1. First we turn to the
underlying theory.
3.2 Inhibiting Intracellular Enzymes: The
Problem
Subsection 2.3.3 of the literature review briefly referred to the problem of
perturbing intracellular enzymes and credibly measuring the the effect of these
perturbations. A good way to understand the problem, lies in the description
of inhibitor-selectivity by Haanstra et al. [80] in Eq 2.3.8. Dividing selectivity
into four categories - inhibitor control, enzyme elasticity, structural differences,
and pharmacokinetic differences [80] - yields useful insight into the issue of
intracellular perturbation. If Eq. 2.3.8 is adjusted to express the difference
not between a host and a pathogen, but between the intracellular environment
and a cell-free extract, then one can see that selectivity of an inhibitor for a
target might also occur when the same enzyme is exposed to the inhibitor in
different contexts:
(dJ/J)cell
(dJ/J)extract
= (C
J
I )cell
(CJI )extract
· (ε
I
[I]T /Kt)cell
(εI[I]T /Kt)extract
· (KI)extract(KI)cell ·
(PI)cell
(PI)extract
(3.2.1)
where the flux control of the inhibitor (CJI ), the sensitivity of the enzyme
to an increase in the inhibitor or an increase in the inhibitor’s affinity for the
enzyme (εI[I]T /Kt), the binding affinity (KI), and the partition coefficient (PI)
all contribute to a "selectivity" of the inhibitor for its target enzyme in whole
cells ("cell") versus cell-free extract ("extract").
The challenge for an experimenter that will measure the effect of an
inhibitor on an enzyme in vitro and the effect on flux in vivo is to ensure
that the effects are not obscured by an enhanced selectivity of the enzyme for
the inhibitor in one environment as opposed to another.
Since the enzymes in cells and in cell extract originate from the same
organism and strain, it is tempting to posit that there will be no selectivity
as all terms remain the same, but this is not so. Smallbone et al. [35], for
example, mention unknown effectors, intracellular crowding, and channelling
as potential causes of differences in in vivo and in vitro enzyme activities.
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This might also apply to the mechanism of inhibition: if the reaction-level
kinetics and the systemic phenotypes are assayed in different contexts, one
might be combining data from two experimental environments that affect
inhibitor action in different ways (Eq. 3.2.1).
The flux control term in Eq. 3.2.1 can be disregarded, as the networks
originate from the same organism, hence will be identical. Terms elasticity,
structural selectivity, and pharmacokinetics (terms 2 to 4 in Eq. 3.2.1),
however, cannot be ignored. By measuring enzyme activity in standardised,
physiologically relevant buffer conditions and extrapolating biochemically
operative phenomenological parameters from measurements (e.g. 40, 41), like
Vmax or Km (see Subsection 2.2.1; 3, 26) one can attempt to minimise the
mismatch between the inhibition contexts, but the sheer number of factors
for which one would need to compensate, render a perfect recreation of the
intracellular environment inconceivable [46].
Ambient conditions can lead to lower affinity of the inhibitor for its target,
like the formation of disulphide bridges in a more oxidised environment [112]
or competition in high substrate concentrations [12]. Conformation changes
might also be brought about by changes in medium ionic strength and might
lead to decreased structural affinity for the inhibitor [6].
Since the elasticity coefficient in Eq. 3.2.1 is also partially determined
by the enzyme-inhibitor affinity, this term is also implicated in contributing
towards possible context-specific selectivity.
The fourth term - the pharmacokinetic term, expressing the availability
of the inhibitor to the enzyme - can also not be assumed to be equal for
whole cells and cell-free extract. Most obviously, the presence of cell envelopes
and intracellular compartments, can lead to to differences in inhibitor
concentrations when administered to incubations containing whole-cells versus
to cell-free extracts [113]. Additionally, something like localised hydrophobicity
in certain parts inside a cell could lead to poor access of a charged inhibitor,
like the conjugate base of IAA, to certain enzymes [102].
The failure of standardised buffers to fully compensate for these
factors complicates the task of determining the flux control of intracellular
enzymes. This complexity can be resolved by in vivo measurement
of intracellular kinetics, something that is becoming increasingly viable
thanks to high-resolution imaging techniques [15]. These techniques are
still comparatively expensive, however, and not readily accessible in all
laboratories.
As has been mentioned, previous model validations have largely escaped
this complexity by focusing on the perturbation of the glucose transporter
(see Subsection 2.3.3): inhibiting the transporter and measuring the effect on
glucose uptake and glycolytic flux does not require cell lysis, as the inhibitor
acts on the cell-surface and both the enzyme-level effect and the flux effect can
be measured on whole cells. The activity of intracellular enzymes, however,
cannot easily be measured in vivo [15]. At the same time, measurements of
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glycolytic flux on cell-free extract will disregard vital intracellular dynamics
that might contribute to the ultimate effect on the flux [28]. The important
task of validating metabolic control distribution predictions for intracellular
enzymes remains hitherto largely unaddressed. In the following sections, we
describe our approach to resolving this problem.
3.3 IAA as a Specific Inhibitor of GAPDH
For the present study, GAPDH was chosen as the target enzyme for
experimental determination of its flux control coefficient. As was mentioned
in Subsection 2.3.2, this enzyme has been computationally identified as a
possible target for rational drug design in both Plasmodium falciparum and
Trypsonoma brucei, due to the high control exerted by GAPDH in the
parasites’ glycolytic pathway compared to red blood cells’ (10, 59).
Besides its purported high glycolytic flux control, GAPDH is a promising
enzyme for our purposes because it has an irreversible, selective inhibitor (IAA;
see Subsection 2.4.1). Succinate dehydrogenase and alcohol dehydrogenase
(ADH) were reported to be susceptible to IAA inhibition, but only at
concentrations above 1 mM [21]. Campbell-Burk et al. [101] investigated
this by measuring anaerobic energy production by 31P NMR: they found a
marked change in the 31P NMR spectrum 15 minutes of incubating S. cerevisiae
cells in 0.25 mM IAA, consistent with the inhibition of GAPDH. In aerobic,
ethanol-fed S. cerevisiae cultures, however, no change in O2 consumption rate
was observed at IAA concentrations below 0.5 mM, consistent with an absence
of inhibition of succinate dehydrogenase and ADH. At concentrations above
this, however, O2 consumption rate quickly decreases, indicating that GAPDH
specificity can no longer be assumed at these concentrations. For the purposes
of this study, then, only IAA concentrations lower than 400 µM are used.
3.4 Prelytic Inhibition
In Subsection 3.2 we explain why pharmacokinetic properties and the
effect of differing ambient conditions on inhibitor affinity cannot be merely
disregarded when measuring whole-cell glycolytic flux as a factor of perturbed
in vitro kinetics. This problem is exacerbated by the usual measurement of
intracellular Vmax values in supraphysiological substrate concentrations: work
by Segal and Boyer [110] suggested a protective effect of substrate against IAA
alkylation - something that will likely differ greatly between the in vitro and
whole-cell assays. Despite our best efforts at imitating in vivo conditions [3],
pharmacokinetic discrepancies will not be accounted for by mere manipulation
of in vitro assay conditions [46].
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The irreversibility of IAA in its effect on GAPDH, however, coupled with
the specificity of this effect in the context of glycolysis [21, 22, 86], offers a
good opportunity to circumvent these issues.
The cells in question can be exposed to IAA for a given duration before
lysis, after which further inhibition can be stopped by washing the cells: this
will remove the extracellular IAA and, considering that the diffusion gradient
of IAA will now be towards the much larger extracellular volume, subsequent
IAA binding to GAPDH can be regarded as negligible. Furthemore, since
inhibition is irreversible, what has taken place in terms of active-site cysteine
alkylation by IAA can be assumed to remain constant from this point. From
this same batch of inhibitor-exposed cells, both whole-cell incubations for flux
determination and production of cell-free extract for measurement of specific
activity can be performed. Under the assumption that the IAA-binding profile
does not change upon cell lysis or transferral to the in vivo-like medium
proposed by Van Eunen et al. [3], any measured specific activity in this study
expresses the maximal remaining catalytic capacity of the enzyme pool [26],
or V appmax,GAPDH .
Comparison between cell-free extract made from prelytically inhibited cells
and cell-free extract to which the inhibitor was administered directly will be
done to quantify the difference between administering the inhibitor before
versus after cell lysis. We hypothesise that IAA should have a significantly
larger effect when administered directly to the cell-free extract, as fewer
barriers to accessing the inhibitory site on GAPDH exist in vitro.
3.4.1 Inhibition of GAPDH: Procedure
The yeast cells harvested in Section 3.1 were split into two batches (Fig.
3.1), one of which would be prelytically incubated in IAA and another which
would be lysed and only exposed to IAA in vitro: these are referred to as
the preinh-batch (prelytically inhibited) batch and the in-vitro-batch (in vitro
inhibited) batch, respectively (importantly, preinh-batch later subdivides into
preinh-flux and preinh-activity: they were lysed and used for GAPDH activity
measurement and kept whole and used for flux measurement, respectively).
The cells were kept on ice or frozen at -20°C until further use.
Prelytic inhibition: the isolated yeast cells from preinh-batch were
resuspended in a preheated (30°C ) growth medium identical to the culturing
medium used by Gustavsson et al. [67], but with a lowered glucose content
(20 mM). This suspension was then divided into identical smaller volumes that
were each administered with a known concentration of iodoacetic acid (IAA)
within the range: 0µM ≤ [IAA] ≤ 400µM . This method of administering
IAA is based on the method of Poolman et al. [22]. The concentrations
administered to the three biological repeats (termed I, II, and III, respectively)
were:
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• I : 0 µM , 25 µM , 50 µM , 100 µM , 200 µM , 400 µM
• II : 0 µM , 18.75 µM , 37.5 µM , 75 µM , 150 µM , 300 µM
• III : 0 µM , 15.625 µM , 31.25 µM , 62.5 µM , 125 µM , 250 µM
A wild-type (zero IAA) sample was included for each biological repeat. The
IAA-containing cell suspensions were incubated at 30°C on a rotary shaker for
60 minutes. The cells were then pelleted by centrifugation at 2700×g for
5 minutes at 4°C . They were resuspended in a wash buffer containing 100
mM potassium phthalate at a pH of 5.0, and centrifuged again at 2700×g
for 5 minutes at 4°C . This wash step was repeated once more. Half the
cells were then kept on ice and used immediately for flux incubations (called
Figure 3.1: Division of a harvested culture into various batches. A single harvested
culture is split into two batches of equal volume: one which will be lysed and
used for GAPDH activity determination in the presence of IAA in vitro (called
in-vitro-batch), and one which will be split into six batches of equal volume that will
be incubated for 60 minutes in varying concentrations of IAA (preinh-batch). The
prelytically inhibited cells will then each be further split into two batches of equal
volume: one destined for lysis and GAPDH activity titration (preinh-activity) and
one of which the flux will be determined by assaying the production and consumption
rates of whole cells (the preinh-flux batch).
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preinh-flux), while the other half was frozen at -20°C for later lysis and
use during GAPDH activity measurements (preinh-activity). Since the flux
measurements and the GAPDH activity measurements are from the same
inhibitor incubation, all pharmacokinetic and structural differences that can
contribute to a context-specific selectivity and which result from differences in
ambient conditions, are eliminated.
In vitro inhibition: the cells from the in-vitro-batch batch were not treated
any further after harvesting. The were stored at -20°C until cell extract was
produced (see Section 3.5). IAA was administered to the cell-free extract
directly and the mixture incubated at 30°C for 60 minutes before being
transferred to and kept on ice until GAPDH activity measurements were
performed. The time between transfer to ice and activity measurement was
kept as short as possible to avoid time-dependent artefacts when comparing
the prelytic and in vitro inhibition techniques - in the end, the extra incubation
time for the in-vitro-batch samples never exceeded 5 minutes. In vitro inhibited
GAPDH enzymes were therefore allowed at least as much incubation time
in IAA before activity was measured. IAA could not be removed from this
mixture by washing like with the prelytic inhibition.
3.5 Cell Extraction
Cell-free S. cerevisiae extract was produced for GAPDH activity measurement
in vitro and for protein determination. For this, harvested cells were
resuspended in the in vivo-like buffer of Van Eunen et al. [3]. The extract was
then produced by means of a glass-bead extraction protocol, according to the
method of Teusink et al. [1]. The isolated cells were placed in Eppendorf tubes,
along with acid-washed glass beads (425 to 600 µm in diameter; Sigma-Aldrich,
St Louis, MO, USA) in a ratio of 1 mg of glass beads per 1 mL of cell
suspension. The glass-bead-containing suspensions were then fastened to a
bench-top vortex (Vortex Genie2TM, Scientific Industries, Bohemia, NY, USA)
and shaken for 5 minutes, after which the tubes were placed on ice for 5
minutes. This was repeated for 10 cycles, or until no white layer of unlysed
cells was visible in the tubes any more.
This process was independently carried out for each preinh-batch sample
and for the in-vitro-batch lysate (see Fig. 3.1).
3.6 Flux Determination
Glycolytic flux was measured as the rate of extracellular product accumulation
or substrate consumption by whole cells. Flux was only measured on whole
cells, and these data used for both the in vitro and prelytically inhibited
cell-free extracts.
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3.6.1 Time Course Incubation
Cells that were harvested and incubated in IAA for 60 minutes were, as
described in Section 3.1, split into two equal batches (preinh-activity and
preinh-flux). One batch was subjected to a cell-extraction protocol (see Section
3.5) and the other was used for flux determination.
For the flux determination the cells were resuspended in 2 mL of an
incubation buffer that had been preheated to 30°C (identical to the culture
medium except for a lowered glucose concentration of 20 mM). The cell
suspension was kept at 30°C for the duration of the incubation. A timer
was immediately started (marking t0) and an initial sample of 200 µL of the
extracellular medium was taken. This sample was centrifuged at a relative
centrifugal force of 2000×g using a benchtop picofuge (Labnet Prism Mini
Centrifuge, Edison, NJ, USA). 180 µL supernatant was extracted (taking care
to avoid pipetting up cells) with a pipette and flash-frozen in liquid nitrogen
before storage at -20°C .
After the first sample was taken and stored, 200 µL aliquots of each
incubation were distributed over 9 clearly marked 1.5 mL Eppendorf tubes to
ease the process of sampling: at each interval, one of these aliquots from each
sample would be centrifuged and the supernatant stored. Sampling was done
every 10 minutes over a duration of 90 minutes, yielding 10 time-points tracking
the changes in extracellular medium composition. After all the time-points had
been extracted, the samples were allowed to thaw at room temperature and
centrifuged again at 2700×g in an Eppendorf 5804 R Centrifuge (Eppendorf,
Hamburg, Germany), and the top 160 µL of the sample supernatant transferred
to new 1.5 mL Eppendorf tubes. The samples were then flash-frozen in liquid
nitrogen and stored at -20°C for ethanol and glucose determination at a later
stage.
3.6.2 Ethanol Determination
The samples collected during the time-course incubation of yeast cells were
assayed for ethanol content according to the method of Bergmeyer [114]. A
buffer of 0.33% (g/mL) Na4P2O7·10H2O , 0.016% (g/mL) glycine, and 0.83%
(g/mL) semicarbazide was made up with milliQ H2O and set to pH = 8.8.
After making up the buffer, it was filter-sterilised using a sterile syringe filter
with a pore size of 0.2 µm (Biosmart, Cape Town, South Africa).
Aliquots of the samples were diluted 1:19 into the assay buffer.
The addition of 1 U.µL -1 alcohol dehydrogenase and 10 mM NAD+
thermodynamically drove the conversion of ethanol to acetaldehyde. The
absorbance at λ = 340 nm was tracked for 10 minutes when all reagents but
NAD+ had been added (E1) and then again after NAD+ had been added
until the reaction reached equilibrium (E2). NADH concentration was tracked
spectrophotometrically (SPECTROstarnano, BMG Labtech, Cape Town, South
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Africa) at λ = 340 nm until plateaus were reached for all samples and
standards. All readings were within the linear range of the spectrophotometer.
After this data was collected, a segment of the absorption increase curves
were chosen as representative of the plateau (see Appendix H) and the mean
of the chosen segment was treated as the end-point value. The absorbance
increase from the end-point of E1 to that of E2 represented the detected ethanol
concentration. The change in absorbance over this segment was converted
to an ethanol concentration using a calibration curve with known ethanol
concentrations assayed according to the same method.
3.6.3 Glucose Determination
Time-course incubation samples were assayed for glucose concentration
according to the method of Ogawa et al. [115]. The assay was carried out
in a buffer consisting of 100 mM triethanol amine hydrochloride (TEA-HCl)
and 10 mM MgCl2 at a pH of 8.2. This buffer was sterilised with a sterile
syringe filter with a pore size of 0.2 µm (Biosmart, Cape Town, South Africa).
Samples were diluted 20 times into the assay buffer, along with NAD+ to a
concentration of 4 mM and ATP to a concentration of 2 mM. The absorbance of
the assay cocktails was spectrophotometrically measured for 10 minutes at λ =
340 nm (SPECTROstarnano, BMG Labtech, Cape Town, South Africa). This
was reading G1. Glyceraldehyde 6-phosphate dehydrogenase from Leuconostoc
mesenteroides was then added to a final concentration of 0.5 U.100 µL -1.
Another 10 minute spectrophotometric reading was performed at λ = 340 nm
(reading G2). Finally, hexokinase from S. cerevisiae was added to a final
concentration of 32.5 U.100 µL -1. The final absorbance reading at 340 nm
was then taken for 10 minutes (G3).
The difference between the readings of G2 and G1 is a control for glucose
6-phosphate (G6P) to see if intracellular metabolites somehow get into the
supernatant samples - nothing like this was observed. G3 minus G2 then
yielded the absorbance change due to glucose detection. This absorbance
change was converted to a glucose concentration using a calibration curve
set up using known standard glucose concentrations.
3.7 Protein Determination
Protein determinations were performed on each sample after IAA incubation
and lysis. This was done according to the method of Bradford [116] as adapted
by Ernst and Zor [117]: the ratio of the measured absorbance at λ = 595 nm
to the measured absorbance at λ = 450 nm was calculated, which extends
the range of absorbance values to which protein concentration relates linearly.
This was successfully done for a serial dilution of bovine serum albumin, which
served as standards (see Appendix A).
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This permitted determinations of the total protein content for each
prelytically inhibited sample (collectively called preinh-batch) as well as for
the cells from in-vitro-batch that were only exposed to inhibitor after lysis.
The measured activity of GAPDH and the flux through the whole cells were
then both normalised to their relevant total protein concentrations.
3.8 GAPDH Activity Measurements
The activity of GAPDH was measured in vitro for the determination of the
relative effect of IAA on the enzyme. The relative effect of IAA on GAPDH
in standard conditions is necessary for the calculation of a control coefficient
using specific inhibition [22]. We opted for the in vivo-like conditions of Van
Eunen et al. [3] as a standardised physiological buffer for the determination of
glycolytic enzyme activities in yeast: 300 mM K+, 20 mM Na+, 1.0 mM Ca2+,
1.0 mM Cl-, 245 mM glutamate, 50 mM phosphate, and 10 mM MgSO4, at a
final pH of 6.8.
The reagent concentrations of the reverse GAPDH activity assay were
adapted from Van Eunen et al. [3], themselves having adapted the
concentrations from Van Hoek et al. [118]. The composition of our reverse
assay cocktail was: 0.6 mM NADH, 50 µM NAD+ (suggested by Byers [119] to
abrogate the initial lag in reverse activity measurements), 1 mM ATP, 5 U.µL
-1 phosphoglycerate kinase (PGK), and 5 mM 3-phosphoglycerate (3-PGA).
The reverse assay assumes that PGK is in equilibrium as a coupling enzyme
and that it converts 3-PGA to 1,3-BPG quickly enough to saturate the reverse
GAPDH reaction. It is unlikely that this is the case, but this assumption does
allow reasonable measurements of GAPDH activity in reverse to be made (see
81 for a more detailed discussion on this assumption).
No forward assay was suggested by Van Eunen et al. [3] so we used - out
of the assays discussed by Byers [119] - the one according to Ferdinand [120].
The final assay cocktail composition was: 0.8 mM NAD+ , 10 mM ADP,
0.8 mM D-glyceraldehyde 3-phosphate (D-GAP), and 5 U.µL -1 PGK. The
thermodynamically unfavourable forward GAPDH reaction would be elicited
by adding high concentrations of PGK to convert the product of GAPDH,
1,3-bisphosphoglycerate, to 3-PGA.
For both assays, the activity was measured as either the consumption
(reverse assay) or production (forward assay) of NADH over time at λ =
340 nm using a spectrophotometer (SPECTROstarnano, BMG Labtech, Cape
Town, South Africa). As was done during the construction of the original
model [1], enzyme activity was measured only where the protein concentration
and the measured activity related to each other linearly.
The measured specific activities are approximate Vmax values, as they
were measured in conditions of substrate excess. The unperturbed specific
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activities measured in this study were therefore treated as Vmax,GAPDH values
for comparison to literature Vmax,GAPDH values.
We also wanted to determine the effect of oxidative damage in cell-free
extract as a contributing factor to the binding efficacy of IAA to the cysteinyl
thiolate of GAPDH. For this, activity titrations were all performed in assay
cocktails that contain 5 mM of the moderate reducing agent dithiothritol
(DTT) and cocktails that have no external reducing agent. Comparison of
these data sets would yield insight into the effect of the redox environment on
IAA binding.
3.8.1 Compensating for the Redox Environment
The reader is reminded of Eq. 3.2.1, where the flux control of the inhibitor
(CJI ), the sensitivity of the enzyme to an increase in the inhibitor or an increase
in the inhibitor’s affinity for the enzyme (εI[I]T /Kt), the binding affinity (KI),
and the partition coefficient (PI) all contribute to a "selectivity" of the inhibitor
for its target enzyme in whole cells ("cell") versus cell-free extract ("extract").
Reports in the literature of GAPDH cysteine being protected from IAA
action by being in a oxidised state suggest another important difference
between the cell-free extract and whole-cell environments: outside of the
regulated intracellular environment, enzymes often become oxidised [106].
Brodie and Reed [105] reported that an oxidised state reduces the affinity
of the GAPDH cysteinyl thiol for IAA. This means that the binding affinity
term (KI) of Eq. 3.2.1 might differ when comparing inhibition in vitro and in
vivo. In order to address this for a good comparison between prelytic and in
vitro inhibitor administration, we needed to compensate for the impact of the
redox environment on IAA effect.
The precise redox conditions of the intracellular environment is
experimentally laborious to measure, and would - owing to the flexibility of
the redox proteome - have to be redetermined for each extraction [107, 121].
In order to address the possibility of a changing redox environment leading to
unaccounted-for variation in the inhibition profile, we will investigate whether
oxidation of the enzyme in the lysate affects the observed effect of IAA: all
specific activity measurements will be conducted in a moderate concentration
of DTT and in the absence of DTT. Divergent results will be regarded as
indicators that the redox environment is influencing the inhibition.
3.8.2 NADH Calibration Curve
Changes in absorbance measurements were converted to changes in NADH
concentration by means of a calibration curve for NADH concentration versus
absorbance at λ = 340 nm. This method compensates for experimental
artefacts where mere calculation of concentrations using the Beer-Lambert
law does not.
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3.8.3 Vmax Segment Selection
In both the forward and the reverse directions, the initial increase/decrease in
NADH in the substrate-saturating assays (for calculation of approximate Vmax)
were selected manually. These segments of absorbance increase were linear and
express GAPDH activity where substrate concentrations are not inhibitory.
Figure D.1 shows some examples to illustrate the of segment selection.
The criteria that were applied during segment selection were:
1. selected initial segments were all 30 seconds (four readings) to a minute
(seven readings) long, depending on the duration of the linear absorbance
increase;
2. the segments were kept consistent within biological repeats for each
reaction direction (forward versus reverse);
3. to avoid underestimation of Vmax , the segments all started at the first
time point, unless there was a clear initial lag in the reaction (e.g. at
31.25 µM and 62.5 µM in Fig. D.1C );
4. if the standard deviation of the data was unstable or large, the members
of a technical triplicate were inspected and the most unstable member
of the set dropped (data cleaning) - no more than one member of each
triplicate was dropped (Fig. D.1E is an example data before cleaning
and Fig. D.1F is an example of the same data after cleaning);
3.9 Data Analysis and Mathematical
Modelling
Data analysis and mathematical modelling were both carried out using
Mathematica 11.1 (Wolfram Research Inc., Champaign, IL, USA). The models
analysed in this study are available on the JWS Online model repository as
the teusink model and the dupreez4 models.
Detail about the model analysis procedure are located in the Model
Analysis chapter (Chapter 5) as the modelling methods are best understood
when presented together with their results.
3.10 Control Coefficient Calculation
The control of an enzyme over the flux through the pathway is defined in Eq.
2.3.2. In this equation, the derivative represents the change in pathway flux,
J , as a function of an infinitesimal change in the rate of one of its steps, vi.
Experimentally, infinitesimal changes in a reaction rate would be undetectable,
so the standard approach is to make noninfinitesimal, detectable perturbations
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and to normalise the effect described by Eq. 2.3.2 using the ratio between the
initial values for which the slope was calculated [25]:
CJvi =
dJ/J
dvi/vi
· v
0
i
J0
= J − J0
vi − v0i
· v
0
i
J0
Flux measurements and GAPDH activity measurements were normalised
to unperturbed flux or activity to yield a relative value. The change in relative
flux or relative GAPDH activity over an IAA concentration change of 3.2 µM
(from 0 µM) is taken as an infinitesimal perturbation. This was the size of
the increment for which model behaviour was simulated in all cases. These
increments were then used to calculate glycolytic flux control and regarded as
equivalent to control at an inhibitor concentration of zero for both the model
predictions and the mathematical fits to the experimental data.
3.10.1 IAA in Control Analysis
In Section 2.3 of the previous chapter, we describe some of the theory
underlying Metabolic Control Analysis (MCA). Importantly, flux control is
defined in Eq. 2.3.2, which we present again for convenience:
CJvi =
dJ/J
dvi/vi
As explained in Section 2.3, this parameter relates the change in flux
through a pathway to the change in the rates of its component steps. To
determine flux control experimentally, it is important to know that the chosen
enzyme is the only component in the pathway that is being varied. To this
end, one can either downregulate an enzyme’s concentration, or administer a
known specific inhibitor. IAA (administered in low concentrations) allows us
to specifically inhibit GAPDH within glycolysis. Poolman et al. [22] present
a derivation of Eq. 2.3.2 where an inhibitor is administered and the resulting
change in pathway flux and enzyme activity expressed together:
CJEi =
(dJ/J)
(dI/I)ss
÷ (dvi/vi)(dI/I)Si,Pi
(3.10.1)
in which the flux through a pathway is controlled by its constituent enzyme,
Ei; in this equation, (dJ/J)(dI/I)ss expresses the change in steady-state (hence the
subscript, ss) flux due to the inhibitor, I, while (dvi/vi)(dI/I)Si,Pi expresses the change
in the reaction rate through enzyme Ei (at constant substrate and product
concentrations,Si and Pi), due to the same inhibitor concentration. Substrate
excess is most useful as they allow the measurement of the inhibition effect
without the decrease in substrate concentration also contributing to a decrease
in enzyme activity. The ratio between these changes gives the flux control of
Ei over the pathway.
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This equation offers a simple way of using IAA as a means for determining
the control coefficient of GAPDH over glycolysis: indeed this was what
Poolman and colleagues [22] used it for.
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Experimental Results
It is important to note that three independent biological repeats were made.
They are named chronologically, I having been grown and assayed first, II
second, and III third, with a time span of 15 days between the first and the
last biological repeat was grown up and harvested.
4.1 Growth Curve Construction
The optical density of two S. cerevisiae X2180 cultures was monitored with
readings at regular intervals at a wavelength of 600 nm. This was done prior
to the growth of repeats I, II, and III, on two cultures with identical growth
medium composition and from the same strain as the cultures that would be
assayed. These optical density data were plotted as a function of time to
visualise the growth of a culture of this strain of yeast with defined starting
conditions. Fig. 4.1 shows these curves. We concluded that the rate of
biomass yield is reproducible and that an optical density measurement at a
wavelength of 600 nm could be used to define the appropriate point in growth
for cell harvesting, namely at diauxic shift, as in Du Preez et al. [2]. Glucose
measurements with urine strips verified that the plateaus seen in the OD600
data coincide with glucose depletion.
4.2 Protein Determination
To convert enzyme activiy to specific enzyme activity, a protein determination
according to the method of Bradford [116] was performed. The protein yield
varied considerably between the different isolates but less so within each one.
The cell-free extracts made from the in-vitro-batch (see Fig. 3.1) of isolate I, II,
and III yielded approximately 1.0, 7.8 and 7.6 mg.ml-1 protein, respectively,
while the preinh-batch extracts contained approximately 0.22 (I ), 0.64 (II ),
and 0.55 (III ) mg.ml-1 protein. We followed common practice and calculated
the protein concentration from multiple dilutions of each sample. The standard
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Figure 4.1: Growth of Saccharomyces cerevisiae X2180 on 1% (w/v) glucose
containing growth media can be accurately tracked to diauxic shift using a
spectrophotometer. The green and the blue data points represent the means of
two independent duplicate sets of the growth curve data. Glucose measurements
using urine strips confirmed that the plateau seen when measuring the OD600 of a
culture coincides with glucose depletion.
deviation of the protein concentrations exceeded 20% in only one case, where
it was close to 21% (see Appendix A). We found this variation acceptable and
continued with the calculated values.
The difference in protein yield between isolates were significant. This is
probably due to incomplete lysis of cells during glass-bead extraction (see
Section 6.4 in the Discussion for more on this). Isolate I appeared to be an
outlier with respect to II and III. Full detail of the protein determination
results can be seen in Appendix A.
4.3 Measuring GAPDH Activity
GAPDH activity was measured as a function of IAA concentration in
each different combination of inhibition methods (prelytic versus in vitro),
compensation for oxidative damage (DTT versus no DTT), and assay direction
(forward versus reverse). As described in the methodology chapter (Chapter
3), the incubation time in IAA was 60 minutes for whole-cells and for cell-free
extract.
Before GAPDH measurements in the aforementioned combinations of
conditions were carried out, we ran tests to confirm the irreversibility of IAA’s
effect on GAPDH (see Appendix B) and whether non-specific NADH oxidation
contributes significantly to the observed absorbance change during the reverse
GAPDH assays (see Appendix C). It was found that GAPDH inhibition was
irreversible over the time scales relevant to our assays, and that non-specific
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NADH oxidation was not responsible for any significant absorbance change.
4.3.1 Rate Data Inspection
Appropriate segments of absorbance change were selected (see Appendix
D) and the gradients of those data were determined. The mean change
in absorbance was taken as the reaction rate, and converted to a NADH
concentration change rate (see Appendix E for the absorbance-NADH
calibration curve). Specific activity was a clear function of IAA concentration.
Appendix F contains more detailed information on the standard error in the
data, but the trends were unambiguous in all cases.
The specific activities measured in our study were approximate Vmax values
according to the method of Van Eunen et al. [3]. The wild-type Vmax,GAPDH
values that we measured were all lower than the Vmax,GAPDH paramaters
determined by Teusink et al. (1; Table 4.2 presents the activities that we
measured in all the different combinations of conditions). As will be discussed
in this chapter, we chose DTT-containing, prelytically inhibited samples for
comparison to the models. In those conditions, we measured approximate
forward Vmax,GAPDH values of 4.15, 2.56, and 2.54 µmol.min-1.mg protein-1 for
repeats I, II, and III, respectively (Table 4.1). In reverse, we measured 6.96,
4.5, and 4.69 µmol.min-1.mg protein-1 (I, II, and III, respectively).
Table 4.1: Simulated and experimentally determined Vmax,GAPDH values. The
Teusink and Du Preez model fluxes are presented (prior to model adjustment) as
well as the three independent experimental triplicates (bottom three rows, below
the double line). The Vmax,GAPDH values are measured in µmol.min-1.mg protein-1.
Vmaxf Vmaxr
Teusink model 4.4 24.3
Du Preez model 1.04 n/a
I 4.15 6.96
II 2.56 4.5
III 2.54 4.69
Teusink and colleagues used a forward Vmax,GAPDH of 4.4 µmol.min-1.mg
protein-1 and, in the reverse direction, 24.3 µmol.min-1.mg protein-1 (Table
4.1). Our measured forward Vmax,GAPDH is therefore no more than a factor of
two removed from the Teusink value, but our measured reverse Vmax,GAPDH is
up to a factor 6 lower than the Teusink values.
Van Eunen et al. report measuring an almost 50% lower Vmax of GAPDH
than was measured in so-called "optimised" conditions by Van Hoek et al.
[118]. The Teusink and Van Hoek buffers are more similar to each other than
either is to the Van Eunen buffer (see Chapter 6). One might speculate that
the difference in measured Vmax could be similarly large when comparing data
43
Stellenbosch University https://scholar.sun.ac.za
CHAPTER 4. EXPERIMENTAL RESULTS
Table 4.2: Experimentally measured approximate Vmax,GAPDH values are
consistently smaller than the Vmax values used by Teusink et al. [1]. The Teusink
Vmax values were: 4.4 µmol.min-1.mg protein-1 forward and 24.3 µmol.min-1.mg
protein-1 in reverse. All values in the top table are our approximate Vmax values
measured in µmol.min-1.mg protein-1 measured in various assay combinations of
assay conditions and inhibitor administration methods. The bottom table also gives
our Vmax measurements as a percentage of the corresponding value in the Teusink
models.
Absolute Vmax,GAPDH Values in μmol.min-1.mg protein-1
Isolate
In vitro inhibition Prelytic inhibition
Reverse Forward Reverse Forward-DTT +DTT -DTT +DTT -DTT +DTT -DTT +DTT
I 4.995 6.955 2.869 4.15 5.662 6.941 3.334 3.506
II 3.998 4.497 2.151 2.563 4.059 3.716 2.593 2.719
III 3.732 4.689 1.873 2.536 3.735 5.51 1.984 2.68
%Size of our Vmax,GAPDH Values against Vmax,GAPDH Values in Teusink Model
Isolate
In vitro inhibition Prelytic inhibition
Reverse Forward Reverse Forward-DTT +DTT -DTT +DTT -DTT +DTT -DTT +DTT
I 20.56 28.62 65.2 94.32 23.3 28.56 75.77 79.68
II 16.45 18.51 48.89 58.25 16.7 15.29 58.93 61.8
III 15.36 19.3 42.57 57.64 15.37 22.67 45.09 60.91
from the Teusink and the Van Eunen buffers. Moreover, the use of this buffer
might affect measured Km values, too. In this way the forward Vmax,GAPDH
could be affected less strongly than the reverse Vmax,GAPDH while maintaining
the Haldane relationship intact. This matter is discussed in more detail in
Section 6.2.
Another contributing factor to the differences in measured Vmax,GAPDH
might be the use of a different strain in our experiments (X2180) than was used
by Teusink et al. (Koningsgist; [1]). We used the same strain as Du Preez and
colleagues [2]. They used a search function which suggested a forward Vmax
that was only 23.6% the size of the forward Vmax,GAPDH in the Teusink model:
the final Vmax,GAPDH used in dupreez4 was 1.02 µmol.min-1.mg protein-1 in the
forward direction (Table 4.1; they do not use an explicit reverse Vmax,GAPDH
). They go on to note that their oscillation experiments were performed at
between 20°C and 25°C and "(a)ssuming a Q10 value of 2 (i.e. a 10°C decrease
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in temperature leads to 1/2 the activity), this temperature would result in up
to 50% lower enzyme activities" [2].
If, for argument’s sake, one doubles the Du Preez parameters to get
hypothetical values of their parameters at 30°C , one would obtain a forward
Vmax,GAPDH of 2.08 µmol.min-1.mg protein-1. This lies close to the 2.56 and
2.54 µmol.min-1.mg protein-1 of repeats II and III, respectively, in our assays.
Within the data sets generated for this study, no more than a factor two
difference was observed between any of our our unperturbed, approximate
Vmax,GAPDH values, indicating internal consistency in our experimental
method. We did not further investigate the differences between our measured
Vmax,GAPDH values and the literature values.
4.3.2 Addition of DTT
Oxidative inactivation of enzymes has been shown to introduce artefacts into
enzymology [122]. The suggestion to reverse this by the addition of DTT [105]
was included as a variable in our investigation. 5 mM of DTT was added to
test its effect on the inhibition of GAPDH by IAA.
In Table 4.3 it can be seen that higher activities were observed in the
presence of DTT in most cases. Only 14 of the 67 data sets had higher activity
in the absence of DTT. In eleven of those fourteen cases, the activity of both
the DTT-containing and non-DTT-containing reactions were close to zero and
heavily influenced by residual noise in the data. The remaining three were the
sole outliers to the observed pattern of DTT effects.
The effect of DTT on the percentage inhibition of GAPDH activity by
IAA, however, was minimal. Reaction rates were expressed as a percentage of
the wild-type (i.e. uninhibited) activity. Across all three biological repeats,
DTT did not affect the relative inhibition of GAPDH activity, e.g. in Fig. 4.2
(complete data not shown).
It was decided that the data from DTT-containing assays would be
authoritative when analysing other variables, as it represents a condition closer
to that encountered in vivo (109; 123). For the sake of brevity, data sets
without DTT are omitted from further reporting and analysis (see Chapter 6,
Discussion, for more on this).
4.3.3 In vitro Addition of IAA vs. Prelytic Inhibition
In Fig. 4.3IA and IB, GAPDH activity was completely or nearly completely
abrogated by an hour-long incubation even in small concentrations of IAA in
vitro, while the GAPDH of prelytically inhibited cell extract remained active at
all the assayed IAA concentrations. This data is from repeat I. For repeats II
and III, however, the specific activities of cell extracts from in vitro and prelytic
inhibitions were almost identical (Fig. 4.3). This is also true of normalised
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Table 4.3: DTT predictably leads to higher absolute measured activity. The table
compares the activity in the presence of DTT and activity in the absence of DTT
(DTT effect = activity(+DTT)/activity(-DTT)). WhereverDTT effect > 1, the data
are shown in black and indicate a higher activity in the presence of DTT. A DTT
effect < 1 indicates that higher activity was observed without DTT (in red). Empty
cells indicate conditions where data were dropped due to excessive error (Table F.1)
and comparisons could not be made. 66 comparisons were made of which 14 had a
DTT effect < 1. I, II, and III represent the biological triplicates.
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Figure 4.2: DTT did not significantly alter the percentage GAPDH inhibition by
IAA. Specific activity was expressed as a percentage of the wild-type (uninhibited)
activity at the same conditions. The blue data points indicate assays without DTT
while the red points represent assays in the presence of DTT. The data in this
figure are from only one biological repeat. A, B,C, and D represent the different
reaction conditions (described in italicized labels above each graph: "in vitro" and
"prelytic" referring to the method of inhibitor administration; see text for details).
All normalised trends remain stable regardless of DTT addition.
rates, as seen in Fig. 4.4. Repeat I also had a significantly lower protein yield
(see Section 4.2) and a higher measured Vmax,GAPDH (see Table 4.2).
The method of inhibitor administration seems to have made a big difference
only in repeat I. Since a prelytic inhibition be used for both flux and GAPDH
activity measurements (Section 3.4), it is a more consistent method for
determining glycolytic control. For brevity, all GAPDH activity data presented
in the following sections - unless explicitly stated otherwise - will be from the
prelytically inhibited cell extract.
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Figure 4.3: In vitro and prelytic inhibitor incubations have nearly identical effects
in two out of three biological repeats. The data here are approximate measurements
of the Vmax,GAPDH according to the method of Van Eunen et al. [3]. These graphics
indicate the different consequences of exposing GAPDH to IAA after lysis, by adding
it directly to the cell-free extract, versus incubating whole cells in a growth medium
containing the inhibitor before cell lysis. I, II, and III represent three biological
repeats. Those labelled A show GAPDH activity when assayed in the reverse
direction while B shows the same activity when measured in the forward direction.
Blue data points indicate the activity measured when IAA was added in vitro while
the red points indicate the data from prelytically inhibited cell extract.
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Figure 4.4: In vitro and prelytic inhibitor incubations have nearly identical effects
in two out of three biological repeats when activity is expressed as a % of the
wild-type (uninhibited) activity at the same conditions. These graphics indicate the
different effects of administering IAA directly to cell-free extract versus incubating
whole cells in a growth medium containing the inhibitor before cell lysis. I, II, and
III represent the three different biological isolates. Those labelled A show reverse
GAPDH activity and while B shows forward GAPDH activity. Blue data points
are from in vitro inhibitions while the red points indicate the data from prelytically
inhibited cell extract.
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4.3.4 Forward and Reverse Activity
The wild-type forward rates were about half the size of the reverse rates (Fig.
4.5). There was also consistent dose-response within repeats but not between
them: repeat I was especially divergent, particularly at higher [IAA]. This was
a trend throughout this study and we return to it in Chapter 6.
Irreversible inhibition kinetics are best described using exponential decay
functions [124], and lines were fitted to the absolute activity inhibition data
from each biological repeat using the method of least squares (Fig. 4.5). It was
striking that R2 ≥ 0.96 was obtained for all of these fits. All of the functions
were constructed to pass through the y-axis, and this intercept represented
the wild-type Vmax,GAPDH value of the relevant data set (see Subsection 5.2.2).
The fitted lines and their functions are all shown in the caption of Fig. 4.5.
The dose-dependent % inhibition of GAPDH activity was almost identical
in the forward and reverse directions (see Fig. 4.6). This was, again, true
within repeats, but not between them. An exponential decay function was
also fitted to these data. For fitting to the % inhibition data, we combined
forward and reverse GAPDH activity inhibition data for each repeat (Fig.
4.6). This proved very useful during model analysis (see Subsection 5.2.2 on
modelling IAA action on GAPDH). The fits all had R2 ≥ 0.96.
Figure 4.5: Forward and reverse GAPDH activity at substrate-saturating
conditions is consistently related to IAA within repeats of the assay but not between
repeats. The different colours represent the different biological isolates: the data
from isolate I is presented in blue, II in green and III in red. A shows the
reactions rates measured in the reverse direction while B presents the rates of the
forward reactions. The fitted lines describe the data of the same colour and are
defined by linear equations). They are (R2 indicated in parentheses): in A, I in
reverse: V appmax,GAPDH = e(1.9−0.0037[IAA]) (0.995); II in reverse: V
app
max,GAPDH =
e(1.4−0.012[IAA]) (0.98); III in reverse: V appmax,GAPDH = e(1.8−0.018[IAA]) (0.98). In
B, I forward: V appmax,GAPDH = e(1.2−0.0050[IAA]) (0.98); II forward: V
app
max,GAPDH =
e(0.97−0.017[IAA]) (0.996); and III forward: V appmax,GAPDH = e(0.91−0.025[IAA]) (0.97).
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Figure 4.6: Forward and reverse normalised specific GAPDH activity form a single
trend to which a function can be fit. The forward and reverse) reactions were each
normalised over the measured wild-type GAPDH activity. The data sets of the
forward (red) and reverse (blue reactions were then combined and an exponential
decay function was fit to them according to the method of least squares. I, II,
and III represent the three biological repeats, and yielded fits with the following
equations (R2 indicated in parentheses): I : V appmax,GAPDH = e(4.6−0.0044[IAA]) (0.98);
II V appmax,GAPDH = e(4.6−0.014[IAA]) (0.98); and III V
app
max,GAPDH = e(4.6−0.020[IAA])
(0.96).
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4.4 Ethanol Production Rate
Glucose was not fixed during the incubations, hence what was measured
was not technically steady-state fluxes. Substrate was added in excess,
however, so the rates of glucose import and product formation are initially
not substrate-limited and will be treated as equivalent to steady-state fluxes.
4.4.1 Ethanol Production Rate Determination
The ethanol concentrations (see Appendices G and H for more on their
determination), were expressed as a function of time during sample incubation
in 20 mM of glucose. The initial ethanol increase that would represent flux
was selected by inspection (for example in Fig. 4.7). A linear model fit was
done on each sample’s initial segment: all fits had R2 > 0.95, except where
the gradients were near-zero (Table 4.4).
Near-zero gradients indicate very low ethanol production, and small
standard deviations therefore had a disproportionate impact on their
goodness-of-fit: these small R2 values constituted only a fifth of all fits (see
Fig. 4.8). Furthermore, of the 15 fits with R2 values greater than 0.95, 13 had
R2 upwards of 0.99. The fits to the ethanol production data were therefore
quite good. No fewer than six out of every data set’s ten points (equal to 50
minutes of incubation) were used for fitting, so the trends were representative.
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Figure 4.7: Example of ethanol production time-course. This sample was
incubated in 18.75 µM of IAA for an hour. Ethanol concentration over time gave
the production rate. Linear model fits through these data were forced through the
origin and selected to reflect the substrate-saturating part of the incubation. The
black points and black solid line represent the experimental data and the linear fit
on those data, respectively. The red data points represent experimental data that
were located at substrate-limiting conditions and excluded from the fit. The linear
fit’s equation was y = 0.43x and had an R2 = 0.995.
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Figure 4.8: Fits with R2 ≤ 0.95. Low ethanol concentrations magnify the impact
of slight standard deviations on the goodness-of-fit measure. The red points on B
were not included in the calculation of the linear model fit. A was constructed with
cells (from isolate II) that were inhibited with 300 µM IAA and had an R2 = 0.6955.
B (from isolate III) was inhibited with 125 µM and had an R2 = 0.9020. C (also
from III was inhibited with 250 µM and had an R2 = 0.8010
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A comparison of these data for each biological repeat showed that the
rate at which ethanol concentration increases, slows down as the inhibitor
concentration increases (Fig. 4.9). The rate of ethanol production could then
be calculated as the first derivative of the lines in Fig. 4.9. These data were
expressed as a function of IAA concentration to show the inhibitory effect.
Glycolytic flux was normalised to the mg of total protein present in each
incubation. In Fig.4.10A the normalised ethanol production rates of the three
biological repeats are compared. For the uninhibited fluxes, we found ethanol
production rates between 0.1 and 0.15 µmol.min-1.mg protein-1 (see Table 4.4),
which is about a factor of five smaller than the 0.5 µmol.min-1.mg protein-1
reported by Teusink et al. [1]. This scales to our Vmax,GAPDH values, that were
also between a factor of two and ten smaller than the Teusink parameters.
Finally, the effects of increasing IAA on the different biological repeats were
clearly dose-dependent within samples but not so between samples (see Section
6.4 for more on this).
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Figure 4.9: Example of a comparison of linear fits on the ethanol production
rates at varying IAA concentrations (isolate I). The legend on the right-hand side
indicates the IAA concentrations to which the different samples were exposed before
the incubation took place. A clear IAA concentration-dependent effect was visible
within each of the three biological repeats (II and III not shown).
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Fig. 4.10B presents ethanol flux as a percentage of the wild-type flux. The
normalised inhibition plots show that, for the inhibition of ethanol flux, the
three biological repeats are comparable, though more disparity is observed
at high IAA concentrations. Normalisation appeared to not improve the
agreement between the repeats by much. This disparity was worst when
comparing repeat I to the other two repeats (see Section 6.4).
Figure 4.10: Specific and normalised ethanol production rates. A depicts the
relationship between specific ethanol production rate and IAA concentration while
B represents the same relationship but with ethanol production expressed as a
percentage of the wild-type (uninhibited) specific flux. The different-coloured dots
represent the three biological repeats (I in red, II in green, and III in blue).
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4.5 Glucose Consumption Rate
Glucose consumption was also tracked by enzymatically assaying aliquots from
10-minute intervals over a 90-minute incubation. A more detailed description
of the process of interpreting the raw data, is given in Appendix I.
Glucose concentrations were expressed as a function of time. Linear model
fits were carried out on each of the data sets. The functions were all forced
through 20 mM of glucose at 0 minutes time (the starting glucose concentration
of all the incubations). In all but one of the data sets, five or more of the data
points were used (40 minutes of more of the incubation). In the remaining
data set, four points were used (Fig. 4.11). Only outliers and points at the
plateaus of the glucose consumption curves were discarded. All of the fits had
an R2 > 0.99 (Table 4.5).
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Figure 4.11: Example of glucose consumption by S. cerevisiae X2180. The graph
shows the decrease in glucose concentration over time in the presence of yeast cells.
The cells in this incubation (from isolate III) were inhibited with 15.625 µM of IAA.
The black data points represent the experimentally measured glucose concentrations
at each time point which were used for fitting. The red points are the points that
were discarded during fitting. The black line is the linear model fit describing glucose
consumption and has a function y = 20− 0.35x and an R2 = 0.999.
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Fluxes were calculated for each incubation as the first derivative of the line
fitted to glucose consumption data (Fig. 4.11). Fig. 4.12A shows the specific
rates of glucose consumption as a function of IAA concentration. Fig. 4.12B
shows these rates as percentages of the the wild-type glucose consumption.
Clear dose-dependence was seen within repeats, but not between them.
Both the ethanol and glucose fluxes measured in our study were lower
than the fluxes reported by Teusink and colleagues [1]. For instance, we
reported ethanol production rates ranging between 0.1 and 0.15 µmol.min-1.mg
protein-1, while Teusink et al. observed an ethanol flux of 0.50µmol.min-1.mg
protein-1. Similarly, our measured glucose flux was between 0.09 and 0.13
µmol.min-1.mg protein-1 (see Table 4.5), while the Teusink value was 0.40
µmol.min-1.mg protein-1. The fact that our measured Vmax,GAPDH values were
also 2 to 10 times smaller, fits with this observation.
Figure 4.12: Specific and normalised glucose consumption rates exhibit dose
dependence with IAA concentration. A depicts the relationship between specific
glucose consumption rate and IAA concentration while B represents the same
relationship but with glucose consumption expressed as a percentage of the wild-type
(uninhibited) rate. The different-coloured data points represent the three biological
repeats (I in red, II in green, and III in blue).
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Fig. 4.13 compares the glucose consumption and ethanol production rates.
The data from these assays indicate an almost 1:1 ratio of ethanol produced
for glucose consumed. Presumably, carbon is lost to the branches and during
pyruvate decarboxylation. Albers et al. [43] indicate a glucose to ethanol
flux ratio of 3:4. We did not investigate the fluxes over the other metabolic
branches, but it appears that flux distribution is independent of [IAA].
When the flux data were normalised to their wild-type values, the % effect
of increasing IAA concentrations on glycolytic flux were obtained. Figure
4.14 shows ethanol production and glucose consumption as a function of
IAA concentration. For control analysis, the relationship between glycolytic
flux and IAA needed to be quantified. The effect of IAA on glycolysis is
non-linear, but we only needed to describe the initial trend: it was evident in
the data that a linear function could describe the initial relationship between
glycolytic flux and IAA concentration. Lines were fitted to the four lowest
IAA concentrations to yield R2 values upwards of 0.97. The fits and their
coefficients of determination are all presented in Fig. 4.14.
Figure 4.13: The specific ethanol production rate and the specific glucose
consumption rate show similar trends within each repeats, although this rate differed
between repeats. I, II, and III represent the different biological repeats, with
different IAA ranges between 0 and 400 µM (maximum IAA concentrations of
400 µM , 300 µM , and 250 µM , respectively). It is clear from this data that
a percentual expression of the glucose consumption and ethanol production rates
should also correlate well with each other.
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Figure 4.14: Fits obtained to low-IAA flux perturbation data for all three repeats.
When the flux data were normalised to their wild-type values, the %wtflux could
be plotted as a function of IAA concentration. In A, the normalised ethanol
production versus IAA concentration is shown, and, in B, the same is shown for
glucose consumption. Linear fits according to the method of least squares yielded
the functions that are shown as dashed lines, all with R2 ≥ 0.97 (red for repeat I,
green for II, and blue for III ). Only the first four data points (i.e. the four lowest
IAA concentrations) were used for the fits, as the flux-to-IAA relation was aptly
described by a linear function for the first four data points in each repeat. The fitted
functions were (with R2 in parentheses): for I, %Ethanol F lux = 100− 0.38 · [IAA]
(R2 = 0.999) and %Glucose F lux = 100 − 0.15 · [IAA] (R2 = 0.99); for II,
%Ethanol F lux = 100 − 0.37 · [IAA] (R2 = 0.998) and %Glucose F lux =
100− 0.091 · [IAA] (R2 = 0.997); and for III, %Ethanol F lux = 100− 0.30 · [IAA]
(R2 = 0.98) and %Glucose F lux = 100− 0.0027 · [IAA] (R2 = 0.992).
61
Stellenbosch University https://scholar.sun.ac.za
CHAPTER 4. EXPERIMENTAL RESULTS
4.6 Glycolytic Flux Control
Glycolytic flux was plotted against specific activity, and yielded a clear trend
(Fig. 4.15). This was true regardless of the direction in which the reaction was
measured or of the method by which glycolytic flux was measured (see also Fig.
4.14). Considerable scatter was visible when combining these data expressed
as percentages of the uninhibited activity. Neither the chosen glycolytic flux
assay (Fig. 4.16A) or the chosen GAPDH activity assay (Fig. 4.16B) deviated
too strongly from the other, except perhaps for ethanol production having
consistently lower % values than glucose consumption. The most significant
deviation in the data was found when comparing the different biological repeats
to each other.
Repeat I diverged from II and III: not only was it the only isolate in which
full inhibition was not observed in the inhibitor range used (Fig. 4.6 and 4.13)
but it had a much higher wild-type Vmax,GAPDH and a lower protein yield (see
earlier, e.g. Fig. 4.6); finally, it was also the only one amongst the triplicate
set for which the in vitro and prelytic methods of administering IAA yielded
different results (Fig. 4.4). All of these exceptions to the behaviour of the
other two isolates rendered the data from repeat I suspect.
GAPDH activity data (A), the %wild-type ethanol flux (B) and the
%wild-type glucose flux (C ) were separately expressed as a function of IAA
concentration (Fig. 4.17 shows these plots for the combined data of repeat
II and III ). The exponential decay functions fitted to the GAPDH activity
titration data (Fig. 4.6) and the linear fits to the initial flux inhibition data
(Fig. 4.14) allowed us to calculate a glycolytic flux control coefficient for
GAPDH in S. cerevisiae, both in terms of glucose consumption and in terms
of ethanol production. The equation for the flux control coefficient of GAPDH,
would be (adapted from Eq. 2.3.2):
CJvGAPDH =
dJ/J
dvGAPDH/vGAPDH
The following equations express glycolytic flux control by GAPDH at
near-zero inhibition:
CJEtOHvGAPDH =
−0.0165221 · e4.60517−0.0165221[IAA]
−0.345396
CJGLCovGAPDH =
−0.0165221 · e4.60517−0.0165221[IAA]
−0.0526257
62
Stellenbosch University https://scholar.sun.ac.za
CHAPTER 4. EXPERIMENTAL RESULTS
The functions are solved for [IAA] = 0, yielding:
CJEtOHvGAPDH = 0.21
CJGLCovGAPDH = 0.032
Figure 4.15: Glycolytic activity as a function of the apparent Vmax,GAPDH ,
according to the method of Van Eunen et al. [3]. Various combinations of metrics
show the relationship between absolute carbon flux and absolute V appmax,GAPDH : A
and B show ethanol production flux, while C and D track glucose consumption; A
and C show reverse GAPDH activity while B and D present the forward activity.
The red data points are the data from biological repeat I, green from II and blue from
III. Besides for the lower V appmax,GAPDH of the forward GAPDH reaction, which is in
agreement with existing biochemical knowledge, no single combination of metrics
exhibited aberrant behaviour when expressed in absolute terms.
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Figure 4.17: Independent fits to the flux and the GAPDH activity decrease data
allows the calculation of the glycolytic flux control coefficient of GAPDH. The
plots in this figure show the fits, according to the method of least squares, to the
relative GAPDH activity (plot A), the relative ethanol production (B), and the
relative glucose consumption data (C ). In each case, the flux or enzyme activity was
normalised to its wild-type value and plotted as a function of IAA concentration.
Repeat I is represented in blue, II in green, and III in red. Due to the consistent
outlier behaviour of repeat I, the fits were only to the data from II and II. An
exponential decay function was fit to the GAPDH activity data, forward and reverse,
that yielded the function %GAPDHActivity = 100% · e4.60517−0.0165221[IAA], with
an R2 value of 0.96. For the ethanol and glucose fluxes, linear functions were
fit to the first four points of the data, yielding functions of %EthanolF lux =
100 − 0.345396[IAA] (R2 = 0.99) and %GlucoseF lux = 100 − 0.0526257[IAA]
(R2 = 0.994).
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Model Analysis
The kinetic models of glycolysis in Saccharomyces cerevisiae by Du Preez et
al. [2] and Teusink et al. [1] were analysed for comparison to experimental
GAPDH inhibition data. These models can be found on the JWS Online model
repository as the teusink model and the dupreez4 models (referred to in this
thesis as the Teusink and the Du Preez models, respectively).
5.1 Modelling IAA Action
The first question when comparing model predictions to experimental results
is how to best simulate the experimental methods in silico. IAA was used to
selectively perturb the activity of GAPDH, which is represented in the Teusink
[1] and Du Preez [2] models in terms of reversible two-substrates, two-products
Michaelis-Menten kinetics.
5.1.1 The Importance of Irreversibility
IAA is regarded as a textbook example of an irreversible enzyme inhibitor
[22, 23, 93]. It covalently modifies GAPDH by alkylating an active-site
cysteine residue, blocking it to inhibit the binding of substrates. Therefore,
unlike reversible inhibition, which is kinetically described with a binding term,
irreversible inhibition can be understood as a removal of enzymes from the
pool of possible catalysts [125]:
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Figure 5.1: Irreversible inhibition removes enzymes from the pool of possible
catalysts. In this scheme, E represents the enzyme, S and P the substrate and
product, respectively, and I the inhibitor. EI and ES are enzyme-inhibitor and
enzyme-substrate complexes. kass expresses the rate at which the inhibitor binds to
the enzyme and captures the time dependence of irreversible inhibition.
The scheme in Fig. 5.1 shows how an irreversible inhibitor, such as IAA,
sequesters enzymes in a time-dependent manner (as captured by kass). This
can also be expressed in an equation representing the different states of the
total enzyme concentration.
[E]0 = [E]bi + [E]f (5.1.1)
where [E]0 represents total enzyme, [E]bi represents total inhibitor-bound
enzyme, and [E]f represents total free enzyme (which includes enzymes in
which the active site is occupied by a substrate). In the presence of an
irreversible inhibitor some of the enzymes in the catalyst pool are occupied
by the inhibitory substance and therefore inoperative. A similar equation can
be constructed for the inhibitor:
[I]0 = [I]be + [I]f
where, as before, [I]0 is the total inhibitor concentration, [I]be the
enzyme-bound inhibitor, and [I]f the total free IAA. IAA is understood to
be promiscuous in its binding [96], however, and being covalently bound to
other cysteine residues removes IAA from the pool of IAA molecules that can
cause GAPDH inhibition. IAA concentration can therefore be expressed as
the sum of free IAA ([I]f ), non-specifically bound IAA ([I]nsbe , which includes
IAA bound to GAPDH, but not to the inhibition site), and GAPDH-bound
IAA ([I]sbe, which includes only inhibitory binding):
[I]0 = [I]nsbe + [I]sbe + [I]f (5.1.2)
IAA can only bind to a single cysteinyl thiol on GAPDH to exert its
inhibitory effect, hence [I]sbe and [E]bi are equivalent expressions. The amount
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of free enzyme, [E]f , can be understood in terms of the concentration of
inhibitor administered to the cell or cell-free extract:
[E]f = [E]0 − [I]0 + [I]f + [I]nsbe
Since IAA-binding is time-dependent (Fig. 5.1), a maximal inhibition will
be reached after a given amount of time, which can be interpreted as the
depletion of unbound free inhibitor:
[E]f = [E]0 − [I]0 + [I]nsbe (5.1.3)
Equation 5.1.3 shows that at the time of inhibitor depletion, the
concentration of free enzyme depends on the starting enzyme concentration,
the non-specific binding, and the concentration of inhibitor added. Two
of these factors - starting enzyme concentrations and non-specific binding
- are, themselves, dependent on enzyme expression in the cultures. For
instance, lower proportional expression of GAPDH amongst intracellular
enzymes might lead to higher levels of non-GAPDH binding and a lower
proportional GAPDH-inhibitory effect of inhibitor addition to a batch of cells.
This logic can also be applied to the difference between whole-cell inhibition
and cell-free extract inhibition: if, for instance, GAPDH localises in a specific
part of a cell (for instance in the glycosome; see 113), the proportion of IAA
that binds specifically to GAPDH will be determined not only by the relative
abundance of GAPDH in the cell, but by the effective concentration of IAA
that ends up reaching it before it is bound non-specifically in the greater
volume of the cell. This is one mechanistic possibility of the pharmacokinetic
effect posited in Eq. 3.2.1.
Though we maintain a consistent cell culturing and harvesting protocol
(see Section 3.1), differences in enzyme expression can arise regardless. This
can be compensated for by assuring that measurements are only compared
to measurements from the same isolate and, therefore, the same inhibitor
incubation. Within each biological repeat, protein expression will be assumed
to be constant, so the fraction of the inhibitor that binds non-specifically will
be constant and can be disregarded. This narrows any change in free enzyme
concentration, hence any change in specific activity, down to the concentration
of inhibitor administered.
5.1.2 IAA in Rate Equations
The question now remains how to incorporate this into an expression of the
reaction rate of an enzyme. To adhere more closely to a bottom-up modelling
approach, it is necessary to know not only that IAA decreases GAPDH activity
but how this effect is achieved [26]. The effect of increasing concentrations of
IAA is most usefully interpreted as a decrease in the concentration of free
GAPDH. Enzyme concentration is not explicitly included in the Du Preez
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and Teusink models, however. Rather, it is subsumed under Vmax [26].
The Briggs-Haldane derivation of the Michaelis-Menten equation (Eq. 5.1.4,
below), allows us to infer a linear relationship between enzyme concentration
and reaction rate (Eq. 5.1.5):
v = Vmax · [S]
Km + [S]
(5.1.4)
v = kcat · [ES] (5.1.5)
In Eq. 5.1.5, [ES] represents the concentration of the enzyme-substrate
complex, kcat represents the rate constant for the conversion from
enzyme-substrate complex to enzyme and product, and v describes the specific
enzyme reaction rate [6].
If assays are set up to measure maximal GAPDH activity, it can be
assumed that all of the enzymes’ active sites are occupied: [ES] is equal
to [E]0, the total enzyme concentration (compare Eq. 5.1.1). Since we use
the substrate-saturating assay conditions of Van Eunen and colleagues [3], we
can treat the measured specific activities as equivalent to Vmax,GAPDH (for
the uninhibited sample) or (apparent) Vmax values (V appmax,GAPDH ; inhibited
activity).
The distinctive contribution of thermodynamics and enzyme concentration
to the Vmax was made explicit in the work of Smallbone and colleagues [35], who
separately determined protein concentration ([E], by targeted proteomics) and
enzyme turnover rate (kcat). [E]0 can then be related to Vmax,GAPDH according
to the following equation:
Vmax = kcat · [E]0 (5.1.6)
As part of the catalytic capacity of the cell extract is lost due to the binding
of inhibitor to enzyme (Eq. 5.1.3), the maximal catalytic potential of the cell
(or cell extract) can be rewritten in terms of the free enzyme:
V appmax = kcat · [E]f (5.1.7)
where V appmax refers to the apparent maximal catalytic capacity of the
inhibitor pool in the presence of a given concentration of inhibitor. When
substituted into Eq. 5.1.4, this gives us the following equation for the reaction
rate through an inhibited, enzymatically catalysed reaction:
vapp = V
app
max · [S]
Km + [S]
= kcat · [E]f · [S]
Km + [S]
(5.1.8)
Eq. 5.1.8 implies that the reaction rate of the GAPDH-catalysed reaction
will be proportional to the concentration of the free GAPDH, which, varies
in response to changes in IAA (Eq. 5.1.3). Since component reactions form
part of a network, the inhibitor’s effect will manifest at a systems-level. The
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inhibition of flux and enzyme activity can then be measured for the calculation
of the flux control of the enzyme (Eq. 2.3.2).
The question remains on how we represent the inhibition in a model that
does not explicitly contain a term for enzyme concentration. We return to this
question later in this chapter (Subsection 5.2.2).
5.2 Recap: Measured Vmax,GAPDH versus
Model Vmax,GAPDH
As reported in Table 4.1, the unperturbed Vmax,GAPDH for the forward reaction
was within a factor of two of those used by Teusink et al. [1] and slightly higher
than what was used by Du Preez et al. [2]. The reverse Vmax,GAPDH however,
was consistently quite a bit lower than the Teusink parameter (the Du Preez
model did not include an explicit reverse Vmax,GAPDH value).
In Subsection 4.3.1, we discussed possible origins for the differences between
our measured specific GAPDH activity at substrate-saturating conditions and
the Vmax,GAPDH values proposed by Teusink et al. [1] and Du Preez et al. [2]
and we return to these differences again in Section 6.2.
Some trends within our data were quite encouraging. For instance, in
keeping with what is understood about GAPDH activity, the rates measured
in reverse were always higher than those measured in the forward direction
([126]; see Subsection 4.3.4). Moreover, the effect of IAA on relative activity
(percentage activity) was almost identical for the forward and reverse reactions
(see Subsection 4.3.4). This is exactly the effect that is expected considering
that IAA alkylates the binding site of the substrates of both directions NAD+
and NADH [21]. This also satisfies the requirement of the Haldane relationship
[6], since a change in affinity or equilibrium is not expected in response to IAA:
Keq =
Vmaxf ·Kmr
Vmaxr ·Kmf (5.1)
Though there was disparity between the absolute Vmax values used in
the construction of the Teusink model and those measured in the present
investigation, the relative responses to IAA reported here were consistent
and can be regarded as credible. They also fell within the range of IAA
concentrations (0 µM to 400 µM ) used to inhibit Vmax,GAPDH selectively in
various other cell types (e.g. 22, 24, 93, 94, 100).
5.2.1 Simulating IAA’s Effect
Mechanistic descriptions of IAA-dependent GAPDH inhibition were
complicated by the fact that no single, quantifiable trend related Vmax,GAPDH
to IAA concentration across all data sets. Though there must, by definition,
be a single mechanism responsible for inhibition, this mechanistic relationship
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was not clear from the collected data. This could be ascribed to factors that
are hidden from the view of the experimenter, such as differences in enzyme
expression between biological isolates [15]. It was clear from this that all factors
influencing the inhibition would not be accounted for in our final simulations
[26].
We decided to use the relative inhibition data instead of the absolute
inhibition data to generate our inhibition terms. Using fits to the absolute
activity assumes that our measured Vmax,GAPDH values can be inserted directly
into the models. The experimental conditions in which the parameters in
the Teusink model were measured, differ from those that were used in our
study [3], however. Additionally, the Teusink and Du Preez model Vmax,GAPDH
parameters themselves are in silico adjustments of experimentally measured
parameters, which indicates that model construction placed some constraints
on the parameter values that could be used to begin with.
A second consideration, was that the factor difference between the
literature and the measured parameters were not equal for the forward and
the reverse Vmax,GAPDH . Though this might be balanced out by concurrent
changes in Km [3], we did not determine the Km and could not model this
balancing. Inserting only our measured Vmax,GAPDH values would change the
equilibrium of the enzyme, which would breach the Haldane relationship (see
Eq. 5.1).
The percentage effect of IAA on Vmax,GAPDH in the forward and reverse
directions were very similar (see Figure 4.6), which allowed us to fit a single
inhibition function on the combined forward and reverse data. In so doing,
the Haldane relationship was kept intact (see Eq. 5.1). Another advantage of
using the relative inhibition data is that it allowed us to combine data from
different isolates, so that we could do a single fit on the data from repeats II
and III together.
Our modelling approach therefore assumes that there is some
unaccounted-for difference between the model construction and model
validation data. A priori assumptions like these are a deviation from a strict
bottom-up modelling approach, though they are not uncommon, e.g. in the
post hoc parameter adjustments by Teusink [1] and Du Preez [2] that allowed
them to simulate certain behaviours. Indeed, it is common practice to depart
from strict mechanistic accuracy in favour of predictive ability [37].
We conducted fits separately to the different data sets (Fig. 4.6), and then
also in a single fit to the data from repeat II and III (Fig. 4.17). The fits
yielded the inhibition terms that were inserted into the model (see Subsection
5.2.2).
5.2.2 IAA’s Effect in Mathematics
Irreversible inhibition can be described in terms of described as a "%
occupancy", with the decrease in activity expressed as an exponential decay
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function [124], e.g.:
% Total Occupancy = 100%−%Remaining Activity
Fractional Occupancy = 1− Fractional Remaining Activity
Fractional Occupancy = 1− e−kobs·time
where % Total Occupancy is the proportion of the inhibition sites that are
occupied; this can also be expressed as a fractional occupancy. Within the
term e−kobs·time, "−kobs" is an observed first-order rate constant with units of
time-1 (usually min-1), and is converted to a time-dependent, dimensionless
inhibition expression when multiplied by time. The concentration of the
inhibitor is subsumed under kobs in this case, and can be expressed as a
fractional remaining activity:
Fractional Remaining Activity = e−kobs·time
which can be used as a modifier of a wild-type Vmax,GAPDH to yield
predictions of the effect of adding given concentrations of IAA. The product
of the inhibition term and the wild-type Vmax,GAPDH is the expected Vmax of
the inhibited enzyme (V appmax,GAPDH , referring to the apparent - or perturbed -
Vmax,GAPDH value):
V appmax,GAPDH = V wtmax,GAPDH · e−kobs·time (5.2)
For the present study, the incubation time in the inhibitor was kept
constant (60 minutes) for all repeats, which - considering Eq. 5.2 - means
that changes in the GAPDH activity were due to differences in kobs only. kobs,
in turn, is defined as follows [124]:
kobs =
kinact · [IAA]
Ki + [IAA]
(5.3)
The reader might note that Eq. 5.3 has the same appearance as the
Michaelis-Menten equation (Eq. 5.1.4; [6]). Similar to the Vmax in the
Michaelis-Menten equation, kinact is a first-order rate constant describing
the maximum potential rate of covalent bond formation, while Ki is the
dissociation constant of the inhibitor, expressing the concentration of inhibitor
at which half-maximal rate of inhibition is attained [124]. [IAA] is the
concentration of the inhibitor.
Assuming that kinact and Ki are constant for each individual data set,
the IAA concentration alone is responsible for the kobs, which, in turn, is
entirely responsible for the % Remaining Activity (see Eq. 5.2). The exact
determination of the parameter values involved in IAA binding, as in Eq.
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5.3, are beyond the scope of this study, however. For our purposes it was
sufficient to note that change in the observed % wild-type Vmax,GAPDH within
each repeat was related only to differences in IAA concentration and that
this change could be expressed as an exponential decay function which, if
multiplied with the wild-type Vmax,GAPDH , gives the perturbed parameter value
(V appmax,GAPDH). These fits were obtained according to the method of least
squares and consistently yielded fits with R2 ≥ 0.95. The fitted function was
an adjusted exponential decay function as in Eq. 5.2:
Fractional Remaining Activity = e−ki·t·[IAA] (5.4)
in which the fractional remaining activity is a function of [IAA], an
inhibition constant (ki), and time.
Since incubation time was kept constant at 60 minutes, fits to the
experimental data were only searches for the inhibition constant, ki, and the
time-dependence was treated as a part of this constant that was equal for all
inhibitor incubations. This approach was applied to each repeat separately
and to the combined data from repeats II and III (see Subsection 5.2.1). The
fits to these data were all exponential decay functions and were fitted in Fig.
4.6 (for the individual repeats) and Fig. 4.17 (for repeats II and III combined):
I : Fractional Remaining Activity = e−0.0044·[IAA]; R2 = 0.98
II : Fractional Remaining Activity = e−0.014·[IAA]; R2 = 0.98
III : Fractional Remaining Activity = e−0.020·[IAA]; R2 = 0.96
II and III : Fractional Remaining Activity = e−0.017·[IAA]; R2 = 0.96
These terms were then used to describe the reaction-level perturbation in
the model. Eqs. 5.5 and 5.6 present the adjusted equations from the Teusink
and Du Preez models, respectively. Indicated in red are the Vmax,GAPDH and
the modifying term.
Some important information on the notation used:
• lower-case names refer to concentrations of metabolites;
• a lower-case "t" in square brackets indicates that a variable is
time-dependent;
• an "f" or a "r" at the end of a parameter’s subscript indicates whether it
pertains to the forward or the reverse reaction, respectively;
The control of an enzyme over a pathway flux can be calculated as the
relative change in flux in response to a perturbation, divided by the relative
change in enzyme activity at constant substrate and product concentrations.
This means that the exact in vivo conditions at which the flux was measured do
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not need to be recreated to relate the flux to the GAPDH activity at constant
conditions. This is captured in Equation 3.10.1, taken from Poolman et al.
[22]:
CJEi =
(dJ/J)/(dI/I)ss
(dvi/vi)/(dI/I)Si,Pi
Since enzyme activity is linearly related to Vmax (see Eq. 5.1.8), the
percentage change in Vmax,GAPDH is equivalent to a the percentage change
in GAPDH activity, and this percentage change is taken as the relative change
in GAPDH activity.
(see next page)
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5.3 The Teusink Model
The Teusink model [1] was constructed based on in vitro kinetics and describes
the steady-state behaviour of a yeast cell. Its kinetics pertains mostly to
the intracellular events of S. cerevisiae glycolysis. Glucose transport was
represented using kinetics that were related to the extracellular environment.
Extracellular glucose concentration was fixed at 50 mM.
Efferent branches were represented as carbon "sinks": trehalose, glycogen,
and succinate production were were all described as constant fluxes; ethanol
production by alcohol dehydrogenase (ADH) and glycerol production by
glycerol 3-phosphate dehydrogenase (G3PDH) were expressed as reversible
equations. All five of these "end products" of the pathway were given fixed
concentrations: succinate, trehalose, and glycogen all had concentrations
of zero, whereas glycerol was fixed at 0.15 mM and ethanol at 50 mM.
Importantly, the model only contains one extracellular variable (glucose) and
expresses all variables in terms of their concentration per cytosolic volume
- hence extracellular glucose is also expressed in terms of the intracellular
volume.
5.3.1 Teusink Model: Glycolytic Activity in a Closed
System
Mimic the measurements of glycolytic activity in the experimental set-up more
precisely, the Teusink model was adjusted to reflect the conditions in a closed
system with limited substrate. This meant unfixing the external glucose and
the ethanol concentration and expressing them as variables. Additionally, a
variable was included for extracellular glucose, as well as an ethanol export
term. This ethanol export term was constructed according to Fick’s Law for
diffusion:
dETOH
dt
= A · PETOH
Vi
(ETOH − ETOHo)
where the rate of ethanol export is a function of the outer area of the cell
membrane (A), the permeability of the the membrane to ethanol (PETOH), the
intracellular volume (Vi), and the ethanol concentration gradient between the
inside and the outside of the cell (ETOH-ETOHo). We followed the example of
Du Preez et al. [2] in assuming a spherical cell with a radius of 2 µm, and used
a permeability constant from existing literature (3× 10−4cm.s−1; 127). All of
this together yielded a diffusion rate constant (270min−1) that - together with
the cross-membrane ethanol gradient - described ethanol export as follows:
dETOH
dt
= 270min−1 · (ETOH − ETOHo)
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Teusink and colleagues expressed the concentrations that form a part of the
in vitro parameter sets in terms of mmol.L-cytosol-1 [1]. They also suggested
a ratio of 3.75 mL cytosol.g protein-1, which allows the conversion of enzyme
rates to specific rates (µmol.min-1.mg protein-1). For the flux data for which
the parameters were adjusted, they state that they used 50 g.L-1 of cells, which
amounts to between 5 and 6 g protein.mL-1 assay volume. Using the average of
these values - 5.5 g protein.mL-1 - and the intracellular protein concentration
mentioned above, an external volume to internal volume ratio of 48.5:1 was
calculated. Following the lead of Du Preez and colleagues [2], we opted for
a ratio of 50:1 (external to internal). This ratio was inserted into the model
in the stoichiometry of the transport steps, allowing for the construction of
ordinary differential equations for external species:
ETOHo′[t] = Vinternal
Vexternal
· vETOHexport
GLCo′[t] = −Vinternal
Vexternal
· vGLCimport
External and internal ethanol was assigned an initial value of zero while
the external glucose concentration was set to 20 mM (compare Chapter 3 for
the experimental methods). All other efferent branches of the pathway were
kept as in the original model.
One of the consequences of unfixing the initial substrate and final product of
the pathway is that the system could no longer reach a steady state. Instead of
calculating steady-state fluxes, dynamic behaviour was simulated as the change
in metabolite concentration over time (Fig. 5.2). Glucose was converted
almost entirely to ethanol, with only ethanol uniformly increasing for the
entire duration of the simulation (see Appendix J for the time-evolution of all
the variables over the simulation time). In the unperturbed model, external
glucose is depleted in 13 minutes, and this period is therefore chosen as the
simulation duration.
We calculated the glucose and ethanol fluxes as the rate of change over the
initial slopes of the simulated glucose and ethanol concentrations (between t =
0 minutes and t = 4 minutes). The calculated values were treated as equivalent
to fluxes for the purposes of this study (see also Section 4.4).
Glucose was depleted much more quickly in the model simulation than
in the experiments. Teusink et al. [1] challenged yeast cells with 100 mM
of glucose, which was depleted in 50 minutes. Considering the linear slope
of glucose consumption seen in my (Fig. 4.11) and Teusink et al.’s data,
this allows us to extrapolate that 20 mM of glucose (our initial glucose
concentration) should be consumed in about 10 minutes. This is close to the
model prediction but very different from what we observed experimentally.
Since we compensated for the extracellular to intracellular volume ratio, the
major difference between our flux measurement assays and those of Teusink
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Figure 5.2: In a closed-system simulation with an adjusted version of the Teusink
model, glucose is depleted in 13 minutes (bottom x-axis). The blue and red solid
lines show the predicted time-dependent increase in external ethanol concentration
(ETOHo) and the predicted decrease in external glucose concentration (GLCo),
respectively, in an unperturbed state. The two simulated graphs mirror each other
almost exactly but for a factor difference of about one glucose consumed per about
one and a half molecules of ethanol produced: this is in line with Albers et al. [43],
who found an ethanol:glucose ratio of 4:3 - carbon loss to the branches and during
pyruvate decarboxylation is suspected to be responsible for glucose not being fully
converted to ethanol according to the expected 1:2 stoichiometry. The wild-type
data for the three biological repeats are also presented: the legend to the right
of the figure identifies the data sets. The experimental data spans a much longer
time frame of 90 minutes (top x-axis). This difference is mainly due to a more
concentrated cell suspension being used, as can be seen when the data is normalised
to protein concentration. It is also apparent that repeats II and III have higher
fluxes than I, which did not use up its glucose in the time of the experiment. Time
on both axes is measured in minutes, while concentration is measured in mM.
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and colleagues was that they used a much more concentrated cell suspension
than we did. Fluxes that are normalised over protein concentration are much
closer to our measured fluxes, as will shortly be discussed.
For a more intuitive view of our experimental observations versus the
model, Fig. 5.2 shows the non-normalised assays as they would be seen
during the experiment. Concentrations are expressed in their non-normalised
millimolar form in Fig. 5.2, and show, in addition to the differences between
the model prediction and the experimental data, that there were also internal
differences in the experimental data of repeat I compared to repeat II and III.
Using Teusink et al.’s factor of 3.75 mL.g protein-1, the rates of
concentration change in the model simulations were converted to fluxes in
µmol.min-1.mg protein-1. The simulated ethanol production rate was 0.49
µmol.min-1.mg protein-1 (compared to 0.50 µmol.min-1.mg protein-1 in the
Teusink paper, 1) while the glucose was consumed at at a rate of 0.32
µmol.min-1.mg protein-1 (versus 0.40 µmol.min-1.mg protein-1 in 1).
The fluxes reported by Teusink and colleagues [1] were not restored by
inserting higher initial glucose in our model simulations (50 mM): very similar
ethanol and glucose fluxes were calculated (0.52 µmol.min-1.mg protein-1
and 0.33 µmol.min-1.mg protein-1, respectively; simulation not shown). The
difference between the Teusink literature fluxes and the simulated fluxes are
probably because of the structural changes that we made to the model.
5.3.2 Teusink Model Predictions: IAA Titrations
Perturbation terms were inserted in the adjusted model by generating fits
that relate the percentage GAPDH activity and IAA to each other for each
biological repeat (Fig. 4.6), and then also for II and III combined (Fig. 4.17).
The perturbation terms were varied by simulating the model at varying
concentrations of IAA and obtaining both the % wild-type activity and
the % flux for each IAA concentration. Figure 5.3 shows the results of
these simulations, including the corresponding experimental data. Since
the GAPDH inhibition function was derived from a fit to GAPDH activity
measurements, it is not surprising that this function correlated very well with
the experimental data (magenta lines in Fig. 5.3). What was striking, however,
was that the resultant change in both glucose and ethanol flux - which are
related to IAA only indirectly - also seemed to be predicted quite well by the
perturbed model (dashed black lines in Fig. 5.3).
Repeat I, as has been the case throughout this study, was the outlier with
the experimentally measured fluxes decreasing much faster in reaction to rising
IAA concentrations than predicted by the model. For the other two repeats,
flux appeared not to change very much until a critical concentration of IAA
(and hence a critical level of GAPDH inhibition) was reached, after which the
flux dropped precipitously, often being abrogated within one doubling of the
IAA concentration.
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Figure 5.3: The Teusink model predicts the relationship between IAA
concentration and normalised glycolytic flux well. The figure shows the change
in % GAPDH activity and % glycolytic flux (the flux in terms of ethanol production
and glucose consumption) as functions of increasing IAA concentrations. The effect
on flux is a non-linear consequence of the local perturbation of GAPDH by IAA.
The labels I, II, and III refer to the relevant repeat, while "Comb" refers to the
combined data of repeats II and III. The suffix of a label indicates the metric
used for flux measurements: the left-hand column (suffixed A) represents flux as a
ethanol production rate, while the right-hand column (suffixed B) shows it in terms
of glucose consumption. Red and blue data points represent data from forward and
reverse activity measurements, respectively, and the magenta line was fitted to the
data in each case and inserted as a modifier of Vmax,GAPDH . The black data points
represent the experimental flux measurements, while the dashed black line is the
normalised Teusink model prediction of the change in flux as a function of IAA.
Flux was predicted well for repeats II and III.
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Interestingly, glucose consumption seemed to yield slightly better
agreement between model prediction and experimental measurement. The
experimental ethanol flux data showed a steeper and earlier decline in flux in
response to IAA than predicted by the model.
The control coefficient can be calculated, according to Eq. 2.3.2, as the
ratio between the slopes where IAA concentration is near zero in Fig. 5.3
(shown in Subsection 5.3.3).
5.3.3 Teusink Model Predictions: GAPDH Control
over Glycolytic Flux
To determine the glycolytic flux control of GAPDH, % flux must be expressed
as a function of % GAPDH activity at constant conditions (Subsection 3.10.1;
[22]). In Subsection 2.3.3, we discuss how flux control can be calculated as a
single coefficient at zero inhibition, but also as a continuous profile of relative
flux as a function of relative enzyme activity. We decided to investigate
the control profile as well as to calculate the flux control at near-zero IAA
concentration for a single-value comparison.
Figure 5.4 reflects the changing glycolytic flux control of GAPDH, both
in the models and as seen in our experimental data. The slope between the
wild-type point and the point at [IAA] = 3.2 µM was used as a proxy for
the flux control of GAPDH at zero inhibitor (3.2 µM IAA is the size of the
inhibitor increments for the simulation). This was done by generating a fit to
the flux inhibition data. As expected, the glycolytic flux control near [IAA]
= 0 µM, as predicted by the Teusink model, was very close to zero. This was
true for both control over glucose consumption and over ethanol production:
CJGLCovGAPDH = 0.0045
CJETOHovGAPDH = 0.031
When comparing the experimental and simulated flux control plots, there
was good agreement between the simulation and the measurements. It can
also be seen that there is substantial agreement between the repeats, except
for repeat I, which predicts a much stronger control of GAPDH over glycolytic
flux (see Fig. 5.4).
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Figure 5.4: The Teusink model predicts the relationship between %GAPDH
activity and % glycolytic flux well. Glycolytic flux was measured and expressed
as a percentage of its wild-type value and plotted against the percentage remaining
wild-type GAPDH activity at the same IAA concentration (see Eq. 5.5). GAPDH
activity measured in the forward direction is presented in blue, while reverse activity
is in red. I, II, and III refer to the individual biological repeats while "Comb"
refers to the combined data of repeats II and III. Label suffixes indicate the metric
used for flux measurements: the left-hand column (suffixed A) represents flux a
ethanol production rate while the right-hand column (suffixed B) shows it as glucose
consumption. The relationship between relative glycolytic flux and relative GAPDH
activity was predicted well by the Teusink model for repeats II and III.
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5.4 The Du Preez Model
The Du Preez model is an oscillating model of the glycolytic pathway of S.
cerevisiae. Seven models were constructed and uploaded to the JWS Online
model repository by Du Preez and colleagues [2, 16]. Our first task was
therefore to decide which was the most appropriate for generating simulations
which could be compared to our experimental data.
Out of the four Du Preez models created during the model construction
phase of the Du Preez study [2], dupreez4 was chosen as it was the final
product of the model construction phase, and represents an oscillating, whole
yeast cell in a population of other oscillating yeast cells, similar to what could
be expected in our assays.
Du Preez et al. [2], for the construction of their models, made use of the
Teusink model with its original parameters in its original units. Though it is
not explicitly mentioned, this means that the concentrations in the Du Preez
model are expressed as mmol.L cytosol-1. Teusink et al. proposed a conversion
ratio of 3.75 mL cytosol.g protein-1. The concentrations and reaction rates
mentioned here will therefore have been converted from the model according
to this ratio. Du Preez and colleagues also include an external to internal
volume ratio of 50:1 in dupreez4. We show in an earlier discussion (Subsection
5.3.1) that the volume ratio in the Teusink model was 48.5:1, which we rounded
to 50:1.
We applied the same changes to the Du Preez model as we applied to
the Teusink model to see how its ability to predict glycolytic flux control
compares with its predecessor’s. Having been expanded to include the ability
to describe glycolytic oscillations, the ability of this model to accurately predict
glycolytic flux control, as was the case with the Teusink model (see Section 5.3),
would align Du Preez and colleagues’ work with the iterative model expansion
approach of the Silicon Cell initiative [13].
5.4.1 The Du Preez Model in Batch Culture
Conditions
Exactly as with the Teusink model, the Du Preez model was adjusted
to resemble the experimental set-up more closely by giving extracellular
species concentrations of zero (cyanide, acetaldehyde, and ethanol), except
for extracellular glucose, which was set to 20 mM. An ethanol transport step
was also included, as explained previously, under Du Preez and colleagues’
assumption [2] of a spherical cell with a radius of 2 µm and Guijarro and
Lagunas’ suggested permeability constant of 3× 10−4cm.s−1 [127].
Acetaldehyde export, which is not present in the Teusink model and hence
was not addressed in Section 5.3, was also removed by setting the rate constant
for acetaldehyde transport to zero: this was done under the assumption that
acetaldehyde is entirely converted to ethanol during aerobic fermentation at
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high glucose, a phenomenon known as the Crabtree Effect [9]. Glucose is then
converted mostly to ethanol (ratio 1:1.5, glucose:ethanol), according to this
model (Fig. 5.5). The loss of carbon to side-branches and as CO2 during
pyruvate decarboxylation explains why full conversion (ratio of 1:2) was not
obtained.
The Du Preez model has a much lower unperturbed flux than the Teusink
model, owing the decrease of Vmax values from teusink to construct dupreez4 :
0.21 µmol.min-1.mg protein-1 for ethanol production and 0.15 µmol.min-1.mg
protein-1 for glucose consumption (compared to 0.50 µmol.min-1.mg protein-1
and 0.32 µmol.min-1.mg protein-1 in our Teusink model simulation). This
means that the Du Preez model can also be run much longer before substrate
is depleted and maximal ethanol concentration is reached (Fig. 5.5). The
Du Preez model, however, still shows a quicker depletion of glucose than our
experimental results, owing perhaps to our incubations having contained more
dilute yeast cell suspensions so that sufficiently quick sampling could be carried
out by a human experimenter. In Fig. 5.5, the concentrations are given in
mM instead of in protein-normalised amounts to give an intuitive view of the
experimental observations versus the model predictions.
Repeat I, again, appears to be an outlier amidst the experimental data.
5.4.2 Du Preez Model Predictions: IAA Titrations
Fits that capture the relationship between IAA concentration and relative
GAPDH activity were inserted in the adjusted model as explained in
Subsection 5.2.2. This was done for each biological repeat, and then also
for II and III together. Changes in the relative flux and the relative GAPDH
activity were calculated in exactly the same way as in the case of the Teusink
model (Subsection 5.3.2).
Figure 5.6 shows the results, and it can be seen that model predicts the
experimental data well for repeats II and III but not for I. It was also the
case again that the initial plateau of the response of flux to the increased
IAA concentration fit better when flux was measured as glucose consumption
rate rather than as ethanol production: the ethanol production rate seemed
to decline more steeply at the low IAA concentrations. The gradients at zero
IAA concentration for relative flux and relative GAPDH activity with respect
to IAA, were again used for the calculation of the control coefficient (see next
subsection).
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Figure 5.5: Dynamic behaviour of Du Preez model glucose and ethanol
concentrations in a closed system shows that glucose stocks are exhausted in 30
minutes. The blue and the red solid lines represent the predicted increase in ethanol
concentration and the predicted decrease in glucose concentration, respectively.
Ethanol concentration eventually plateaus at about 30 mM - 1.5 times greater than
the administered glucose. This agrees with the finding of Albers et al. [43], who
noted an glucose:ethanol ratio of 3:4, instead of the expected 1:2 ratio. This is
likely due to a loss of carbon to the branches, for which glycogen, succinate, and
trehalose production are expressed as constant rates and not sensitive to decreasing
flux through the pathway, and due to carbon loss during pyruvate decarboxylation.
We did no investigate the activity of the branches further. The wild-type data for
the three biological repeats are also presented: the legend to the right of the figure
identifies the data sets. The experimental data spans a much longer time frame of
90 minutes (top x-axis). It is also apparent that repeats II and III have higher
fluxes than I, which did not use up its glucose during the experiment. Time on both
axes is measured in minutes, while concentration is measured in mM. Ethanol in
the experimental data appears to be produced at a stoichiometry of 1:1 to glucose
molecules consumed.
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Figure 5.6: The Du Preez model predicts the relationship between IAA
concentration and normalised glycolytic flux well. The figure shows the change
in GAPDH activity and glycolytic flux (in terms of ethanol production and glucose
consumption) as functions of increasing IAA concentrations. The effect on flux is
a non-linear systemic effect. The labels I, II, and III refer to the relevant repeat,
while "Comb" refers to the combined data of repeats II and III. The suffix of a label
indicates the metric used for flux measurements: the left-hand column (suffixed A)
represents flux as a ethanol production rate while the right-hand column (suffixed B)
shows it in terms of glucose consumption. Red and blue data points represent data
from forward and reverse activity measurements, respectively, and the magenta line
was fitted to the data in each case and inserted as a modifier of Vmax,GAPDH in the
model. The black data points represent the experimental flux measurements, while
the dashed black line is the normalised Du Preez model prediction of the change in
flux as a function of IAA. Flux was predicted well for repeats II and III, bit not so
well for repeat I.
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5.4.3 Du Preez Model Predictions: GAPDH Control
over Glycolytic Flux
Exactly as with Teusink model, we created a flux control plot by presenting
% glycolytic flux as a function of the % GAPDH activity at the same IAA
concentrations (Fig. 5.7). The model predictions, again, to matched up well
with the experimental data from repeats II and III.
The glycolytic flux control coefficient at near-zero IAA concentration
(in our case, between the predicted points of zero inhibition and the first
simulated increment, at [IAA] = 3.2 µM) were then calculated for both ethanol
production and glucose consumption. As with the Teusink model predictions,
the control of GAPDH was very close to zero:
CJGLCovGAPDH = 0.0068
CJETOHovGAPDH = 0.024
Control increases very sharply when GAPDH is inhibited further below
about 40% wild-type activity. The model also predicts this behaviour well.
5.5 Du Preez versus Teusink
Both models predicted the change in glycolytic flux in response to the
inhibition of GAPDH well. This is clearest in Fig. 5.8, where the models
are compared to each other, and also to the experimental data. The model
predictions are quite similar. For yeast isolate I, the measured glycolytic flux
control of GAPDH is consistently different from the model predictions, but
also from the other two biological repeats. This data set was regarded as an
outlier, as the combination of the other two data sets showed strong correlation
with the model predictions.
Both the model predictions and the experimental determination of
glycolytic flux control suggest a higher control over ethanol production rate
for GAPDH (the factor difference for the Teusink model, the Du Preez model,
and the experimental data being about 7, 3.5, and 6.5). In this sense, there
seems to be agreement between the models and the experimental data that
glucose consumption rate is affected less strongly by GAPDH inhibition: one
could speculate that this might be due to carbon flux being redirected to the
branches in upper glycolysis (which would be the case in the model, where
there is a fixed flux in some of the branches).
The ratio between GAPDH control over glucose consumption and ethanol
production might be deceptive, however, as they do not reveal that the
control exerted over both fluxes are very small (3% and lower) in the model
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Figure 5.7: The Du Preez model predicts the relationship between % GAPDH
activity and % glycolytic flux well. Glycolytic flux was measured and expressed as
a percentage of its wild-type value and plotted against the percentage remaining
wild-type GAPDH activity preincubated at the same IAA concentrations (see Eq.
5.6). GAPDH activity data measured in the forward direction are presented in blue,
while reverse activity is in red. I, II, and III refer to the individual biological repeats
while "Comb" refers to the combined data of repeats II and III. Label suffixes the
metric used for flux measurements: the left-hand column (suffixed A) represents
flux an ethanol production rate while the right-hand column (suffixed B) shows
is as glucose consumption. The relationship between relative glycolytic flux and
relative GAPDH activity was predicted well by the Du Preez model for repeats II
and III.
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simulations, and also for the experimentally observed control over glucose
consumption. The only significant control exerted over any flux at near-zero
IAA concentrations was the experimentally observed control over ethanol
production (Fig. 5.8C shows this most clearly). The combined ethanol
production data from repeat II and III are also affected by a large amount of
scatter.
However, if the plots of flux to GAPDH activity are inspected (Fig. 5.8),
a different picture can be seen: both models appear to exhibit extremely low
flux control by GAPDH over both production and consumption. The ethanol
production fluxes seem just as flat at first, except that they are generally
lower than the glucose consumption fluxes. One might speculate that the
wild-type ethanol flux is an overestimation and leads to this high apparent
ethanol production control at zero IAA.
We posit that the experimentally observed control of GAPDH over glucose
consumption is a validation of the model predictions, but that the ethanol
production flux data are inconclusive, owing to the high level of scatter.
The agreement between the model predictions and the experimental data is
actually striking when one inspects the relationship of relative flux and relative
V appmax,GAPDH to IAA, and to each other (Figs. 5.3, 5.6, and 5.8).
The control coefficients, both calculated from the models and determined
experimentally, are:
Teusink:
CJGLCovGAPDH = 0.0045
CJETOHovGAPDH = 0.031
Du Preez:
CJGLCovGAPDH = 0.0068
CJETOHovGAPDH = 0.024
versus the experimental data, which yielded the flux control coefficients:
CJGLCovGAPDH = 0.032
CJETOHovGAPDH = 0.21
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Figure 5.8: Both models predict the change of glucose consumption rate as a
function of GAPDH inhibition better than ethanol production rate. In A, the
model predictions for the Teusink and the Du Preez models using the inhibition
equation for data sets II and III combined, are both presented. In B, glucose
consumption appears to have a higher rate than ethanol production for most of the
GAPDH perturbations, and ethanol also declines earlier in response to GAPDH
inhibition. The empty circles indicate the data arising from biological isolate I,
which consistently diverged from the other two members of the biological triplicate
set. Ethanol production data (C ) deviate slightly from the trend of the model
predictions, however. In D, glucose consumption is highly correlated for both the
Teusink and Du Preez models, and for the experimental data. Legends to the right
of each figure contain full information about its contents.
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Limits in experimental time and resources make it necessary to investigate
metabolic pathways in a piecemeal way: larger models are often difficult to
validate, and are more easily studied by linking smaller, validated models [13].
Adherence to the modular approach would eliminate much duplicative work.
Another benefit of metabolic modelling lies in fact that a network-level view
of a pathway can illuminate useful metabolic characteristics, like drug targets
[18, 28], and deepen our understanding of metabolic behaviour. Metabolic
Control Analysis (MCA) is a very useful tool for the investigation of systemic
properties in metabolism [19]. Within MCA, flux control coefficients can be
experimentally determined [25] as well as predicted [20]. These metabolic
flux control coefficients are not only useful tools for interpreting metabolic
models, but also constitute core predictions for model validation [4, 20, 54].
Model validation is of cardinal importance, as model application and model
expansion often presuppose models that are correctly parameterised at their
current level of detail [15, 36, 47].
In this study, we experimentally determined the glycolytic flux control
coefficient of GAPDH in S. cerevisiae cells that were grown to diauxic shift
and then challenged with excess glucose. We did this to test the validity of two
related, kinetic models of S. cerevisiae glycolysis by Du Preez et al. [2] and
Teusink et al. [1]. This validation serves both as a validation of the two models
and also sheds light on how the computational adaptation of the Teusink model
by Du Preez and affected the original model’s ability to predict the glycolytic
control of GAPDH. For this, credible ways of perturbing and measuring the
rate enzyme activity and glycolytic flux needed to be established.
6.1 Iodoacetic Acid
One of the restrictions of applying MCA to an experimental context stems
from the difficulty of perturbing individual enzymatic steps in an isolated
fashion [25]. IAA was suggested by Fell [128] as a way of experimentally
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determining the flux control of GAPDH. Before evaluating the Teusink and Du
Preez models for their ability to predict the glycolytic flux control of GAPDH,
we investigated some aspects of GAPDH inhibition by IAA to confirm the
appropriateness of the compound for our purposes.
Authors had used this inhibitor in a variety of organisms as an alkylating
agent that targets the active thiol group of GAPDH (e.g. 22, 86, 93, 101, 103).
We performed time-course assays on lysate incubated in IAA and found - in
accordance with what is understood in the literature - that GAPDH activity
is not recovered when the concentration of IAA is lowered (Appendix B). If
the inhibitor bound reversibly, a decreased inhibitory effect would have been
seen when the volume of the sample increased.
In Subsection 6.1.1, we discuss prelytic inhibitor incubation as a way
to circumvent possible differences in pharmacokinetics and inhibitor affinity
that might arise when comparing kinetic measurements in cell-free extract to
whole-cell fluxes (see also Subsection 2.3.3). This technique is by no means
novel: for instance, Poolman et al. [22] exposed Streptococcus lactis and
Streptococcus cremoris cells to IAA before lysis, after which cell-free extract
was produced. Though the technique has been used before, previous authors
have not made explicit the benefit of prelytic inhibitor administration. Ours
is the first study of which we are aware in which the potential of IAA for MCA
is discussed specifically with regard to overcoming in vitro-in vivo differences
in the laboratory (see Subsection 6.1.1).
Though we gathered evidence for irreversibility over a two-hour incubation
in cell-free extract, one can reasonably ask the question whether this
irreversible bond survives the mechanic stresses of our glass-bead extraction
(see Section 3.5). This was not directly tested in our study, but evidence of the
inhibition withstanding the lytic steps was forthcoming from the comparison of
samples that were exposed to IAA prelytically and samples that were subjected
to glass-bead extraction before inhibition. In Fig. 4.3.3, it can be seen that
the IAA titrations of GAPDH activity yielded very similar measurements of
V appmax,GAPDH (according to the method of 3) irrespective of the method of IAA
addition. This was the case for biological repeat II and III, but not for I,
which was a consistent outlier to the other two isolates (see Section 6.4). The
measured V appmax,GAPDH of the prelytically inhibited cells could only match that
of the directly inhibited cell-free extract if IAA diffused over the cell envelope,
then evenly into the cytosol, and then did not dissociate from the target thiol
during the glass bead extraction.
Unlike irreversibility, specificity of IAA was not investigated in this study.
It was concluded from literature that IAA could be used as a specific inhibitor
of GAPDH activity. In his "Handbook of Enzyme Inhibitors", Zollner [96] cites
over 100 targets for IAA in various metabolic pathways across species, which
is unsurprising, considering its chemistry: a small-molecule thiol-alkyating
agent with no specific structural affinity for a given enzyme [92]. Despite
the known promiscuity of IAA, it has been reported to act on glycolysis
92
Stellenbosch University https://scholar.sun.ac.za
CHAPTER 6. DISCUSSION
via GAPDH since the 1930s [21]. IAA has subsequently been used as a
selective inhibitor of GAPDH in multiple organisms, including S. cremoris
and S. lactis [22], Trypsonoma cruzi [23], and human lung carcinoma cells
[105]. According to what was reported by Campbell-Burk et al. [101], we
kept to IAA concentrations that were below 500 µM so that we could assume
specific GAPDH inhibition.
Finally, we also collected data on the effect of the redox state on IAA
inhibition. The findings by Brodie and Reed [105] show that the an oxidated
state of the cysteinyl thiolate can protect GAPDH from IAA binding. An
oxidised state reduces the affinity of the cysteine residue for the electrophilic
inhibitor [124]. The addition of DTT to our assay cocktails did not to a change
in the % inhibition (Fig. 4.2).
Accounting for all of these factors allowed us to directly link the decrease
in GAPDH activity to the specific and irreversible action of IAA. The rest of
the discussion will elaborate on how this knowledge was applied.
6.1.1 Prelytic Inhibition
Beyond its GAPDH specificity, the fact that IAA acts irreversibly makes it
doubly useful as a model validation tool. The reason for this was discussed
in detail in Section 3.2: a major concern with inhibiting flux in whole cells,
and then doing the same in cell-free extract for the measurement of its local
effect, lies in the differences in the composition of the two environments -
the whole cell versus cell-free extract. These differences can often lead to
quite substantial disparities between enzyme activity measurements in vitro
and in vivo [26]. We captured this idea in Eq. 3.2.1, an adaptation of a
selectivity equation by Haanstra et al. [80], with which we explained how
differences in the ambient conditions in which the IAA alkylates the active-site
cysteine of GAPDH can lead to unaccounted-for differences in pharmacokinetic
availability of the IAA and the affinity of the enzyme for the IAA (see Section
3.2).
The irreversibility of IAA allowed us to incubate cells in set concentrations
of IAA before lysis, and only to split them after the incubation into the cells
that would be lysed for GAPDH activity determination and the cells that
would be kept intact and incubated in a glucose-containing medium to measure
flux (Section 3.4). We found that the % inhibition seen when administering
IAA prelytically versus administering it directly to the cell-free yeast extract
yielded nearly identical results in two out of the three biological repeats (see
Figure 4.3.3). This suggests that the inhibitor permeates the cell envelope
and that equilibrium is reached within the hour incubation of the cells in the
inhibitor, contrary to what was reported by Hansen and Winther [102].
For S. cerevisiae, therefore, it appeared that the method of IAA
administration did not make a difference, hence the differences in the ambient
conditions were unimportant. However, this does not necessarily mean that
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the same will be the case for other organisms. Yeast glycolytic enzymes
are all located in the cytosol [3], whereas in some other organisms they are
localised inside organelles that might more effectively restrict the access of
IAA to these enzymes (e.g. the glycosome, which has a membrane that is
known to be impermeable to small molecules 61). Beyond extra barriers,
compartmentalisation or localisation of certain enzymes might also lead to
different binding conditions for inhibitors in vivo and in vitro that are not
present in the cytosolic distribution of GAPDH in S. cerevisiae. Differences
in redox conditions [105] or macromolecular crowding conditions [44] are
examples of intracellular conditions that might be heterogeneous inside a cell
and lead to poorer IAA access to GAPDH in the whole cell.
Our results show, at least in principle, that prelytic inhibition of GAPDH
with IAA can be a work-around when differences in ambient conditions are
suspected to lead to different inhibitory profiles between whole cells and
cell-free extract: this by exposing cells to IAA prelytically and then measuring
the flux and GAPDH inhibition by assaying the same cells (or extract from
these same cells). Though we saw no such disparity in binding between whole
cells and cell extract, we did confirm that IAA can be administered prelytically
and that GAPDH does not recover activity upon lysis or dilution. However,
these results would have to be revisited if the inhibitor is used on organisms
that house GAPDH in an intracellular compartment (like T. brucei; [113]) to
see if the inhibitor reaches GAPDH at all. Typical cell-lysis techniques like
the application of mechanical force or sonication have been known to lead to
the breakage of covalent bonds [129], and though it might not have been the
case in the current study, future work making use of prelytic IAA incubations
should investigate whether their extraction method leads to IAA dissociation
or not.
There are two other potential advantages of the prelytic inhibition method
that, though they did not make a difference in our work, are important to note.
First, that the experimenter has more precise control over the incubation time:
by washing external IAA away, the IAA concentration gradient is reversed
from the inside to the outside of the cell, which will lead to an abrogation of
further inhibition. Second, since the cell extract on which GAPDH activity
is measured and the whole cells on which flux is measured, come from the
same IAA-exposed cell suspension, the effect of experimental error between
flux inhibition and GAPDH inhibition is eliminated.
Note that, for the sake of brevity, all GAPDH activities discussed in the
rest of this chapter (unless explicitly stated otherwise) were measured in the
presence of DTT and were exposed to IAA before lysis. We choose to focus
on prelytic inhibition as it is the main focus of this study, and also prefer the
presence of DTT, as it is common in literature to add a moderate reducing
agent like DTT to reverse the effects of oxidative damage (e.g. during the
construction of the Teusink model [1]).
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6.2 GAPDH Activity Measurements
The GAPDH activities measured in this study were all measured in the in
vivo-like buffer proposed by Van Eunen et al. [3]. Their buffer was designed
to have an ionic composition and pH that is as close as possible to what
they determined for the S. cerevisiae CEN.PK113-7D strain, while still being
practical in a laboratory environment. In spite of the strain difference, the
buffer that they proposed should be a good approximation of the cytosolic
conditions in most S. cerevisiae cells.
The approximate Vmax,GAPDH that we measured in the buffer by Van Eunen
et al. was smaller than the same parameter in the Teusink model regardless
of the assay buffer of method of IAA administration: the forward Vmax,GAPDH
reported by Teusink et al. was 4.4 µmol.min-1.mg protein-1, compared to our
measurements of 4.15, 2.56, and 2.54 µmol.min-1.mg protein-1 for the repeats
I, II, and III ; in the reverse direction, their Vmax,GAPDH of 24.3 µmol.min-1.mg
protein-1 was considerably higher than our 6.96, 4.5, and 4.69 µmol.min-1.mg
protein-1 (I, II, and III, respectively).
Repeat I, which yielded the highest flux measurements, was a consistent
outlier to the other data in this study and to what was expected, so the true flux
probably lies closer to the measurements of II and III : a forward Vmax,GAPDH
of about 2.5 µmol.min-1.mg protein-1 and a reverse Vmax,GAPDH of about 4.5
µmol.min-1.mg protein-1.
Higher literature Vmax values are not unexpected, as experimentally
measured Vmax values are never truly substrate-saturating, and parameters are
typically determined using fits that are extrapolated to infinitely high substrate
conditions [26]. This technicality, though important, cannot account for the
factor two (in the case of the forward Vmax,GAPDH) or factor six (in the case
of the reverse Vmax,GAPDH) difference between the literature values and our
measured values.
One contributing factor to the differences between our measured,
approximate Vmax,GAPDH values and those from Teusink and colleagues [1],
could be the different strains (Koningsgist versus X2180). Du Preez et al.
[2], however, used X2180, as did we. We adjusted the parameter in the
dupreez4 model upwards to yield 2.08 µmol.min-1.mg protein-1, according to
the temperature difference and Q10 value suggested by Du Preez et al. [2]
themselves (Subsection 4.3.1). This is much closer to our measured forward
Vmax,GAPDH of about 2.5 µmol.min-1.mg protein-1.
In light of this, strain differences do seem to partially account for the
disparity between our measured forward Vmax,GAPDH and what was reported
by Teusink et al. [1]. The disparity between the reverse Vmax,GAPDH is more
puzzling, however, as the Du Preez model has no expicit reverse Vmax,GAPDH
, and the difference between our and Teusink et al.’s values is much larger
(about a factor of six): it would be a breach of the Haldane relationship if
the Km values did not concurrently change to conserve the Keq (see Eq. 5.1).
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Since we did not determine the Km values, however, we could not confirm
that the Haldane relationship remains in tact. What is interesting to note, are
the differences between the buffer proposed by Van Eunen and colleagues [3]
and what they called "optimised" conditions. The composition of the different
buffers were:
• Van Hoek: 100 mM triethanolamine, 1 mM EDTA, 1.5 mM MgSO4, pH
= 7.6;
• Teusink: 50 mM Pipes, 100 mM KCl, 5 mM MgSO4, pH = 7.0;
• Van Eunen: 300 mM K+, 20 mM Na+, 1.0 mM Ca2+, 1.0 mM Cl-, 245
mM glutamate, 50 mM phosphate, 10 mM MgSO4, pH = 6.8;
What is most striking about the buffers, is that the Van Eunen buffer
contains more different solutes than the buffers used by Van Hoek et al. [118]
and Teusink et al. [1], for instance the amino acid glutamate and a larger
variety of ions (specifically calcium, potassium, sodium, and free phosphates).
Van Eunen and colleagues [3] report that the GAPDH activity that they
measured in the reverse direction in the in vivo buffer is two times smaller
than what they measured in the Van Hoek buffer. They do not measure the
activity of GAPDH in the forward direction, so it is not clear from their work
whether the Vmax is affected similarly in both directions.
García-Contreras and colleagues [46] reported a similar finding when
comparing measured enzyme capacity in an optimised versus an in vivo-like
medium: eight out of twelve assayed glycolytic and nitrogen assimilation
enzymes in an Escherichia coli cell extract had significantly different Vmax.
Specifically, they found E. coli GAPDH to have an almost 80% lower activity
in an in vivo-like buffer than in an optimised buffer; they also found that
potassium ions and inorganic phosphates can account for almost all of this
activity loss, while glutamate had no or only a moderate effect on the activity
of glycolytic enzymes. If the inhibitory effect of potassium and free phosphates
also applies to S. cerevisiae enzymes, the absence of both potassium and
inorganic phosphate in the Van Hoek and Teusink buffers might account for
the comparatively lower GAPDH activity measured in the Van Eunen buffer.
Under the assumptions that the disparity in measured enzyme activity
is equal for the forward and the reverse reactions, and that the expected
difference between the measured values in the Van Eunen [3] and Teusink
[1] buffers will be similar to what was seen when comparing the Van Eunen [3]
and the Van Hoek [118] buffers, one could reduce the Teusink parameters by a
factor of two for comparison. The hypothetical values that would be measured
in the Van Eunen buffer on the Koningsgist (DSM Bakery Ingredients, Heerlen,
The Netherlands) enzymes used by Teusink et al. would be: 2.2 µmol.min-1.mg
protein-1 in the forward direction and 12.15 µmol.min-1.mg protein-1 in the
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reverse direction. In the following paragraphs, we refer to them simply as the
hypothetical parameters.
For the forward parameter, the experimental values (2.5 µmol.min-1.mg
protein-1) are now very close to the hypothetical value of from the Teusink
model (2.2 µmol.min-1.mg protein-1). When one compares the reverse
parameter to the experimental result, however, the measured Vmax,GAPDH of
about 4.5 µmol.min-1.mg protein-1 is still up to a factor of three smaller than
the hypothetical parameter of 12.15 µmol.min-1.mg protein-1.
It is, then, not just the measured Vmax values that change, but the ratio
between the two. Since we did not perturb the substrate concentrations, we
could not fit a Vmax parameter to see whether the ratio between the parameters
are restored when a true Vmax is calculated, but we followed the method of
Van Eunen et al. [3] for the measurement of the reverse Vmax,GAPDH and the
method of Ferdinand [120], in Van Eunen et al.’s buffer, for the measurement
of the forward Vmax,GAPDH . These measurements are therefore expected to be
at least close to substrate-saturating and not at arbitrary conditions.
An asymmetric change in the Vmax values of a reversible enzymatic step
means, according to the Haldane relationship (Eq. 5.1), that the equilibrium
constant (Keq) or the enzyme’s affinity for its substrate (Km) must also change.
In our case - assuming the Keq does not change - the Km ratio (Km,BPGKm,GAP ) would
need to increase by a factor of between two and three to compensate for the
change in Vmax ratios. This is not unrealistic, as "other kinetic parameters,
such as affinity constants, are also likely to be affected by the composition
of the assay medium" [3]. We did not measure the Km values of GAPDH
to confirm that this was, indeed, the case. However, the combination of
strain differences and buffer differences offer two testable hypotheses for future
studies to validate our work.
6.2.1 Percentage Response of GAPDH to IAA
Encouragingly, the relative effect of IAA was almost identical for the forward
and the reverse GAPDH activity titrations (see Fig. 4.6). This means that the
Haldane relationship was perfectly obeyed in terms of relative activity decrease.
IAA sequesters individual GAPDH enzymes by binding to their NADH/NAD+
site [93]. The relative inhibitory effect should therefore be identical in the
forward and reverse direction, as the substrates of both reactions are prevented
from interacting with the active site of the enzyme. That this was what we saw,
was confirmation that we could proceed with the relative activity inhibition
functions as descriptions of IAA action.
We inserted the inhibition term as a modifier of Vmax,GAPDH (see Eqs. 5.5
and 5.6), since IAA is irreversible in its action and permanently decrease the
catalytic capacity in a given cell/extract (Subsection 5.1.1).
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6.3 Glycolytic Flux Measurements
By incubating S. cerevisiae cells in high glucose concentrations, we could
assume that the Crabtree effect would cause nearly all glucose to be converted
to ethanol, instead of being diverted to the branches of glycolysis or being
further oxidised in the tricarboxylic acid (TCA) cycle [9]. For the purposes
of this study, therefore, our assumption was that glucose consumption and
ethanol production should be equivalent, albeit stoichiometrically different.
We measured the glucose consumption and the ethanol production rates
as expressions of glycolytic flux. The measured glucose consumption rate
was 0.1 to 0.13 µmol.min-1.mg protein-1 and the ethanol production rate was
measured to be 0.11 to 0.15 µmol.min-1.mg protein-1. If the mean of repeats II
and III are taken, glucose flux was 0.12 µmol.min-1.mg protein-1 and ethanol
flux 0.13 µmol.min-1.mg protein-1: a ratio of about 1:1 (see Fig. 4.13). The
models predicted a glucose:ethanol ratio closer to 1:1.5 (see Section 6.5.1): the
Teusink model predicted a glucose flux of about 0.32 µmol.min-1.mg protein-1
and an ethanol flux of 0.50 µmol.min-1.mg protein-1 (ratio 3:5), while the Du
Preez model predicted the glucose and ethanol fluxes to be 0.15 µmol.min-1.mg
protein-1 and 0.21 µmol.min-1.mg protein-1 (3:4), respectively.
We reproducibly measured flux values that were within a factor of two from
each other (Fig. 4.13). Moreover, our forward Vmax,GAPDH approximations
were all much larger than our measured flux values. This shows that
our measured approximate Vmax,GAPDH values can realistically support our
measured flux, which is a requirement for experimentally determined flux and
enzyme activities to be acceptable [35]. What remained unexplained, however,
was why our fluxes were so much lower and, in a different ratio, than the
literature values.
Albers et al. [43] experimentally measured glucose consumption and
ethanol production in S. cerevisiae X2180 cells that were grown to diauxic
shift and then challenged with 50 mM of glucose: they found a glucose
flux of about 0.3 µmol.min-1.mg protein-1 and an ethanol flux of about 0.40
µmol.min-1.mg protein-1; glycerol and acetate fluxes were comparatively very
small, as expected in high-glucose conditions [82]. Unlike the Teusink and
the Du Preez models, Albers and colleagues used the same strain at the same
temperature (30°C ) as we did. In their and our experiments, the yeast cells
were grown to diauxic shift and challenged with an excess of glucose. That
they also found a lower glucose to ethanol flux ratio (3:4) is good support
of the validity of our experimental results. However, Albers et al. [43] still
measured glycolytic fluxes that were quite a bit higher than ours.
One possible explanation could be the he Pasteur effect - the inhibition
of fermentation by oxygen. This effect is known to slow glycolysis by
diverting some of the traffic of glycolysis to the slower, higher energy-yielding
respiratory pathway downstream from pyruvate kinase [130]. The repression
of fermentation is avoided in S. cerevisiae culturing by partially sealing culture
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flasks and filling them to half or more of their total volume, making the
environment in the flask less aerobic, hence curbing the Pasteur effect (e.g.
in 43). Our culturing was done in this way, but during our flux measurements
the incubating cell suspensions were redistributed to 1.5 mL Eppendorf tubes
where the aliquots of ≤ 200 µL occupied not even 10% of the volume. It
is feasible that an increased oxygen to sample volume allowed inhibition of
glycolysis by the up-regulation of respiration. Davies and Brindle [130] showed
that aeration can lower both glucose consumption and ethanol production
rates. This might be a partial explanation of why were measured lower fluxes.
We did not measure the rate of respiration, however, for instance by measuring
oxygen consumption, so we do not have evidence for this effect. But it does
provide a hypothesis for suture studies in a similar manner.
That leaves the question of the disparity between the ratio of
glucose:ethanol between our experimental data and what was reported in
literature. A first instinct is to ascribe it to the branches of glycolysis.
Neither the a computational interrogation of the Teusink model [33], nor our
experimental results suggested that flux is redistributed to the branches in
any significant way, however. One can also see this in the fact that the %
flux only diverges for glucose consumption and ethanol production at very low
GAPDH activity (Fig. 5.8: only when flux is very low (40%), do the branches
between glucose import and ethanol export significantly impact the relative
flux of carbon so what goes in and what comes out starts to look different in
relative terms.
Interestingly, the idea of the Pasteur effect also fits with our observation of
a lower ethanol to glucose ratio than was seen by Teusink et al. [1]: exposure
to oxygen lowered the ethanol to glucose ratio to close to 1:1 in the study by
Davies and Brindle [130], which was similar to our results. This could be a
consequence of some part of the carbon flux not ending up as ethanol but being
further metabolised in the TCA cycle. This hypothesis could be confirmed by
measuring the rate of respiration, as mentioned earlier.
6.4 Disparity between Repeats
One of the recurring findings of this study was the outlier behaviour of
biological repeat I. A number of considerations led us to believe that repeats
II and III are more credible data sets.
The considerably lower protein yield of I (1.0, 7.8, and 7.6 mg.mL-1
for I, II, and III, respectively; see Section 4.2), despite the similar growth
conditions (Fig. 4.1) was puzzling. This disparity between the cultures might
be explained by an incomplete cell extraction for repeat I. This difference was
considerably lower when the protein concentrations were determined for the
preincubated lysate (0.22, 0.64, and 0.55 mg.mL-1, respectively, for I, II, and
III ).
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Under the assumption of an incomplete glass-bead protein extraction, we
considered insufficient lytic cycles (see Section 3.5; "Lysis") as a potential cause
of the extraction inefficiency. All of the samples (prelytic and otherwise) were
subjected to the extraction protocol concurrently and for the same length of
time within each biological repeat. There were a minimum number of lytic
cycles for each biological repeat, but we judged by eye when the lysis protocol
had been completed in the case of incomplete lysis after the minimum number
of cycles. It might well be that not enough time was given for the full lysis of
the yeast cells in isolate I, which was done first (hence when the experimenter
was at his most inexperienced): in this situation, a more dilute cell suspension
would see a larger percentage of its cells successfully lysed, compared to more
concentrated cell suspensions. The fact that the difference in protein yield is
less pronounced for the prelytically inhibited cells (preinh-batch, which were
more dilute during extraction) than for the larger batch (in-vitro-batch), is in
line with this hypothesis.
If a lower protein extraction efficiency is assumed, much of the disparity
in the data begins to make sense. Since equal concentrations of IAA were
added to equal volumes of the general lysate batch for the in vitro inhibition
assays, an equal inhibitor concentration would have been exposed to a lower
enzyme concentration in I. The understanding of IAA as reducing the free
enzyme concentration (Eq. 5.1.7) implies that equal concentrations of IAA
will have a much greater effect if the enzyme concentration is lower to begin
with. This might be compensated for by normalising the data to protein
yield, unless the protein concentration is so low as to yield full or nearly
full inhibition at all IAA concentrations - as was, indeed, the case (Fig.
4.3.3). In contrast to this, the prelytic inhibitor incubations take place before
lysis: the prelytically incubating enzyme concentration is therefore not yet
affected by poor extraction efficiency. Assuming that the lytic procedure does
not somehow select for cells that have been more or less strongly inhibited,
the fractional inhibition of GAPDH should not be increased by low protein
extraction efficiency (as is seen in Fig. 4.3.3).
Poor protein extraction could therefore be responsible for some aberrant
observations of repeat I. This was, however, not the full story: since the
protein concentrations determined in Section 4.2 were used to normalise the
measured fluxes as well (which are measured on whole cells), one would expect
a seven times less effective protein extraction to suggest a seven times higher
normalised flux. This was not the case - rather, the flux in I was about two
times higher than in II and III (see Fig. 4.13). This suggests that the trouble
with repeat I is more than just poor protein extraction efficiency. We could
not identify the cause of this discrepancy, and that - together with the fact
that IAA did not elicit full GAPDH inhibition at 400 µM of IAA in repeat I
even when the other repeats were fully inhibited at IAA concentrations below
200 µM - was the big consideration for treating repeat I as an outlier when
comparing the data sets.
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6.5 Model versus Experiment
6.5.1 Du Preez versus Teusink: Glycolytic Flux
One of the main aims of this study was to test the validity of two models in
their prediction of the the glycolytic flux control of GAPDH in yeast. Cvijovic
and colleagues [37] refer to the challenge of maintaining the consistency of
integrated models with respect to the original models. If the model adjustment
of Du Preez et al. [2] is regarded as an attempt to expand the predictive
capacity of the Teusink model [1], then it would be interesting to know whether
that improvement required a rebalancing of the relations between the enzymes.
In light of the asymmetry of the parameter changes made by Du Preez et al.
(for instance, the Vmax glucokinase being adjusted to 101% of its Teusink size
while Vmax,GAPDH was decreased all the way to 23.6% of its original size; [2])
it seems intuitively possible that flux control might be redistributed by the
model adjustment.
Both models were adapted to simulate the conditions of our assays: batch
culture and glucose excess, with the addition of an ethanol export step. Under
the assumption that all acetaldehyde is quickly converted to ethanol (Crabtree
effect; [9]) we set the rate constant of the acetaldehyde export step to zero.
The fluxes predicted by the adjusted models with an initial external glucose
concentration of 20 mM, were:
Table 6.1: Simulated glycolytic flux in two adapted kinetic models of yeast
glycolysis. The fluxes are measured in µmol.min-1.mg protein-1.
Glucose consumption Ethanol production
Teusink model 0.32 0.50
Du Preez model 0.15 0.21
The Teusink model simulated fluxes that were about two times larger than
the Du Preez simulations. The mean downwards adjustment of the Vmax values
by to 50% of their original sizes during the algorithmic adaptation of the
Teusink model to the Du Preez model are accounted for by an assumed Q10
value of 2, as explained in [2]. The effect was also seen in the flux, where the
20 mM of initial glucose was depleted by the Teusink model in 13 minutes,
and by the Du Preez model in 30 minutes.
6.6 Glycolytic Flux Control
To simulate GAPDH inhibition by IAA, we modified the Vmax,GAPDH values of
the original models by multiplying them with an exponential decay function
(see Fig. 4.6; [124]). Repeats II and III combined yielded the fit:
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Fractional Remaining Activity = e−0.017·[IAA] (6.6.1)
with an R2 value of 0.96. [IAA] was varied over the concentration range 0 µM
to 200 µM to simulate a GAPDH activity titration.
The predicted control coefficients were very similar for the two models
(see below). Calculating the control over ethanol production and glucose
consumption, both models predicted almost zero control for GAPDH:
Teusink:
CJGLCovGAPDH = 0.0045
CJETOHovGAPDH = 0.031
Du Preez:
CJGLCovGAPDH = 0.0068
CJETOHovGAPDH = 0.024
From these calculated control coefficients, we could conclude that Du Preez
and colleagues’ computational adjustment of the Teusink model [2] did not
significantly redistribute flux control. This is in agreement with the parameter
scan by Pritchard and Kell [33]: they varied the Vmax values of the Teusink
model in different combinations and found flux control not be significantly
redistributed by these changes. We compared the models not just for their
control coefficient at zero IAA, however, but over a range of intermediate
GAPDH activity: the models were good predictors of the experimental results
(Fig. 5.8). Together with the control coefficients, these graphs were good
evidence that the parameter adjustment by Du Preez et al. did not change
the control distribution of the original Teusink model significantly.
The slopes of the experimentally measured relative GAPDH activity and
relative glycolytic flux as functions of IAA near [IAA] = 0µM , could be used
to calculate glycolytic flux control (Figs. 5.3 and 5.6):
CJEtOHvGAPDH = 0.21
CJGLCovGAPDH = 0.032
It is striking how different the control over production and consumption
appears to be: the excess glucose in the flux incubations was expected to
initiate aerobic fermentation, during which flux through glycolysis is quick and
fermentative, and flux to the branches is limited [9]. In this case, one would
expect control over the flux of ethanol production and glucose consumption to
be very similar. Interestingly, Poolman and colleagues [22] found that GAPDH
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in S. lactis and S. cremoris had a glycolytic flux control of almost unity
(CJvGAPDH = 0.9). These organisms are also both fermentative, like yeast, and
Poolman et al. [22] measured glycolytic activity as H+ increase (pH decrease):
this is a product formation rate and hence agrees more closely to our measured
ethanol production flux rather than glucose consumption flux.
Poolman and colleagues noted that flux control is additive and that other
enzymes might have negative control that allows flux control to be more
distributed through glycolysis. The difference in control over production
and consumption must be due to branching pathways diverting some of the
glycolytic flux away from the main chain - otherwise flux through glycolysis
would be the same everywhere in the pathway [131].
Considering our application of glucose excess conditions, we did not
expect glycolytic flux to be strongly influenced by branching pathways.
However, the Pasteur effect (Section 6.3; [130]) might have contributed to
a redistribution of flux control by slowing down main-chain glycolysis and
leading to proportionally larger branch fluxes and incomplete conversion of
glucose to ethanol. This might then also contribute to a difference in the
amount of control that GAPDH can exert over the two enzymes: the presence
of significant branch fluxes will mean that carbon flux can be redirected to
the branches and kept constant at the import step, while ethanol production
slows down due to GAPDH inhibition. That the parameter scan by Pritchard
and Kell [33] did not suggest this redistribution of flux, might be due to the
fact that it was performed on the Teusink model, which has limited detail in
its branch kinetics. It might therefore be that the Teusink model cannot be
simulate this effect. The same could be true for the Du Preez model, which
also lacks some detail in its branches.
Despite this possible explanation for the higher experimental flux control
of GAPDH over ethanol production than over glucose consumption, the
possibility also exists that the experimentally determined flux control
coefficient over ethanol production is not accurate. Figure 5.8 shows both
experimental and simulated results for relative flux as a function of relative
GAPDH activity. The relative ethanol production flux lies lower than at a
given relative GAPDH activity, but the slope is not obviously steeper. It
looks plausible that the wild-type ethanol production flux is an overestimation,
which yields a high control when moving from the wild-type flux value to
the low-IAA flux values: this might, however, be an artefact and might be
corrected by simply generating more data. It is worth noting, also, that
the ethanol production curves that were fitted to the data were consistently
worse fits than the glucose consumption curves (Table 4.4 versus Table 4.5).
Ethanol is very volatile and evaporation during sampling and analysis might
be responsible for some artefacts in the data.
A repeat of the experiments and the independent measurement of
respiratory and branch flux would be able to confirm the significance of
the Pasteur effect and the contributions of the side-chains, and shed light
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on whether the higher experimentally measured control is an experimental
artefact or a true result.
6.6.1 Glycolytic Flux Control at High [IAA]
Between 40% and 20% remaining activity of GAPDH, there is sudden
precipitous decline in glycolytic flux in the model simulations and the
experimental data (Fig.5.8). This is reminiscent of the tps1∆ phenotype,
where lower glycolysis fails to keep up with upper glycolysis, leading to toxic
accumulation of the metabolites of upper glycolysis [132]. This makes sense
considering that inhibition of GAPDH, which is located directly after the
branch point of the pathway, effectively limits the maximum rate at which
lower glycolysis can use the triose phosphates coming from upper glycolysis.
If the glucose and ethanol concentrations of the models are fixed at 20 mM
and 20 mM, respectively (as in the original models), the gradual increase in the
glycolytic flux control of GAPDH seen in Fig.5.8 is replaced by a sudden and
precipitous collapse of glycolytic activity (from close to 100% flux to effectively
0% without any intermediate points; data not shown) at between 20% and
40% GAPDH activity. If the glucose and ethanol concentrations change (as
in our simulations), intermediate flux control is seen since the flux through
upper glycolysis slows down as the external glucose concentration decreases,
alleviating some of the pressure that causes upper glycolysis to be so much
more active than lower glycolysis [82]. If the organism is at very high glucose
concentrations that do not significantly decrease due to its activity (similar
to glucose clamped at high concentrations) the tps1∆ phenotype is especially
deadly, as the pressure from the oversupply of glucose remains constant.
For the batch culture conditions, the Du Preez and Teusink model
predictions and the experimental data seemed to agree in their description
of a sudden and strong increase in glycolytic flux control by GAPDH when
the enzyme is inhibited below a certain threshold point (between 20% and 40%
of its wild-type activity). This is evidence that the models are, indeed, credible
representations of steady state S. cerevisiae aerobic fermentation behaviour.
6.7 Conclusions and Future Prospects
The models by Teusink et al. [1] and Du Preez et al. [2] predicted the
glycolytic control of GAPDH as measured experimentally in this study quite
well. Unexplained differences between our experimental data and the literature
still exist: the difference of a factor three between our measured fluxes and
those measured by Albers et al. [43] on the same strain as ours; the fact
that we observed ethanol to be produced in a 1:1 ratio for every glucose
molecule consumed, as opposed to the higher ethanol yields seen by Teusink
and colleagues [1] and by Albers and colleagues [43]; and, finally, that ethanol
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production flux was calculated to be more strongly controlled by GAPDH than
glucose consumption flux. We have presented multiple possible explanations
for these findings, but in the absence of confirmatory evidence, we cannot
decisively ascribe our observations to any of them.
Despite these remaining questions, the agreement between the model
predictions and the experimentally predicted behaviour was remarkable,
particularly what is seen in Fig. 5.8. The initially weak response of glycolytic
flux to the decrease in GAPDH activity gives way to a sudden, precipitous
decline in both ethanol and glucose flux between 40% and 20% remaining
GAPDH activity. It is not unreasonable to speculate that more data might well
get rid of the discrepancy between ethanol production and glucose consumption
control, as the flux versus IAA plots are in shape very similar for production
and consumption (Figs. 4.13 and 5.8).
Measuring the glycerol and O2 production in replications of these
experiments should also shed some light on the question of whether a higher
oxygen-to-sample volume-ratio during the flux incubations elicited the Pasteur
effect [130]. This would have partially repressed fermentation and activated
respiration, hence slowing glycolysis and changing the glucose to ethanol ratio.
Measurement of the fluxes through branching pathways can illuminate whether
this was the case.
A control for the evaporation of ethanol from the flux measurement samples
should also reveal whether the volatility of ethanol had much to do with the
differences seen between glucose and ethanol flux.
The Teusink and Du Preez models are related, and benefit from almost
twenty years of investigation and validation (e.g. [16, 33, 43, 47]). The
accuracy of their predictions in this study, adds to a large accumulation of
evidence that the models are good descriptions of the steady-state glycolytic
activity of yeast cells in excess glucose conditions. It also shows that a
consistency in the relation between GAPDH and its pathway was maintained
during the model adaptation by Du Preez et al. [2]: the summation theorem
of glycolytic flux control [20] implies that this is also a partial and indirect
validation of the flux control distribution through the rest of the pathway.
IAA itself appears to have good bona fides as an experimental tool for
metabolic control analysis [128]: exposing whole cells to this irreversible,
GAPDH specific inhibitor can allow systems biologists to partially circumvent
the problem of differences in in vitro and in vivo conditions during inhibition
titration. Along with the glucose transporter, which is situated on the outside
of a cell and can be perturbed and assayed without lysing the cells, the flux
control of GAPDH can be used as a standard check for glycolytic model
validity. IAA has been used on a wide variety of organisms and can be
appropriate for any number of glycolytic models [22, 93, 101].
GAPDH, being the first enzyme of lower glycolysis, has been reported to be
involved in a number of metabolic behaviours. IAA can be used to investigate
these behaviours without the need for cell lysis before inhibitor administration.
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Production of NADH by alcohol dehydrogenase, fuelled by the capture of
acetaldehyde by cyanide, leads to a build-up in fructose-1,6-bisphosphate
(FBP) by inhibiting GAPDH activity - this FBP build-up then hypothetically
causes the increased ATP sensitivity of PFK, manifesting in glycolytic
oscillations [67]. Wolf et al. [111], also argue that NADH-ATP coupling via
the GAPDH-PGK module transduces extracellular acetaldehyde to glycolytic
oscillations, which lead to the synchronisation of oscillations. These claims
can be investigated using IAA as an inhibitor of GAPDH in whole-cells.
Most importantly of all, perhaps, IAA offers the opportunity to directly
measure the glycolytic flux control of human pathogens for which GAPDH has
been reported to be a major controlling enzyme. The glycolysis of Plasmodium
falciparum and Trypsonoma brucei, the causal agents of malaria and African
sleeping sickness, have both been suggested to be strongly controlled by
GAPDH in their blood-borne stages [10, 59], while red-blood cells have been
shown to lack clinical symptoms even upon a 95% reduction in their GAPDH
function [133]. The application of IAA to validating the predictions of high
flux control by GAPDH, can be a potentially fruitful route to rational drug
design according to the principles of network-based selectivity [79].
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Protein Concentration
Table A.1: Protein yield varied considerably between different biological repeats
but not within them. Protein concentrations, determined from assaying multiple
dilutions of the protein extract, sometimes had high standard deviations (up to 20%
of value itself). 80% accuracy was accepted as sufficiently precise for the purposes
of this study.
I
II
III
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Inhibitor Irreversibility
To confirm the purported irreversibility of IAA’s binding [21, 22, 95], cell-free
extract was incubated at 30°C in a physiological buffer according to Van Eunen
et al. [3]: one sample was incubated without any IAA and another with 400 µM
. Periodic measurements of GAPDH reaction rates, both forward and reverse,
were then taken over two hours (the inhibition incubation). This cell-free yeast
extract was then diluted to five times its original volume, and an identical 120
minute time-course assay performed (the dilution incubation). A recovery of
activity after dilution would be indicative of a reversible inhibition mechanism.
In the case of reversible binding, however, the speed of the adjustment of the
binding upon dilution might exceed the sampling rate in the assay and prevent
us from seeing the dynamics. Therefore it was considered insufficient to merely
observe the absence of an increase in activity during dilution. Preliminary
results showed 400 µM of IAA to fully abrogate GAPDH activity, while its
five-times dilution (80 µM) does not. The presence of activity (even if its
recovery is much faster than our sampling speed) would therefore be evidence
of binding reversibility.
Fig. B.1 shows the measured reaction rates as a function of time during
inhibition and dilution phase, respectively. There was a time-dependent loss of
specific activity upon IAA addition, and activity was effectively abrogated after
60 minutes of incubation (Fig. B.1 A and C ). Fig. B.1C contains significant
scatter: this scatter - which is troublesome when trends are sought - arose from
high levels of noise in the initial readings of the activity assays that are often
unavoidable when high concentrations of cell-free extract are used. For the
purposes of this assay, however, it was necessary only to ascertain that high
levels of activity remain when IAA is not added: the stark contrast between
the low-noise, low-activity data of the inhibited extract and the highly active,
very noisy data from the positive control confirmed this.
After the inhibition phase, a 5 times dilution of the extract was made:
no recovery of activity was seen over 120 minutes in the inhibitor-containing
samples, though a constant level of activity was observable in the positive
controls throughout (Fig. B.1 B and D). It followed from these results that
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IAA acted irreversibly over the time-scales that were implemented in this
study, and subsequent data are treated as such.
Figure B.1: Dilution of an inhibited cell-free extract does not reduce the effects of
IAA on GAPDH activity. GAPDH activities, both forward and reverse, are shown
as a function of incubation time after the cells were first exposed to 400 µM of the
inhibitor (A and C ), and then again after the same extract was diluted 5 times (B
and D). The red data points were administered with IAA while the blue data points
were positive controls and were incubated for the same length of time, but in the
absence of IAA. It can be seen that there is a time dependence in the effect of IAA
on the measured specific activity values. After the maximal effect has been reached,
however, dilution does not lead to a recovery in activity. The y-axis expresses specific
GAPDH activity in units of µmol.min-1.mg protein-1
.
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Non-specific NADH Oxidation
To control for residual NADH oxidation, a range of lysate dilutions was put
in the presence of a fully prepared reverse GAPDH activity assay, save for the
starting metabolite, 3-PG. Fig. C.1 shows that background activity accounted
for no more than 3% of the observed activity in an activated assay. The
influence of this background activity would henceforward be disregarded.
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Figure C.1: Non-specific NADH oxidation accounts for only a negligible
background absorbance change. Negative controls were tested at varying cell-extract
concentrations, with only the starting metabolite (PGA) omitted. The points
represent the protein concentrations that were assayed for background activity,
normalised over the same measured specific activity (approximate Vmax,GAPDH ,
horizontal red line). The Vmax,GAPDH was calculated to be 0.39µmol.min-1.mg
protein-1 - it was measured at a protein concentration of 0.003 mM.mL-1.
Background activity at various protein concentrations contribute no more than 3%
of the specific activity visible in an initiated assay.
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Vmax Segment Selection
In both the forward and the reverse directions, the segments which would be
used to calculate the reaction rate were selected manually (Figure D.1 shows
some examples to illustrate this process).
The criteria that were applied for segment selection were:
1. selected segments were all at least 30 seconds (four readings) to a minute
(seven readings) long;
2. the same segments were used within each technical replicate in the same
direction (e.g. B and C ) for consistency (see 4.3.2);
3. to avoid underestimation of Vmax , the segments all started at the first
time point, unless there was a clear initial lag in the reaction (e.g. at
31.25 µM and 62.5 µM in C );
4. if the standard deviation of the data was unstable or large, the members
of a triplicate were inspected and the member with the higher error
dropped (cleaning) - no more than one member of each triplicate was
dropped(E is an example data before discarding and F is an example of
the same data after cleaning);
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Figure D.1: Examples of selections of Vmax segments. The data in these plots are
the means of the absorbance measurements at λ = 340nm as a function of time.
The segments from which reactions rates would be calculated were selected by hand.
A to C are examples of this for reverse activity assays, while D to F are examples
of forward Vmax segment selections.
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NADH Calibration Curve
The function relating NADH concentration to absorbance at 340 nm (y =
1.30801x ( R2 = 999855); from Fig. E.1 below) was used to convert absorbance
measurements to NADH concentrations.
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Figure E.1: A good correlation exists between measured absorbance values at λ =
340nm and NADH concentration. Varying NADH concentrations were visualised
spectrophotometrically in the buffer of [3]. The experimentally constructed
calibration curve is shown in red, both the data and the linear model fit. The
fitted function was y = 1.30801x ( R2 = 999855). The dashed black line was created
by calculating the expected absorbance reading from the NADH concentrations of
the standards, the extinction coefficient of NADH, and the light path length through
100 µL of contents in a well of a Greiner F-bottom mictrotitre plate (specification
sheet available here); it has a function y = 1.89088x. The disparity between the
theoretical trend and the measured trend is not worrisome, however, since a very
reliable fit through the experimental data can be obtained.
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Inspection Error in Rate Data
Table F.1 shows the standard deviation within technical triplicates for each
reaction condition as a percentage of the the wild-type ([IAA] = 0 µM ) rate for
the same reaction condition. Data represented in red are standard deviations
more than 20% the size of the wild-type and those that are both underlined
and red are more than 30% the size of the wild-type rate. These % standard
deviations guided decisions on data that might have to be discarded due to
large error.
Using the normalised standard deviations from Table F.1 as a guide,
graphic representations of reaction rate (in µmol.min-1.mg protein-1) as
function of IAA concentration were inspected. In Fig. F.1, examples are
presented to illustrate the considerations when deciding whether to discard
data points with large standard deviations or not. No more than one point
was dropped for each set of conditions and care was taken not to obscure or
suggest trends that are not suggested by the data.
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Table F.1: Normalised standard deviations at various assay conditions suggest
possible outliers. The standard deviations of the GAPDH activity rates within
triplicates were normalised over the wild-type rate for each reaction condition.
Points with a standard deviation 20% the size of the wild-type rate are presented in
red, while points with a standard deviation 30% the size of the wild-type rate are
presented in red and underlined. The three tables - I, II, and III - represent the
three biological repeats.
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Figure F.1: Examples of inspected plots of GAPDH activity as a function of
IAA concentration. These examples illustrate the approach taken to discarding or
retaining data with large error. The red data points were dropped after inspection -
no more than one point was dropped for each set of conditions (e.g. from the assay
that was DTT-containing, measured in the forward direction, and from biological
repeat I ). A (see Table F.1A) showed standard deviations that were more than
30% of the wild-type activity, but the data point with the large error fell exactly
into the trend created by the other points. B had a very clear trend encompassing
all the data points and had standard deviations lower than 20% of the wild-type
activity in all cases. The points dropped from C and D were dropped from their
respective sets because they had standard deviations which were greater than 30%
of their respective wild-type rates and they would suggest trends that might not be
suggested in their absence.
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Ethanol Detection: Calibration
Curve Construction
Absorbance measurements (see Appendix H) were converted to ethanol
concentrations using a calibration curve (Fig. G.1). The linearity of the
experimental calibration curve and its consistency over multiple iterations
with the same concentration range (complete data not shown) confirmed that
ethanol concentration is predicted reliably by this method, though it does
not strictly correspond to the Beer-Lambert equation. It was concluded that
any under-detection of ethanol concentrations is uniform for a given set of
experimental conditions. This would imply that possible under-sensitivity
to sample ethanol concentrations would be compensated for by equivalent
under-sensitivity to known standard ethanol concentrations.
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Figure G.1: An ethanol determination calibration curve shows high agreement
with experimental data. End-point absorption values, at 340 nm, of ADH-catalysed
conversion of ethanol and NAD+ to pyruvate and NADH. The ADH is from S.
cerevisiae . The red points indicate the means and standard error of triplicate reads
of a set of standards. The solid red line represents the best-fitting linear function
(y = 1.04x, R2 = 0.997) on the experimental means. The dashed black line indicates
the function which would be expected if the Beer-Lambert law were perfectly obeyed
(y = 1.9x).
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Ethanol Determination -
Plateau Selection
Theoretically, only end-point reads should be required for ADH-dependent
ethanol determination. The plateaus after full conversion, however, exhibited
some instability which could cause misestimations if only single end points were
read. Hence, absorbance reads at 340 nm were taken over time until a plateau
was observed and then for another 30 minutes to an hour. A segment of this
plateau which is sufficiently flat was then selected by inspection: the average
absorbance reading over this segment was taken as the end point for the read
(Fig. H.1). This segment was kept constant over all ethanol determinations
within each technical replicate.
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Glucose Detection: Calibration
Curve Construction
The absorbance measurements that were used for glucose determination
had very little error. This supports the validity of the concentrations
determinations very stongly. In Fig. I.1A, one of these sets of absorbance
data is presented. Figure I.1B shows the calibration curve that was used
to convert absorbance readings into glucose concentrations. Though the
gradient of the calibration curve does not correspond to the theoretical function
according to the Beer-Lambert Law, multiple iterations of this curve (data not
shown) consistently showed very similar gradients, confirming the method as
a reproducible concentration determination assay.
121
Stellenbosch University https://scholar.sun.ac.za
APPENDIX I. GLUCOSE DETECTION: CALIBRATION CURVE
CONSTRUCTION
Figure I.1: Glucose determination. A shows an example of raw absorbance data as
a function of time and the selection of a linear segment (shaded area) of which the
average will be used as the end-point value. The time-course data in A come from
yeast cells inhibited with 50 µM IAA. B is a comparison between a experimentally
generated calibration curve (y = 1.43x;R2 = 0.9996) and the theoretical curve
according to the detection assay’s stoichiometry and the Beer-Lambert law (y =
1.89x). The experimentally constructed curve has a different gradient than what was
calculated using the extinction coefficient of NADH, the concentrations of glucose
added (assuming full conversion of glucose), and the path length of 100 µL of liquid
in a well of a Greiner F-bottom plate (specification sheet available here). The
experimentally constructed calibration curves were consistent and had very little
error in all cases, however, and are considered reliable.
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Model Predictions: GAPDH
Metabolite Changes
Fig. J.1 shows the time evolution of the model variables (metabolite
concentrations) for the duration of the simulation. The simulation is the final
simulation as we used it for the prediction of metabolic flux control, but at
a IAA concentration of 0 µM. The ratio between the internal and external
volumes is 1:50 and concentrations were adjusted accordingly.
This time evolution serves to show how the changes in external glucose
and external ethanol concentrations were the products of changing internal
metabolite concentrations. A peculiarity of the simulation appears to be the
fact that the ethanol concentrations inside and outside the cell are the same.
This can be understood in terms of the diffusion rate of ethanol across the
yeast cell envelope being so free and quick that the trans-envelope ethanol
concentration is constantly in equilibrium [127].
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